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ABSTRACT 
 
Retinoblastoma-Binding Protein 4 (RBBP4) is a chromatin adaptor protein that 
associates with numerous activating and repressive chromatin regulatory complexes. 
RBBP4 is overexpressed in human gliomas, and has been shown to promote survival of 
GBM cells and p300-dependent expression of DNA repair genes (Kitange et al., 2016). 
We previously established a zebrafish RB-defective neural progenitor-like brain tumor 
model (Solin et al., 2015) and recently found Rbbp4 is highly upregulated in the RB- 
brain tumors. Here we demonstrate Rbbp4 is essential for zebrafish brain development 
and show it has distinct requirements in neural stem and progenitor cells. CRISPR/Cas9 
targeting was used to isolate a 4 base-pair frameshift mutation in the zebrafish homolog 
rbbp4. Homozygous mutant rbbp4Δ4/Δ4 are lethal at approximately 5-7 days post 
fertilization and show a dramatic reduction in the size of the brain and retina. 
Overexpression of rbbp4 cDNA in a Tg(Tol2<ubiquitin:rbbp4>) transgenic line rescues 
the rbbp4 mutant phenotype, demonstrating disruption of neurogenesis in rbbp4Δ4/Δ4 
homozygotes is due to lack of functional Rbbp4. Beginning at 2 days post fertilization, γ-
H2AX and activated caspase labeling was detected in post-mitotic regions in the larval 
midbrain and retina, suggesting RBBP4 is required to prevent DNA-damage and 
apoptosis in neural progenitors or newborn neurons. γ-H2AX and caspase were not 
detected in the stem cell niches at the brain ventricle or retinal ciliary marginal zone, 
however, stem cell morphology was abnormally large. Pulse chase BrdU labeling 
experiments confirmed a delay in stem cell proliferation and a lack of survival of post-
mitotic neural progenitors. TP53 morpholino knockdown in rbbp4Δ4/Δ4 homozygotes 
transiently suppressed neural progenitor apoptosis, indicating the absence of Rbbp4 
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activates TP53-dependent programmed cell death. Together these results suggest distinct 
requirements for Rbbp4 in neural stem cell proliferation and neural progenitor survival. 
Overall, our results indicate RBBP4 may drive RB-defective brain tumor growth by 
promoting proliferation and preventing DNA damage induced apoptosis of tumor cells.
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CHAPTER 1.  INTRODUCTION 
General Introduction 
In the influential paper by cancer researchers Douglas Hanahan and Robert 
Weinberg, the hallmarks of cancer are defined as the ability to sustain proliferative 
signaling, evasion of growth suppressors, resistance to cell death, replicative immortality, 
induction of angiogenesis, activation of invasion and metastasis, and enabling genome 
instability and mutation (Hanahan and Weinberg, 2011). In addition to these core 
hallmarks, the view of cancer as a misappropriation of normal developmental processes is 
also an important notion in the attempt to understand cancer (Aiello and Stanger, 2016). 
Development is a unique period when cells are highly dynamic and undergoing broad 
changes including proliferation, cell cycle exit, migration, and differentiation. These 
processes are normally tightly controlled by signaling molecules and genetic regulation at 
the transcriptional and epigenetic level. However, in the progression of tumorigenesis 
these processes become re-activated and dysregulated to promote the development of a 
tumor which can itself be seen as a complex organ consisting of different cell types with 
different functions.  
The classic approach to studying cancer has been the use of mouse models 
containing genetic mutations in a few key genes. The problem with this approach is that 
often times the mouse models display different phenotypes than what is observed in 
humans. This underlines the limitations in relying solely on one model to understand the 
mechanisms of tumorigenesis. The zebrafish is coming to the forefront as a viable and 
useful model organism in which to study cancer (Mione and Trede, 2010). Zebrafish are 
highly fecund and produce large clutches of transparent embryos that can be closely 
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followed during development. Additionally, a fully sequenced genome and numerous 
genetic resources including cutting edge CRISPR/Cas9 technologies make zebrafish an 
ideal alternate model in which study cancer. Therefore, the approach of this dissertation 
is a two-prong effort to understand the mechanisms specifically involved in the initiation 
of tumorigenesis in the zebrafish model. The use of both germline and somatic 
mutagenesis has allowed for the study of undifferentiated neural tumors in the adult 
zebrafish. This has provided a model for understanding how signaling molecules like 
Leptin and the tumor suppressor Rb1 contribute to phenotypically similar human 
pediatric brain tumors. Additionally, this work has been expanded on by examining the 
role of a candidate oncogene, Rbbp4, in the normal neural developmental process. By 
understanding how the inactivation of Rbbp4 affects development we can gain insight 
into how dysregulation of this gene contributes to the initiation of tumorigenesis. 
Literature Review 
Leptin 
Leptin was discovered in the 1990’s as the cause of the obesity phenotype seen in 
ob/ob mice (Zhang et al., 1994).  It was determined to be a master regulator of appetite 
and energy homeostasis, being secreted from adipose tissue and having its signal 
transduced through its receptor in the hypothalamus (Friedman and Halaas, 1998).  The 
functions of Leptin are mediated through interaction with its receptor which activates 
several pathways including the JAK/STAT, PI3K/AKT, and MAPK pathways, all of 
which are implicated in cell growth and proliferation (Banks et al., 2000) (Donato et al., 
2010) (Sweeney, 2002).  It has received a great deal of attention for its role in metabolic 
disorders such as obesity, however, additional studies have elucidated roles for leptin in 
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processes such as angiogenesis (Sierra-Honigmann et al., 1998b), lipid and glucose 
metabolism (Bryson et al., 1999), wound healing (Tadokoro et al., 2015), and immunity 
and inflammation (Fernández-Riejos et al., 2010). Furthermore, Leptin expression has 
been detected in tissues other than adipose tissue such as placenta (Cameo et al., 2003), 
stomach (Bado et al., 1998), skeletal muscle (Wang et al., 1998) and several areas of the 
brain including cortex, cerebellum, and pituitary (Morash et al., 1999).  
Given that Leptin’s involvement in numerous key physiological processes and in 
the regulation of cell growth and proliferation, it is not surprising that Leptin has recently 
been implicated in progression of many cancers. For instance, up-regulation of Leptin 
expression has been found in breast (Ishikawa et al., 2004) (Andò et al., 2014), colon 
(Uddin et al., 2014), and prostate (Habib et al., 2015) cancers. Many of the studies 
examining Leptin’s role in cancer have found that is often associated with increased 
aggressiveness and worsened prognosis. These studies have reported that Leptin’s role in 
cancer progression is through promotion of invasiveness (Attoub et al., 2000), epithelial-
to-mesenchymal transition (Andò et al., 2014), proliferation (Konopleva et al., 1999), cell 
survival and suppression of apoptosis (Somasundar et al., 2004), and finally increased 
angiogenesis in concert with VEGF (Ambrosini et al., 2002). Much of the current 
research on Leptin focuses on the relationship between obesity and cancer and the role 
Leptin plays in this connection. Many studies hypothesize that Leptin levels seen in 
cancer, particularly in an obese subject, are controlled by de-regulated signals such as 
insulin, glucocorticoids, or feedback loops of the sympathetic nervous system 
(Somasundar et al., 2004).  
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However, there is another mechanism by which Leptin levels are altered which 
may also play a role in the changes seen in Leptin in cancer. Specifically, Leptin has been 
shown to be a hypoxia-responsive gene, containing a HRE (hypoxia responsive element) 
in its promoter sequence which allows its expression to be altered by HIF-1α in response 
to decreased oxygen levels (Ambrosini et al., 2002). Research has shown that Leptin 
responds to hypoxia in several different tissues, including smooth muscle cells (Chiu et 
al., 2015) and alveolar epithelial cells (Chen et al., 2015). Additionally, increased Leptin 
expression has been seen in several glioblastoma cell lines (Morash et al., 2000) (Ferla et 
al., 2011) (Yeh et al., 2009), and its expression has been correlated with increased 
malignancy in brain tumors (Riolfi et al., 2010). This is of particular interest because 
malignant gliomas are known to contain areas of hypoxia within the central core of the 
tumor mass. These hypoxic areas show features typical of hypoxic response such as 
secretion of cytokines and growth factors that promote angiogenesis (Evans et al., 2004), 
maintenance of cancer stem cell populations (Irshad et al., 2015), and changes in 
metabolism favoring glycolysis over oxidative phosphorylation (Kucharzewska et al., 
2015). Therefore, it is possible that in transformed glial cells within the hypoxic core, 
decreased levels of oxygen drive expression of Leptin, which in concert with other 
factors such as VEGF, promote changes in growth, metabolism, and apoptosis allowing 
the tumor to not only survive in hypoxic conditions, but also giving it a growth and 
metastatic advantage. Specifically, one study has shown an increase in Leptin in response 
to radiation in colon cancer cells (Suman et al., 2015). It can be surmised that Leptin 
confers apoptotic resistance to radiation, allowing for selection of increasingly resistant 
cells with treatment. 
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Retinoblastoma 1 
A search of RB1 (Retinoblastoma 1) can find it referred to as the master cell cycle 
regulator, gatekeeper of the cell cycle, or major tumor suppressor. It is understandable 
given its history why RB1 is usually so narrowly categorized. It was initially discovered 
that mutations in RB1 served as the genetic basis of familial and sporadic retinoblastoma 
(Knudson, 1984). In these cases, when RB1 function is lost either though an inherited 
mutant allele or sporadic mutation, patients develop bilateral tumors of the retina before 
adulthood. Furthermore, patients with germline RB1 mutations show an increased risk for 
developing small cell lung cancer and osteosarcoma and later in life (Weinberg, 1995) 
(Wistuba et al., 2001) (Marees et al., 2008). It was through his initial studies of RB1 and 
retinoblastoma that Alfred Knudson developed his “two hit” theory of how mutations in 
tumor suppressor genes could cause predispositions to cancer and the idea of the tumor 
suppressor was born (Knudson, 1971) (Comings, 1973).  
 Initial molecular studies identified a straightforward and overarching role for RB1 
in regulation of the cell cycle (Weinberg, 1995) (Goodrich et al., 1991). It was discovered 
that hypophosphorylated pRB binds to and inhibits E2F family members and prevents the 
expression of genes necessary for progression of the cell cycle (Classon and Harlow, 
2002) (Hiebert et al., 1992). Upon mitogenic signals, cyclin dependent kinases 
phosphorylate pRB which then releases E2Fs and allows for transcription of cell cycle 
genes and the progression of G1 to S phase (Mittnacht, 1998). Continuing through the 
cell cycle, upon mitosis pRB is re-activated (de-phosphorylated) by PP1 (Kolupaeva and 
Janssens, 2013). Numerous studies have shown that loss of pRB leads to excessive 
proliferation (Lipinski et al., 2001) (Sidle et al., 1996) as well as inappropriate re-entry of 
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both stem and differentiated quiescent cells into the cell cycle (Mayhew et al., 2005) 
(Sage et al., 2003) (Burkhart and Sage, 2008). 
 While it is tempting to focus on the paradigm of phosphorylation of pRB as a 
master switch for G1 to S phase, a close examination of the structure of pRB give the first 
insights that there is more to the story than simple repression of E2F transcription factors. 
Human pRB contains three main domains: an amino terminal domain (RBN) consisting 
of cyclin folds (Hassler et al., 2007), a central pocket domain consisting of an A and B 
subdomain (Lee et al., 1998), and in intrinsically disordered carboxy-terminal domain 
(Rubin et al., 2005). The pocket domain is the most important interaction domain for 
pRB and gives the first clues to the function of pRB beyond E2F inactivation. The pocket 
domain contains two binding regions; the E2F transactivation domain which binds E2F 
factors (Lee et al., 2002) (Xiao et al., 2003) as well as an L-X-C-X-E binding cleft which 
has been shown to mediate interaction between pRB and chromatin modifying enzymes 
and viral proteins (Kim et al., 2001) (Morris and Dyson, 2001). Importantly, pRB can 
interact with multiple binding partners simultaneously through these different domains 
making it function more as an adaptor rather than a simple inhibitor (Dick and Rubin, 
2013) (Goodrich, 2006). In fact, pRB has been shown to have over 150 different 
interacting partners (Chinnam and Goodrich, 2011). Thus pRB can interfere with E2F 
both through binding and inhibiting formation of transcription initiation complexes, but 
also through association of various chromatin modifying complexes at particular 
promoter sites to alter chromatin structure.  
 As mentioned above, studies have shown that pRB can interact physically with 
several different chromatin modifying proteins through its L-X-C-X-E binding cleft 
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(Frolov and Dyson, 2004). Experiments have shown that this interaction is not necessary 
for pRB to regulate transition from G1-S phase (Isaac et al., 2006), suggesting roles for 
these interactions in modulating RB function beyond cell cycle control. It has been long 
known that pRB and the histone deacetylases HDAC1 and HDAC2 form a complex 
(Brehm et al., 1998) (Luo et al., 1998) (Magnaghi-Jaulin et al., 1998). As deacetylation is 
associated with closed/transcriptionally inactive chromatin it is thought that pRB serves 
to bring HDAC1/2 to specific (usually E2F associated) locations on the genome and 
promote gene silencing (Brehm and Kouzarides, 1999). The functionality of this 
interaction has been supported by studies that have shown treatment with the HDAC 
inhibitor trichostatin A does lead to inhibition of pRB repression at some promoters (Luo 
et al., 1998). Additional studies in mouse embryo fibroblasts (MEFs) show that loss of 
pRB leads to a more open, accessible chromatin structure again supporting the idea that 
pRB in association with chromatin remodelers plays a role in transcriptional repression 
(Trouche et al., 1996). Furthermore, the DNA methyltransferase DNMT1 has also been 
found, in complex with RB/E2F1/HDAC1, to promote DNA methylation and silencing 
(Robertson et al., 2000). Additionally, pRB is known to interact with the histone 
methyltransferase SUV39H1 which methylates lysine 9 of histone H3 (Nielsen et al., 
2001) (Vaute et al., 2002) and Suv4-20h1 and Suv4-20h2 which trimethylate H4K20 
(Gonzalo et al., 2005). The methylation of histones promotes spreading of 
heterochromatin and gene silencing (Spencer and Davie, 1999). Recent studies have also 
shown that pRB can form a complex with histone methyltransferase enhancer of zeste 
homolog 2 (EZH2), a component of the Polycomb Repressive Complex, to promote 
H3K27me3 and thus silencing of repetitive elements in the genome such as transposons, 
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LINEs, and SINEs (Ishak et al., 2016). In addition to repressors, pRB has also been 
shown to interact with HBRM and BRG1 which are part of the ATP-dependent 
remodeling complex SWI/SNF (Dunaief et al., 1994) (Strober et al., 1996) (Trouche et 
al., 1997). This complex uses helicase and ATPase to unwind DNA and make it more 
accessible thereby activating gene expression (Cairns, 1998). Thus, pRB can participate 
in the activation of gene expression through chromatin remodeling which may be relevant 
in its role promoting differentiation. As will be discussed below, many of these 
interactions mediate the diverse array of roles pRB plays in various different cellular 
processes beyond just control of the cell cycle. 
 In addition to its canonical role in regulation of the cell cycle, pRB is also 
involved in regulation of many other processes that suppress tumorigenesis including 
senescence, genome stability, and differentiation. Senescence is the process whereby a 
cell permanently withdraws from the cell cycle due to stress and is an important barrier to 
cellular immortalization and transformation (Prieur and Peeper, 2008). Studies have 
shown that pRB plays a crucial role in the initiation and maintenance of senescence 
(Chicas et al., 2010) (Dannenberg et al., 2000) (Sage et al., 2000) (Ben-Porath and 
Weinberg, 2005). One of the ways it most likely does this by aiding in the formation of 
senescence associated heterochromatin foci and overall reorganization of the chromatin 
into a less permissive state (Talluri et al., 2010).  
Maintenance of genome stability as well as the ability to detect and repair DNA 
damage is another important process in the prevention of cellular transformation 
(Knudsen et al., 2006). Loss of pRB leads to aneuploidy and other chromosomal defects 
in mouse ES cells or human primary fibroblasts (Zheng et al., 2002) (Amato et al., 2009). 
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pRB contributes to genome stability  through the repression of the E2F target gene 
MAD2 which is a mitotic checkpoint gene that has been shown to cause chromosomal 
instability when overexpressed (Schvartzman et al., 2011) (Kabeche and Compton, 
2012). Additionally, experiments have shown that triple knockouts of all three pocket 
proteins leads to decreased methylation, tangled chromosomes, and aneuploidy (Gonzalo 
et al., 2005). pRB has also been shown to be a binding partner of Condensin II 
(Longworth et al., 2008) and upon pRB loss defects in condensin loading and 
subsequently chromosome condensation are observed (Manning et al., 2010) (Coschi et 
al., 2010) (van Harn et al., 2010). Mutations in the LXCXE which inhibit pRB 
interactions with chromatin remodelers also leads to chromosomal defects (Isaac et al., 
2006), further indicating that pRB mediates its effect on genome stability primarily 
through its interaction with chromatin remodelers.  
pRB is also well known to influence cellular differentiation, which is the process 
whereby precursor or progenitor cells exit the cell cycle and undergo global alterations in 
gene expression to activate genes that promote the function and morphology of the 
mature cell type  (Korenjak and Brehm, 2005) (McClellan and Slack, 2007) (Nguyen and 
McCance, 2005). Several studies have demonstrated that pRB interacts with different 
transcription factors to promote cellular differentiation. For instance, pRB interacts with 
MyoD to promote muscle differentiation (Gu et al., 1993), GATA1 to promote 
erythrocyte differentiation (Kadri et al., 2009), CBFA1/RunX2 to promote bone 
differentiation (Thomas et al., 2001), and C/EBP to promote adipocyte differentiation 
(Chen et al., 1996). Furthermore in plants, loss of pRB homolog actually causes failures 
in differentiation rather than proliferation  (Borghi et al., 2010). In mice it has been 
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shown that pRB loss leads to defect in differentiation as well (Zhang et al., 2004a) 
(Papadimou et al., 2005). Clearly, pRB doesn’t just regulate the cell cycle; instead it is an 
important master regulator that integrates signals about genome integrity, differentiation 
status, and response to stress and helps the cells respond appropriately to these 
conditions. 
 While many of the observed functions of pRB play an obvious role in tumor 
suppression, pRB does have a paradoxical role in apoptosis that would suggest an 
oncogenic effect (Indovina et al., 2015). Many studies have reported an increase in 
apoptosis, particularly in differentiating rather than cycling cells, upon the loss of pRB 
(Chau and Wang, 2003) (Khidr and Chen, 2006) (Wang et al., 2010a). Studies have also 
found that the loss of pRB leads to increased apoptosis and sensitivity to anti-cancer 
agents and UV radiation (Ishii et al., 1997) (Zagorski et al., 2007) (Sharma et al., 2007) 
(Biasoli et al., 2013) (Chau et al., 2006) (Agerbaek et al., 2003). This controversial 
activity seems to be based primarily on a specific pattern of phosphorylation of pRB and 
its interaction with E2F family member E2F1. E2F1 has been shown to bind to pro-
apoptotic gene promoters and induce their expression in response to DNA damage 
(DeGregori et al., 1997) (Trimarchi and Lees, 2002). Furthermore, E2F1 displays a 
unique interaction with pRB through binding to the RBC c-terminal domain rather than 
the pocket domain (Dick and Dyson, 2003) (Julian et al., 2008) (Seifried et al., 2008). 
Models have been proposed whereby during normal progression through the cell cycle, 
phosphorylated pRB can still bind E2F1 and block expression of genes involved in 
apoptosis while at the same time permitting progression through cell cycle (Wells et al., 
2003) (Cecchini and Dick, 2011) (Calbó et al., 2002). However, upon DNA damage pRB 
11 
 
and E2F1 undergo a series of post-translational modifications by ATM and CHEK1/2 
allowing for the formation of pRB/E2F1/p300/CBP activating complexes at promoters of 
apoptotic genes (Korah et al., 2012)  (Avni et al., 2003) (Munro et al., 2012). However, 
additional research suggests that pRB also has a pro-apoptotic interaction with E2F1 by 
inducing its acetylation and activation (Ianari et al., 2009) (Carnevale et al., 2012). 
Additionally, some studies suggest that active, hypo-phosphorylated pRB can actually 
promote apoptosis in some circumstances (Day et al., 1997) (Wagner and Roemer, 2005) 
(Bowen et al., 2002). Overall, the observation of whether or not loss of pRB contributes 
to increased apoptosis is context dependent and may also be dependent on the type of 
mutation. For instance, increases in apoptosis are often observed in mutants with null 
mutations in RB1 rather than mutants with defects in phosphorylation or regulation of 
pRB (Delston and Harbour, 2006). This could explain the puzzling observation that many 
mutations in RB1 occurring in tumorigenesis are in the regulation of its phosphorylation 
rather than direct null mutant as the tumor cells are selecting for mutations that maintain 
suppression of apoptosis (Chau and Wang, 2003). Clearly, there is still much to be 
elucidated about the role pRB plays in apoptosis which is a critical barrier to the 
formation of transformed cells.  
 Given all of the roles pRB plays in normal cellular processes, what does this 
indicate in terms of its role in promoting or preventing tumor formation? One observation 
is that the effect of loss of pRB on tumor formation is highly context dependent. For 
instance, as mentioned above, germline loss of RB1 only leads to cancers in certain 
tissues with regularity even though pRB or pathway regulating it is mutated/dysregulated 
in almost all cancers (Sherr, 1996) (Knudsen and Knudsen, 2008) (Hanahan and 
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Weinberg, 2000). In the case of retinoblastoma, osteosarcoma, and small cell lung cancer 
RB1 clearly plays a crucial role in homeostasis in those cell types and loss of RB1 
appears to be an initiating event (Knudson, 1984). However, most other cancers mutation 
in RB1 is a late event in the progression of transformation (Burkhart and Sage, 2008). 
This may be due to the fact that it does contain paradoxical oncogenic effects which may 
be beneficial to early tumors and only when other pathways have been deactivated, like 
p53, are RB1 mutations helpful (Sherr and McCormick, 2002). Whether it plays a role in 
promoting de-differentiation of more mature cells or promoting excess proliferation in 
stem and progenitor cells that already contain the potential to divide or both remains to be 
determined.  
 There have been several null alleles of RB1 generated in different species with the 
intent of studying both the mechanistic role of pRB in normal cellular processes as well 
as its role in tumorigenesis. In early mouse models containing an Rb1 null allele, 
homozygotes were embryonic lethal at approximately 15 days post conception and 
displayed abnormal proliferation, defects in erythropoiesis, and apoptosis in the nervous 
system, lens, and skeletal muscle (Clarke et al., 1992) (Jacks et al., 1992) (Lee et al., 
1992) (Chau and Wang, 2003). However, while heterozygous and chimeric mice did 
develop pituitary tumors, they did not develop retinoblastoma as is the case in humans. 
Furthermore, several follow up studies have suggested placental defects as a possible 
contributing factor to the observed embryonic apoptosis (Wu et al., 2003) (de Bruin et al., 
2003). Due to the confounding placental effects and the lack of observed retinoblastoma, 
in the intervening years many conditional and tissue specific Rb1 alleles have been 
generated in mice. In particular, when Rb1, pocket protein p107, and tumor suppressor 
13 
 
p53 are ablated in mice models the animals do develop retinoblastoma (Zhang et al., 
2004b).   
The zebrafish rb1 gene shows 67% homology to the human and mouse RB1/Rb1. 
The first rb1 null alleles generated in zebrafish were named space cadet (Gyda et al., 
2012). In fish homozygous for these alleles, retinal ganglion cell (RGC) precursors 
displayed delayed cell cycle exit and subsequent defects in post mitotic RGC axon 
guidance, retinotectal connectivity, and phototactic defects. Unlike Rb1 null mouse 
models, homozygous rb1 null zebrafish embryos did not display embryonic apoptosis, 
which is possibly due to the fact that zebrafish larvae develop externally with maternal 
RNA possibly rescuing early gene loss phenotypes. However, homozygous embryos did 
fail to survive past approximately 10 days post fertilization (dpf) due to the failure 
develop swim bladders which zebrafish need to swim and feed properly. Thus, the rb1- 
homozygotes are larval lethal and could not be tracked for the development of juvenile 
retinoblastoma.  Recently, our group showed that injection of the genome editing 
nuclease TALEN RNA targeting rb1 leads to somatic inactivation of rb1. F0 animals 
survive to adulthood and 11-33% develop undifferentiated, primitive neuroectodermal-
like tumors starting at approximately 3 months of age. Another recent study has also used 
TALENs to generate germline rb1 null alleles in zebrafish (Zhang et al., 2018). This 
study focused on lymphocytes and found that loss of rb1 led to early lymphocyte 
apoptosis due to elevated caspase-3. Similar to results mentioned above, these results 
suggest rb1 plays a role in inhibiting E2F1-driven apoptosis. While there has been a great 
effort recently in using zebrafish to model cancer (Shive, 2013) (White et al., 2013), there 
is still much to be learned from studying loss of rb1 in zebrafish beyond just retinal or 
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lymphocyte phenotypes. Detailed explanations of how loss of RB1 affects proliferation 
and function of neural progenitors leading to both developmental defects and 
tumorigenesis remain to be fully elucidated.    
Primitive neuroectodermal tumors 
As mentioned above, somatic inactivation of rb1 in zebrafish results in 
undifferentiated tumors similar to human primitive neuroectodermal tumors of the central 
nervous system (CNS-PNET). This class of brain tumors is usually present in children, 
though can present in adults, and makes up approximately 3-5% of all pediatric brain 
tumors (Pizer et al., 2006). These tumors are defined by small, poorly differentiated or 
undifferentiated embryonal cells that can differentiate into both neural and glial subtypes 
(Louis et al., 2007). CNS-PNETs are aggressive tumors and the 5-year survival rate is 
only 48-73% (Jakacki et al., 2015). A major obstacle in understanding and treating CNS-
PNETs is the difficulty in defining and categorizing tumor types. Early studies by Picard 
et al used gene expression, copy number, and immunohistochemical data to define three 
main CNS-PNET subtypes (Picard et al., 2012). These include the primitive-neural 
subtype which displays high LIN28 expression and is generally highly aggressive; the 
oligoneural subtype displays high OLIG2 expression and is seen in older children; and 
the mesenchymal subtype shows low OLIG2 and LIN28 expression, increased 
metastases, and is present in all ages. However, a more recent analysis combining data 
from gene expression, genome-wide sequencing, copy number, histopathology, and DNA 
methylation analyses categorized CNS-PNETS into four subtypes (Sturm et al., 2016b). 
In addition to our recent work, other studies in zebrafish have shown that activation of the 
RAS/MAPK pathway in oligoneural precursor cells leads to oligoneural subtype-like 
15 
 
brain tumors expressing Olig2 and Sox10 (Modzelewska et al., 2016). Clearly, additional 
work is needed to understanding the molecular mechanisms driving transformation of 
early progenitor and precursor cells in the brain resulting in the formation of CNS-
PNETs. 
Retinoblastoma binding protein 4 
RBBP4 (Retinoblastoma Binding Protein 4) and its homolog RBBP7 
(Retinoblastoma Binding Protein 7) are WD40 repeat proteins that share a 90% identical 
amino acid sequence. While these two proteins do exist in certain complexes together, 
they appear to have distinct functions. For example, RBBP7 is exclusively associated 
with the HAT1 (histone acetyltransferase) (Verreault et al., 1998), while RBBP4 is 
exclusively associated with the CAF-1 (chromatin associated factor 1) complex 
(Verreault et al., 1996). Much of the research to date on these homologous proteins has 
focused on RBBP4 which is highly conserved from plants, nematodes, yeast, drosophila, 
and zebrafish among others, and in fact it shows 100% amino acid sequence homology 
between mouse and human (Qian and Lee, 1995).  
RBBP4 contains an n-terminal alpha helix, seven WD40 repeats forming a seven 
blade β-propeller structure, and a one turn helix c-terminus (Song et al., 2008). While the 
protein itself does not contain enzymatic activity, there are two known binding sites 
where it binds to a diverse array of interactors (Gururaja et al., 2002). First is the binding 
pocket formed at the side of the propeller structure formed by the n-terminal alpha helix 
and binding loop emerging from seventh blade (Song et al., 2008). This is most notable 
for binding the n-terminal helix 1 of histone H4. This binding pocket has also been shown 
to bind the SUZ12 subunit of PRC2 (polycomb repressive complex 2) (Nowak et al., 
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2011b) and the MTA1 subunit of the NuRD (nucleosome remodeling deacetylase 
complex) (Lejon et al., 2011).  Additionally, there is a channel on the top of the b-
propeller structure that has been shown to bind un-methylated histone H3 (Song et al., 
2008) and the transcriptional regulator FOG-1 (Lejon et al., 2011). And while RBBP4 
can bind H3 or H4 individually, it can also bind H3/H4 dimers (Murzina et al., 2008) 
(Zhang et al., 2013). The presence of multiple binding sites as well as its affinity for 
histones H3 and H4 has given RBBP4 the designation as an adaptor protein that serves to 
tether or locate specific chromatin modifying complexes to the chromatin. 
While the specific nature of all of the binding interactions may not be known, a 
large body of research has shown that RBBP4 interacts with a wide array of different 
partners (Wolffe et al., 2000). As its name suggests, RBBP4 was first identified when it 
co-immunoprecipitated with RB1 in HeLa cell lysates (Qian and Lee, 1995). RBBP4 
likely interacts with the c-terminus of un- or hypo-phosphorylated RB1 (Qian et al., 
1993) (Qian and Lee, 1995). It has been further shown that RBBP4 complexes with 
RB1/HDAC1/E2F1 and appears to help mediate RB1-based suppression of E2F 
promoters (Nicolas et al., 2000) (Nicolas et al., 2001). However, contrary evidence has 
shown that the formation of this complex is dependent on the LXCXE binding domain of 
RB1, suggesting that the interaction between RB1 and RBBP4 is indirect and mediated 
by HDAC1 (Nicolas et al., 2000). Further evidence has also suggested that de-regulated 
E2F activity, as in the case of tumor cells with RB1 deficiency, actually promotes the 
increased expression of RBBP4 via GC repeat sites in the RBBP4 promoter region 
(Kitamura et al., 2015). 
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The association of RBBP4 with HDACs (histone deacetylases) is well 
documented and it has been found as part of several repressive histone deacetylating 
complexes including the Sin3 complex (Vermaak et al., 1999) and the NuRD complex 
(Xue et al., 1998) (Zhang et al., 1999) (Millard et al., 2016). The Sin3 complex contains 
HDAC1, HDAC2, SAP30, SAP18, and both RBBP4 and RBBP7 (Alland et al., 1997). 
This complex is recruited to specific regulatory sites by DNA-binding proteins and co-
repressors such as Mad-Max to mediate gene silencing (Ayer et al., 1995). RBBP4 is also 
a component of NuRD which is a major co-repressor complex. The NuRD complex 
contains CHD3 and CHD4 which are ATP-dependent helicase chromatin remodelers, 
HDAC1 and 2, MBD2 which binds CpG methyl domains, MTA1, 2, and 3 which target 
the complex to different genomic locations, and finally RBBP4 and RBBP7 (Allen et al., 
2013). The multi-combinatorial subunits of the NuRD complex allow it to perform 
various functions in different cellular contexts. It is especially critical in embryonic 
development and in particular in promoting proper cellular differentiation (Ahringer, 
2000) (Yoshida et al., 2008) (Denslow and Wade, 2007) and it has also been implicated 
tumorigenesis (Lai and Wade, 2011). One possible function of the NuRD complex may 
be to use ATP-dependent chromatin remodeling to allow RBBP4 access to helix 1 of H4 
which may be inaccessible when assemble into the nucleosome octamer. 
In addition to HDAC-containing repressor complexes, RBBP4 is also a 
component of the methylating repressive complex PRC2 (Schmitges et al., 2011) 
(Kuzmichev et al., 2002). PRC2 is comprised of four subunits including EED 
(Embryonic Ectoderm Development), SUZ12 (Suppressor of Zeste 12), RBBP4, and 
finally the catalytic subunit EZH1 or EZH2 (Enhancer of Zeste Homolog 1 or 2) 
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(Kuzmichev et al., 2002). EZH1 or 2 is the catalytic lysine methyltransferase subunit 
responsible for trimethylation of lysine 27 in histone 3 (H3K27me3) (Margueron and 
Reinberg, 2011). PRC2 plays a key role in early epigenetic regulation during embryonic 
development and differentiation (Pasini et al., 2004) (O'Carroll et al., 2001) and is also 
dysregulated in cancer (Conway et al., 2015). RBBP4 has been shown to bind the SUZ12 
subunit in drosophila via the binding pocket at the side of the beta propeller and it 
thought to facilitate high affinity binding of the PRC2 complex to the nucleosome 
(Nowak et al., 2011b). In addition to PRC2, studies have also shown RBBP4 and RBBP7 
to be found in a complex with HDAC1/2 and the K9H3 methyltransferase SUV39H1 and 
together are thought to facilitate the formation of heterochromatin (Vaute et al., 2002). 
RBBP4 is also an integral component of the CAF-1 complex (Verreault et al., 
1996). CAF-1 consists of three subunits including p150, p60, and RBBP4 and functions 
to assemble nucleosomes onto newly synthesized DNA (Kaufman et al., 1995). RBBP4 
has also been shown in yeast to be required for proper loading of the kinetochore-specific 
histone CENP-A to the centromere (Hayashi et al., 2004). Besides just repressive 
complexes, RBBP4 is also a member of the activating acetylating complex CBP/p300 
(Zhang et al., 2000). CBP (CREB binding protein) and its homolog p300 are histone 
acetyltransferases which activate gene transcription either through direct interaction or 
post-translational modification of the basal transcriptional machinery or other 
transcriptional activators (Shiama, 1997).  Experiments have shown that RBBP4 interacts 
with CBP/p300 and in fact enhances its activity (Zhang et al., 2000). Finally, RBBP4 is a 
member of the DREAM (dimerization partner, RB-like, E2F and multi-vulval class B) 
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complex which is an RB-independent complex that controls cell cycle gene expression 
during quiescence (Litovchick et al., 2007) (Sadasivam et al., 2012). 
To date much of the work done analyzing the functional role of RBBP4 has been 
performed in vitro or in invertebrate models. However, several clear roles for RBBP4 
have become apparent in chromatin assembly and stability, development, aging, and 
cancer. Experiments in chicken cells have demonstrated that loss of RBBP4 leads to 
decreased DNA synthesis resulting in S-phase delays, chromatin instability, mitotic 
defects and abnormal chromosomal segregation, and apoptosis (Satrimafitrah et al., 
2016). These defects are most likely caused by loss of functionality of the CAF-1 
complex when RBBP4 is depleted leading to defects in packaging of newly synthesized 
DNA into chromatin. Additionally, in yeast, loss of the RBBP4 homolog Mis16 results in 
misloading of CENP-A and subsequent chromosomal segregation defects and aneuploidy 
(Hayashi et al., 2004). In both cases, the loss of RBBP4 is also results in an increase in 
acetylation of histones highlighting the additional role of RBBP4 in proper targeting of 
HDACs. Further supporting this idea, in mouse oocytes knockdown of RBBP4 led to 
defects in meiosis, chromosomal alignment, multipolar spindles, aneuploidy, and histone 
H3 and H4 hyperacetylation (Balboula et al., 2015). The authors posit that the 
hyperacetylation resulting from the loss of RBBP4 prevents the spindle assembly 
checkpoint protein AURKC from properly localizing and thus the formation of meiotic 
defects. 
To date studies examining the role of RBBP4 in development have been limited 
to cell culture and invertebrate models such as nematodes and planarians. In C. elegans, 
the RBBP4 homolog LIN-53 is expressed throughout the nuclei of most if not all cells 
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during embryogenesis and loss of LIN-53 leads to embryonic lethality (Lu and Horvitz, 
1998). It was shown that LIN-53, in coordination with the RB1 homolog LIN-35, 
antagonizes the Ras/RTK pathway and prevents vulval cell fate specification. In human 
pluripotent stem cells, higher expression of RBBP4 was associated with a more 
undifferentiated state and knockdown of RBBP4 led to an increase in differentiation and 
neurogenesis-specific genes and thus in these cells likely functions to maintain 
pluripotency (O'Connor et al., 2011). It was proposed by the authors that RBBP4 acts to 
sequester RB1 and prevent it from inducing genes necessary for differentiation programs. 
Contrary to the results presented in human pluripotent stem cells, in planarians the loss of 
RBBP4 leads to apoptosis due to a failure of neoblast cells to commit to a cell fate and 
differentiate suggesting a role for RBBP4 in promoting differentiation rather than 
pluripotency (Bonuccelli et al., 2010). Finally, in Arabidopsis reduction in the RBBP4 
homolog MSI1 led to ectopic expression of floral homeotic genes, inability of primordia 
to differentiate properly, and loss of heterochromatin structure (Hennig et al., 2003). The 
authors surmise that in this case MSI1 is required to maintain epigenetic silencing of 
developmental patterns of gene expression from one cell division to the next.  
Interestingly, several links have been made between RBBP4 and aging-related 
phenotypes. For instance, 48% of patients with the accelerated aging condition known as 
Progeria show reduced levels of RBBP4 (Pegoraro et al., 2009). Furthermore, RBBP4 
fails to bind with the mutated form of LaminA, or Progerin, which causes the disorder. 
This reduction of RBBP4 was also seen in normal aged cells vs. normal young cells. To 
confirm the role of RBBP4 in this disease and the physiological process of aging, 
researchers demonstrated that silencing of RBBP4 and RBBP7 produced phenotypes 
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similar to those seen in cells from progeria patients including defects in heterochromatin 
formation, loss of CENP-A, re-expression of SatIII, and increases in DNA damage. 
Based on the fact that the NuRD complex components MTA2 and HDAC1 were also 
decreased in cells from Progeria patients, the authors concluded that these defects are 
mediated by mis-regulation of the NuRD complex. Experiments in mice have confirmed 
that the amount of RBBP4 is reduced in the brain of older animals, and furthermore the 
knockdown of RBBP4 in young animals led to defects in memory (Pavlopoulos et al., 
2013). Finally, experiments in vitro have shown an association between loss of RBBP4 
and induction of cellular senescence (Tsujii et al., 2015). In this study the authors show 
novel binding between RBBP4 and Importin alpha and suggest that RBBP4 plays a role 
in regulating importin-mediated nuclear import to prevent replicative senescence.   
 Given the number of major regulatory complexes and pathways RBBP4 is 
associated with, it is no surprise that it has been implicated as being dysregulated in many 
different cancers. Several large-scale expression studies have found altered RBBP4 
expression in cancers including multiple myeloma (Gao et al., 2017), mesothelioma 
(Vavougios et al., 2015), medulloblastoma (Bunt et al., 2013), childhood germ cell 
tumors (Haskins et al., 2012), oropharyngeal tumors (Lohavanichbutr et al., 2009) (Bai et 
al., 2015), salivary gland carcinomas (Leivo et al., 2005), and hepatocellular carcinoma 
(Song et al., 2004). Studies are now beginning to examine the specific role of RBBP4 in 
the progression of these malignancies. In malignant melanoma, a W382X truncation is 
thought to cause improper cytoplasmic localization of RBBP4 contributing to 
tumorigenesis (Pauty et al., 2017). In thyroid tumors, increased levels of RBBP4 were 
observed as compared to normal tissue, and tumor cell proliferation was diminished upon 
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RBBP4 inhibition (Pacifico et al., 2007). In this study it was determined that RBBP4 
gene transcription is controlled in part by the oncogenic NF-kB transcription factor. 
Several other studies have actually found that RBBP4 expression is decreased in tumor 
tissues. For example, in cervical cancer a decrease in expression in RBBP4 is found in 
malignant tissue and this decrease is associated with increased proliferation, decreased 
senescence, and decreased RB1 and p53 expression (Kong et al., 2007). Additionally, in 
liver tumors a decrease in RBBP4 expression is associated with increased tumor 
aggressiveness and an increase in E2F1-responsive oncogenes including Oct4, Myc and 
Sox2 (Li et al., 2015a). In this study the authors determined that reduced RBBP4 
expression was due to suppression by the microRNA miR-429. Several additional studies 
have also looked at the role of RBBP4 in response to different therapeutic cancer 
treatments and have generated conflicting results. Increased expression of RBBP4 was 
associated with increased sensitivity to radiation in breast cancer cells (Torres-Roca et al., 
2005) (Scuto et al., 2007) and photodynamic therapy in cervical cancer cells (Wu et al., 
2017). While in the case of breast cancer cells RBBP4 is thought to mediate this effect 
through antagonizing the Ras pathway (Scuto et al., 2007), in cervical cancer cells it was 
shown that RBBP4 is associated with increased expression of tumor suppressor genes 
such as TP53, RB1, and Caspase-3 (Wu et al., 2017). However, contrary to these results, 
studies in glioblastoma cells have found that decreased RBBP4 is associated with 
increased susceptibility to temozolomide treatment and that RBBP4 is likely mediating 
resistance to drug sensitivity through interaction with CBP/p300 to activate expression of 
DNA repair genes (Kitange et al., 2016). Overall, these results suggest that the 
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mechanism and nature of RBBP4 function in a tumorigenic paradigm is dependent on the 
tumor and treatment type. 
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Abstract 
In the central nervous system (CNS) injury induces cellular reprogramming and 
progenitor proliferation, but the molecular mechanisms that limit regeneration and 
prevent tumorigenesis are not completely understood. We previously described a 
zebrafish optic pathway tumor model in which transgenic Tg(flk1:RFP)is18/+ adults 
develop non-malignant retinal tumors. Key pathways driving injury-induced glial 
reprogramming and regeneration contributed to tumor formation. Here we examine a 
time course of proliferation and present new analyses of the Tg(flk1:RFP)is18/+ 
dysplastic retina and tumor transcriptomes. Retinal dysplasia was first detected in 3-
month old adults but was not limited to a specific stem cell or progenitor niche. Pathway 
analyses suggested a decrease in cellular respiration and increased expression of 
components of Hif1-α, VEGF, mTOR, NFκβ, and multiple interleukin pathways is 
associated with early retinal dysplasia. Hif-α targets VEGFA (vegfab) and Leptin (lepb) 
were both highly upregulated in dysplastic retina, however each showed distinct 
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expression patterns in neurons and glia, respectively. Phospho-S6 immunolabeling 
indicated mTOR signaling is activated in multiple cell populations in wild type retina and 
in the dysplastic retina and advanced tumor. Our results suggest multiple pathways may 
contribute to the continuous proliferation of retinal progenitors and tumor growth in this 
optic pathway tumor model. Further investigation of these signaling pathways may yield 
insight into potential mechanisms to control the proliferative response during 
regeneration in the nervous system. 
Introduction 
Elucidating the molecular mechanisms controlling cellular reprogramming and 
regeneration is important for improved treatment of nervous system injury and disease. 
Proper regulation of regenerative programs is necessary to limit proliferation and prevent 
cellular transformation and neoplasia. In injured tissue dying cells and damaged 
vasculature lead to inflammation and a hypoxic environment (Corcoran and O'Connor, 
2013; Rock and Kono, 2008). The pro-inflammatory cytokine and hypoxia inducible 
factor Hif-α pathways are critical for mediating the cellular response to cell death and 
hypoxia (Kono et al., 2014; Semenza, 2012). How activation of hypoxia and 
inflammatory pathways contribute to proliferation and regeneration in the nervous system 
is still not completely understood. 
Hypoxia has been shown to activate regeneration gene programs in injured 
peripheral sensory neurons by Hif1-α induced expression of its direct target, the vascular 
endothelial growth factor VEGF (Cho et al., 2015). VEGF receptor tyrosine kinase 
signaling is essential to embryonic blood vessel development, adult angiogenesis, tumor 
vascularization, and disease related vascular retinopathies (Koch et al., 2011). In addition, 
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multiple non-vascular functions have been described for VEGF in the developing and 
adult CNS (Lange et al., 2016; Mackenzie and Ruhrberg, 2012). VEGF is expressed by 
glial progenitors and astrocytes in response to hypoxia in the neonatal subventricular 
zone and stimulates proliferation of glial progenitors (Bain et al., 2013). In the 
subgranular zone/neurogenic niche of the adult mouse hippocampus, secretion of 
VEGFA and VEGFB by neural stem and progenitor cells is thought to influence the 
microenvironment and maintain the stem cell pool (Kirby et al., 2015). Treatment of 
embryonic cortical neural precursors in vitro with VEGF induces expression of E2F 
family members and cell cycle regulators cyclin D1, cyclin E and cdc25, supporting the 
above observations that VEGF may have a direct role in promoting progenitor 
proliferation in vivo (Zhu et al., 2003). In the retina, VEGF has been shown to act directly 
on chick retinal progenitors to promote proliferation (Hashimoto et al., 2006), however, 
whether VEGF mediates the proliferative response to hypoxia in the retina has not 
previously been shown. 
A second transcriptional target of Hif-α, the cytokine Leptin, is expressed in 
response to hypoxia (Ambrosini et al., 2002), and has been shown to stimulate 
proliferation of neural progenitors (Perez-Gonzalez et al., 2011) and regulate 
angiogenesis (Bouloumie et al., 1998; Cao et al., 2001; Sierra-Honigmann et al., 1998a) 
and wound healing (Murad et al., 2003). The presence of Leptin in the eye vitreous is 
associated with inflammation and vision loss in patients with diabetic retinopathy 
(Gariano et al., 2000). Experimentally, Leptin expression is increased as part of the 
inflammatory response in a guinea pig model of uveitis (Kukner et al., 2006) and induces 
accumulation of reactive oxygen species in human endothelial cells (Bouloumie et al., 
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1999). This suggests Leptin and VEGF together might integrate hypoxia and 
inflammatory signaling pathways, which are both implicated in solid tumor initiation and 
cancer progression (Candido and Hagemann, 2013; Coussens and Werb, 2002; Semenza, 
2013). Most recently it has been shown that extended exposure of normal bronchial 
epithelial cells to hypoxia and proinflammatory cytokines TNF-α and IL1-β induces 
cancer-like phenotypic changes, providing a link between hypoxia, inflammation and 
cellular transformation in vitro (Baird et al., 2016). How sustained signaling due to a 
combination of hypoxia and chronic inflammation contributes to transformation in solid 
tumor initiation in vivo remains an open question. Moreover, the connection between 
hypoxic induction of Hif-α targets, such as VEGF and Leptin, to neoplastic 
transformation and tumor induction is less clear than the well-documented role of these 
factors in vascularization supporting tumor growth (Connolly et al., 1989).  
Zebrafish has been used extensively as a model system for studying activation of 
latent progenitor populations and the molecular pathways controlling injury induced 
regeneration in the vertebrate nervous system (Alunni and Bally-Cuif, 2016; Kizil et al., 
2012). Two populations of progenitor cells contribute to the growth of the zebrafish 
retina; latent progenitors derived from Müller glia in the inner nuclear layer, and neural 
progenitors from neuroepithelial stem cells present in the ciliary marginal zone at the 
retina periphery (Alunni and Bally-Cuif, 2016). Chemical, mechanical, genetic and light-
induced injury of the zebrafish retina has revealed multiple growth factor and cytokine 
signaling pathways stimulate latent progenitor proliferation and Müller glia 
dedifferentiation and reprogramming, both of which contribute to regeneration 
(Goldman, 2014; Gorsuch and Hyde, 2014; Lenkowski and Raymond, 2014). Together 
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these studies reveal the importance of coordinated activation of multiple pathways, 
including Heparin-Binding EGF-like Growth Factor, Wnt, Leptin, Interleukin-6, and 
Jak/Stat signaling, in progenitor proliferation and subsequent fate specification and 
differentiation (Goldman, 2014; Zhao et al., 2014). The initial response to injury in the 
zebrafish retina involves transient expression of the proinflammatory cytokine TNF-α, 
which prevents gliosis and stimulates induction of inner nuclear layer progenitor 
proliferation and regeneration (Nelson et al., 2013). The limited regenerative response 
indicates control mechanisms are enacted to prevent unregulated growth and dysplasia. 
Hif-α and mTOR signaling have been reported to work together in regulating ciliary 
marginal zone progenitor proliferation in Xenopus retina after nutrient starvation 
(Khaliullina et al., 2016; Love et al., 2014), and mTOR has been shown to be required for 
Müller glia-derived progenitor proliferation in injured chick retina (Zelinka et al., 2016). 
A role for Hif-α or mTOR signaling in zebrafish retinal development and regeneration 
has not previously been reported. 
 We previously reported the characterization of a zebrafish optic pathway tumor 
model in which transgenic Tg(flk1:RFP)is18/+ adults develop non-malignant retinal 
tumors at ~80% penetrance (Solin et al., 2014). The molecular basis for tumor induction 
is not known, however our analyses showed the retinal tumors may originate in part from 
Müller glia derived progenitors, and activated signaling pathways in the tumor 
transcriptome are similar to injury induced regeneration pathways driving Müller glia 
reprogramming and progenitor proliferation. In contrast to injury induced regeneration 
models, our retinal tumor model is distinct in that TNF-α expression is not upregulated 
and proliferation is not transient. Once initiated, proliferation is sustained and contributes 
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continuously to the growth of dysplastic tissue and the development of non-malignant 
glial-like tumors. These observations indicate other molecular pathways can stimulate 
retinal progenitor proliferation and override the normal controls that limit regeneration. 
 To identify pathways that might be associated with proliferation and the responsive 
retinal cell populations, we performed additional immunocytochemical and differential 
gene expression analyses on adult Tg(flk1:RFP)is18/+ retina.  Early proliferation and 
dysplasia was not restricted to the ciliary marginal zone or to Müller glia-derived 
progenitors in the inner nuclear layer, the normal stem cell/progenitor niches of the 
teleost retina (Alunni and Bally-Cuif, 2016; Than-Trong and Bally-Cuif, 2015). Ingenuity 
Pathway Analysis of the early dysplastic retina identified Hif-α signaling targets VEGF 
and Leptin, components of inflammation pathways NFκβ, IL-1, IL-6, and IL-8, and 
pathways required for Müller glia-derived progenitor proliferation in injured retina 
including HBEGF(Zhao et al., 2014), (Wan et al., 2014) and mTOR (Zelinka et al., 
2016). Novel pathways that act in tissue repair and regeneration (Baker and Tuan, 2013), 
but not previously implicated in retinal regeneration, were represented, such as GADD45 
growth arrest and DNA damage response, endothelin-1 signaling, and caveolin-1-
mediated endocytosis. Our results suggest multiple signaling pathways might trigger 
progenitor proliferation and contribute to tumor growth. The Tg(flk1:RFP)is18 tumor 
model may provide insight into the molecular mechanisms that prevent neoplastic 
transformation during regeneration in the nervous system. 
Results 
Analysis of cellular proliferation and dysplasia in Tg(flk1:RFP)is18/+ adult retina 
 To examine morphological changes and dysplasia in the Tg(flk1:RFP)is18 retina, 
30 
 
we performed histopathology on serial sectioned head tissue from cohorts of age matched 
wild type sibling and Tg(flk1:RFP)is18/+ zebrafish.  Wild type and transgenic siblings 
were sacrificed at 4 weeks (n=10 wild type, n=10 Tg(flk1:RFP)is18/+), 3 months/11 
weeks (n=8 wild type, n=9 Tg(flk1:RFP)is18/+), and 4 months (n=5 wild type, n=15 
Tg(flk1:RFP)is18/+) of age. In all individuals 6um sections extending from the anterior 
to posterior limits of the eyes were examined for the frequency and location of ectopic 
cell proliferation and abnormal retinal architecture.  
 Comparison of 10 four-week-old Tg(flk1:RFP)is18/+ with 10 age-matched wild 
type siblings did not reveal any obvious morphological abnormalities or ectopic 
proliferation in the retinas, indicating that during juvenile stages in Tg(flk1:RFP)is18/+ 
heterozygotes, the growth of the retina and the rate of progenitor proliferation and 
production of neurons and Müller glia proceeds normally. At three months of age, in 
comparison to wild type retina (Figure 2.1 a, e), 6/9 Tg(flk1:RFP)is18/+ fish had regions 
of ectopic proliferation in the retina in at least one eye that contained clusters of 
proliferating cells in the inner nuclear layer, inner plexiform layer, or retinal ganglion cell 
layer (Figure 2.1 b, f). Cells with processes stretched across the inner plexiform layer 
were frequent (Figure 2.1 f arrows). In contrast, the ciliary marginal zone appeared 
normal compared to wild type. A similar frequency of retinal abnormalities was observed 
in 4 month old Tg(flk1:RFP)is18/+ fish, with 10 out of 15 individuals presenting with 
ectopic proliferation in one or both retina. However, phenotypes ranged from retina with  
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Figure 2.1  Detection of aberrant cell migration and ectopic proliferation in young adult 
Tg(flk1:RFP)is18 dysplastic retina. a, e Histological staining of retina section 
from 3-month old adult wild type zebrafish showing nuclear layers and 
organized laminar structure. b, f Representative image of section through 
retina of 3-month-old Tg(flk1:RFP)is18 adult reveals aberrant migration of 
cells across the inner nuclear layer (arrows, f) (n=9). c-h Representative 
images of retinal sections from 4-month-old Tg(flk1:RFP)is18 adults (n=15). 
c, g Retina from 4-month-old Tg(flk1:RFP)is18 adult with dysplasia reveals 
disruption of inner, outer and ganglion cell layers with numerous mitotic 
Figures (arrows, g). d, h 4-month-old Tg(flk1:RFP)is18 adult with advanced 
retinal tumor filling the vitreous space. Tumor tissue is composed of fibrous 
material interspersed with numerous mitotic Figures, cells showing 
heterogeneous nuclear morphology and forming occasional rosettes (arrows, 
h), and blood vessels (arrowheads, h). pe, pigmented epithelium; onl, outer 
nuclear layer; inl, inner nuclear layer; gcl, ganglion cell layer. Scale bars a, b 
200 μm; c, d 500 μm; e, f, g, h 50 μm. 
 
a normal appearance, to retina containing multiple regions of proliferation and 
disorganization with gaps in the inner nuclear layer or large lesions distending the nuclear 
layers (Figure 2.1 c, g), and retina completely replaced by neoplastic tumors that filled  
the vitreal cavity (Figure 2.1 d, h), which was not observed in the 3 month old retinas. 
Regions of proliferation and disorganization were expanded across the retina layers and 
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included the outer nuclear layer (Figure 2.1 c, g). Mitotic figures, which are rarely 
detected in mature regions of wild type adult retina, were numerous in these regions 
(Figure 2.1 g arrows). Larger tumors contained rosettes with mitotic figures (Figure 2.1 h 
arrows) and blood vessels (Figure 2.1 h arrowheads) embedded in a fibrous matrix, 
similar to the advanced retinal tumors previously reported in older adult 
Tg(flk1:RFP)is18/+ fish (Solin et al., 2014).  
 To examine proliferation and progenitor cells in early dysplastic retina, serial 
sections from three wild type and three Tg(flk1:RFP)is18/+ four-month-old adults were 
histologically stained with H&E and adjacent sections labeled with PCNA and Sox2 
antibodies (Figure 2.2). In wild type (Figure 2.2 a-e) a small number of PCNA and Sox2-
labeled cells were present at the ciliary marginal zone (Figure 2.2 c arrow) and in the 
region just adjacent to the ciliary marginal zone (Figure 2.2 c bracket). Few PCNA-
positive cells were detected in the outer nuclear layer at the periphery (Figure 2.2 c 
arrowhead) or central regions of the retina (Figure 2.2 e arrowheads). The Sox2 
expressing cells detected in the inner nuclear layer and ganglion cell layer (Figure 2.2 c, 
e) have previously been described as Müller glia, amacrine, and displaced amacrine cells 
(Jusuf and Harris, 2009). In contrast to wild type, 3/3 four-month-old Tg(flk1:RFP)is18/+ 
adults had regions of ectopic proliferation in multiple serial sections (Figure 2.2, Figure 
2.3). Groups of cells in the inner plexiform layer and gaps in the inner nuclear layer could 
be detected at multiple locations in a single retina (Figure 2.2 f). The ciliary marginal 
zone (Figure 2.2 g, h arrow), and adjacent progenitor region (Figure 2.2 g, h bracket), 
appeared expanded in the Tg(flk1:RFP)is18/+ retina  
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Figure 2.2   Ectopic proliferation and Sox2 expressing cells in young adult 
Tg(flk1:RFP)is18 dysplastic retina. a-e Wild type 4-month-old adult (n=3) 
shows PCNA-positive cells are restricted to stem/progenitor cells at the 
ciliary marginal zone (cmz, arrow, c) and rod precursor cells in the 
photoreceptor outer nuclear layer (arrowheads, e). Sox2-expressing cells 
overlap with PCNA-positive stem cells at the ciliary marginal zone (bracket, 
c) and are present in amacrine/displaced amacrine cells in the inner nuclear 
and ganglion cell layers (c, e). f-j Retina from 4-month-old Tg(flk1:RFP)is18 
adult (n=3) shows numerous regions of proliferation distributed throughout 
the neural retina (f). The ciliary marginal zone (g, h) and ventral ciliary 
circumferential artery (asterisk, g) are expanded. Small masses of PCNA and 
Sox2 positive cells (arrowheads g, h) are present in the normally single cell 
layered non-pigmented epithelium extending from the ciliary marginal zone  
 
34 
 
(Figure 2.2 continued) (small arrow, g, h – compare to small arrow in wild 
type b). Ectopic regions of proliferation in the neural retina contain 
disorganized cells expressing PCNA and Sox2 (arrowheads, j). cmz, ciliary 
marginal zone; gcl, ganglion cell layer; inl, inner nuclear layer; onl, outer 
nuclear layer; pe, pigmented epithelium. Scale bars a, f 200 μm; all other 
panels 50 μm. 
 
compared to wild type. The diameter of the ventral ciliary circumferential arteries was 
increased (Figure 2.2 g, h asterisk), and the non-pigmented epithelium that lines the 
vitreal face of the iris was expanded (Figure 2.2 g, h small arrow) and contained small 
masses with PCNA and Sox2 expressing cells (Figure 2.2 g, h arrowheads). In the 
internal retina, PCNA was detected in cells within each nuclear layer and in disorganized 
masses in the inner plexiform layer (Figure 2.2 i, j arrowheads). Sox2 expressing cells 
were present scattered throughout the masses and inner nuclear layer and ganglion cell 
layer. Quantification of Sox2 and PCNA positive cells at the ciliary marginal zone and 
regions of dysplasia in the inner retina showed the increase in Tg(flk1:RFP)is18/+ 
compared to age-matched wild type siblings was significant (Figure 2.3).  
 In summary, the histological analysis of tumor onset indicates that in the 
Tg(flk1:RFP)is18/+ retina, neurogenesis proceeds normally through juvenile stages of 
development. Abnormal proliferation begins in early adulthood and occurs in the inner 
nuclear layer and ganglion cell layers of the retina (Figure 2.1). The non-pigmented 
epithelium that extends away from the ciliary marginal zone along the vitreal surface of 
the iris is also affected (Figure 2.2 g). In contrast, the ciliary marginal zone appears 
expanded but relatively normal overall, even in fish with advanced tumors (Figure 2.1 d, 
Figure 2.2 g). The data suggest multiple cell populations in the Tg(flk1:RFP)is18/+ retina 
are stimulated to proliferate, and may include cells in the pigmented epithelium or  
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Figure 2.3  The ciliary marginal zone and dysplastic regions of Tg(flk1:RFP)is18/+ retina 
in 4 month old adults contain increased numbers of PCNA and Sox2 positive 
cells. Total number of PCNA and Sox2 labeled cells were counted at the 
ciliary marginal zone and in a 300μm long section of the internal retina in 
three wild type and three age matched 4 month old Tg(flk1:RFP)is18/+ 
siblings containing a region of dysplasia identified by H&E staining. a 
Ciliary marginal zone PCNA positive cells 19 ± 4 vs. 7 ± 1, p=0.0082. b 
Ciliary marginal zone Sox2 positive cells 19 ± 4 vs. 7 ± 1, p=0.0168. c 
Internal retina PCNA positive cells: 11 ± 2 vs. <1, p=0.0001. d Internal retina 
Sox2 positive cells: 47 ± 5 vs. 28 ± 3, p=0.007. n=9 retinal sections, three 
each from three individuals of each genotype. Error bars represent standard 
error of the mean. cmz, ciliary marginal zone; ir, internal retina. 
 
ganglion cell layer, in addition to the known progenitor populations in the inner nuclear 
layer and at the ciliary marginal zone (Than-Trong and Bally-Cuif, 2015).  
Transcriptomics reveals elevated expression of VEGF, leptin, and mTOR signaling 
pathways correlates with Tg(flk1:RFP)is18/+ retinal dysplasia 
 We previously reported transcriptome analysis of age matched adult wild type 
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retina, Tg(flk1:RFP)is18/+ dysplastic retina (formerly designated Pretumor) and 
Tg(flk1:RFP)is18/+ retinal tumor tissue was consistent with activation of signal 
transduction pathways known to be required for Müller glia reprogramming during injury 
induced regeneration (Solin et al., 2014). GO Term analysis of the RNASeq dataset using 
genes with an FPKM of ≥ 1 and a significant change in expression level between samples 
(p<=0.01) revealed translation, vascular development and blood vessel development 
processes were upregulated in Tg(flk1:RFP)is18/+ dysplastic retina (Figure 2.4 a; 
Supplementary Table S2.1-S2.4). In retinal tumor the analysis revealed a significant 
decrease in phototransduction and ion transport and an increase in cellular processes 
necessary for proliferation, including DNA replication, cell division, and 
ribonucleoprotein complex biogenesis (Figure 2.4 b, Supplementary Table S2.1-S2.4).  
 We used IPA analysis to further examine the altered molecular pathways that might 
initiate transformation and proliferation of progenitor cells leading to tumor formation. 
To increase the stringency of the analysis the original RNASeq data was first filtered to 
remove genes with a read count of less than 10 in wild type retina, dysplastic, or tumor 
tissues. Next, genes with less than three-fold change in expression level between wild 
type retina and dysplastic retina, or between wild type retina and tumor tissue, were 
removed, leaving a set of 2587 genes. Human homologs of the 2587 gene set were 
recovered at BioMart (Smedley et al., 2015). Individual zebrafish genes of interest absent 
from the BioMart conversion (ie., ENSDARG00000045548_lepb,  
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Figure 2.4  Tg(flk1:RFP)is18/+ dysplastic retina associated GoTerm and Ingenuity 
Pathway Analysis canonical pathways. a GoTerm analysis of DGE of 
dysplastic retinal tissue suggests decreased oxidative metabolism and 
increased vasculogenesis pathways. b GoTerm analysis of DGE of retinal 
tumor tissue is consistent with loss of phototransduction and increased 
proliferation. c IPA canonical pathways to which the Tg(flk1:RFP)is18/+ 
dysplastic retina transcriptome is associated. d IPA regulator pathway analysis 
of VEGF targets involved in cytokine signaling, transcriptional response and 
extracellular matrix remodeling underlying invasion of tumor cells. 
 
ENSDARG00000076972_si:dkey-208k22.3_plvap) were identified using BLAST, 
leaving 2570 genes for IPA analysis (Supplementary Table S5). Pathways with the most 
significant overlap in the dysplastic tissue were EIF2 Signaling (p=4.65E-26), 
Phototransduction Pathway (p=4.65E-15), mTOR signaling (p=2.28E-08) and Cell Cycle 
Control of Chromosomal Replication (1.46E-07). General categories of disease, disorders  
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and molecular and cellular function were consistent with injury and tumorigenesis and 
included cancer, organismal injury and abnormalities, and neurological disease, and 
predicted an increase in cell movement, growth, and proliferation and a decrease in cell 
death and apoptosis. Specific canonical signaling pathways represented in the dysplastic 
retina included caveolin-mediated endocytosis, EIF2 translation, Hif1-α, endothelin-1, 
VEGF, mTOR, and gadd45B (Figure 2.4 c; Supplementary Table S2.5). NFκβ and 
multiple interleukin pathways (IL1, IL6, IL8) were present (Supplementary Table S2.5). 
A glioma invasiveness pathway was activated (Figure 2.4 c; Supplementary Table S2.5) 
as expected given the involvement of glial reprogramming pathways and the glioma-like 
cellular and molecular features of the tumors. Together the data suggest activation of 
multiple signaling pathways is associated with dysplasia in the Tg(flk1:RFP)is18/+ 
retina. 
VEGFA and Leptin are induced in distinct cell populations in the early dysplastic 
Tg(flk1:RFP)is18/+ retina 
A number of genes with the greatest change in expression between wild type and 
Tg(flk1:RFP)is18/+ dysplastic retina are direct targets of hypoxia inducible factor Hif1-α 
(Benita et al., 2009; Greenald et al., 2015; Ortiz-Barahona et al., 2010; Wang et al., 2005) 
or components of the Hif1-α (egln1a, egln3, lepb, vegfab, stc2a), vascular endothelial 
growth factor VEGF (hmox1, ptgs2b) or JAK/Stat signaling pathways (socs3a) 
(Supplementary Table S5). Other hypoxia-inducible targets whose expression was 
significantly increased included cxcr4b, cxcl12, ddit4 and gadd45ba. Hypoxia regulates 
the level of Hif1-α through protein stabilization (reviewed in (Corcoran and O'Connor, 
2013)). The level of hif1aa and hi1ab gene expression was not significantly changed 
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between wild type, Tg(flk1:RFP)is18/+ dysplastic retina and tumor tissue. Together these 
observations suggest a hypoxic environment is one possible trigger associated with 
ectopic proliferation in the Tg(flk1:RFP)is18/+ retina. Because both VEGF and Leptin 
are direct targets of Hif1-α and have been shown to promote neural progenitor 
proliferation (Forsythe et al., 1996; Shweiki et al., 1992) we examined these two 
signaling molecules in more detail.  
In dysplastic Tg(flk1:RFP)is18/+ retina tissue the level of vegfaa increased 2.9 
fold and vegfab increased 11-fold. IPA analysis showed increased expression or 
activation of many components in the VEGF regulatory pathway that promotes tumor cell 
invasion (Figure 2.4 d), including multiple growth factors (TGFβ, hbegf), cytokines 
(endothelin-1, cxcl12), matrix metalloproteases and peptidases (mmp2, mmp9, plau), and 
enzymes involved in prostaglandin synthesis (cox2, ptgs2). In the retina, VEGF promotes 
proliferation of retinal neural progenitors through activation of E2F via the MEK-ERK 
signal pathway (Hashimoto et al., 2006; Nishiguchi et al., 2007). The E2F family of 
transcription factors has been shown to activate expression of gene networks regulating 
cell cycle progression, DNA damage and mitotic checkpoints, chromosome maintenance 
and chromatin assembly (Ren et al., 2002). Many direct targets of E2F were significantly 
increased in the dysplastic retina transcriptome, including cyclin dependent kinase cdk1 
and cdk2, minichromosome maintenance deficit family members mcm3, mcm5, mcm6, 
and mitotic kinases aurora kinase aurkb and polo-like kinase plk1. Together, the data is 
consistent with VEGF’s role as a mitogen that induces cell migration and stimulates 
cytokine signaling and angiogenesis. 
A second target of Hif1-α signaling, the cytokine Leptin (Grosfeld et al., 2002), 
40 
 
was dramatically increased in the dysplastic retina transcriptome (~500 fold) and 
remained elevated in tumor tissue. IPA analysis did not indicate a significant overlap of 
genes in the canonical pathways of which Leptin is a component including Leptin 
signaling in obesity, insulin or Jak/Stat. However, Leptin can mediate activation of the 
Jak/Stat pathway through induction of Socs3, one of the genes most highly altered in the 
dysplastic retina transcriptome. Leptin has also been shown to synergize with interleukin 
IL-6 in Müller glia reprogramming in injury-induced regeneration (Zhao et al., 2014). 
Together, this indicates that like VEGF, Leptin may play an important role in mediating 
the response to metabolic changes in the Tg(flk1:RFP)is18/+ retina, either contributing to 
dysplasia and tumorigenesis or as a result of increased proliferation. 
To examine which cell types in the retina express vegfaa, vegfab and lepb, in situ 
hybridization was performed on retinal sections from wild type and Tg(flk1:RFP)is18/+ 
adults (n= 3-5 biological replicates). The panel of in situ hybridization results shown in 
Figure 5 is composed of images from the same Tg(flk1:RFP)is18/+ retina, in order to 
illustrate expression for multiple genes in a retina with dysplasia as well as an advanced 
tumor. As shown in Figure 2.5, dysplastic retina was defined by a thickening and 
distortion of the neural retina layers compared to wild type, whereas tumor represents a 
mass that completely distorts the retinal layers and extends into the vitreous. In wild type 
retina the vegfaa signal was weak in all three nuclear layers (Figure 2.5 a, b) and was 
only slightly elevated in dysplastic retina and tumor (Figure 2.5 c box, d asterisk). vegfab, 
the VEGF receptor flk1, lepb, and the Leptin receptor lepr were not detected in 
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Figure 2.5  Induction of vegfab and lepb expression in distinct cell populations in 
Tg(flk1:RFP)is18 dysplastic retina and retinal tumor. in situ hybridization of 
retina cryosections from +/+ (a, b, e, f, i, j, m, n, q, r, u, v) and 
Tg(flk1:RFP)is18 (c, d, g, h, k, l, o, p, s, t, w, x) adult siblings. Weak 
expression of vegfaa is detected in the three nuclear layers of the retina (a, b) 
and in early dysplastic (c box, d) and retinal tumor tissue (c asterisk).  
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(Figure 2.5 Continued) Expression of vegfab (e, f), the VEGF receptor flk1 (i, 
j), lepb (m, n), or the Leptin receptor lepr (q, r) are not detected in wild type 
+/+ retina. g, h In early dysplastic retina vegfab is detected throughout the 
inner and outer nuclear layers (g small bracket, h). In the tumor containing 
region (large bracket) vegfab is detected in a central region of the lesion 
(asterisk). k, l The VEGF receptor flk1 was present in small groups of cells 
scattered throughout the tissue that may overlap with microvessels. o, p lepb is 
highly expressed in a subset of cells in the inner nuclear layer and cells in the 
ganglion cell layer in dysplastic retina, and present in many cells evenly 
distributed in the early tumor (bracket). s, t The lepr receptor expression is 
faint and diffuse in dysplastic retina and tumor tissue. u, v In wild type retina 
the glial marker apoeb is strongly expressed in inner nuclear layer Müller glia 
and astrocytes in the ganglion cell layer/nerve fiber layer. w, x apoeb 
expression is highly elevated in dysplastic retina and is detected in projections 
crossing the inner plexiform layer. Numerous cells throughout the tumor 
tissue labeled intensely with apoeb. gcl, ganglion cell layer; inl, inner nuclear 
layer; onl, outer nuclear layer; pe, pigmented epithelium.  All scale bars, 100 
μm, except panels g, k, o, s, t scale bars, 500 μm. 
 
any layer of the wild type neural retina (Figure 2.5 e, f, I, j, m, n, q, r), as expected given 
the low number of reads in the wild type retina transcriptome. The glial marker apoeb 
was readily detected in the inner nuclear layer and ganglion cell layer (Figure 2.5 u, v), 
presumably expressed in Müller glia and nerve fiber layer astrocytes, respectively. In 
regions of the Tg(flk1:RFP)is18/+ retina with dysplasia a high level of vegfab labeling 
was present and appeared to be expressed in the inner and outer nuclear layers but was 
absent from the ganglion cell layer (Figure 2.5 g small bracket, h). The retina also 
contained a region with a tumorous lesion that distended the nuclear layers (Figure 2.5 g 
large bracket). vegfab was detected in a central region in the lesion (Figure 2.5 g 
asterisk). The VEGF receptor flk1 showed a low level of expression in cells scattered 
throughout the dysplastic region and larger lesion in the retina (Figure 2.5 k, l). In 
contrast to vegfab, in dysplastic tissue lepb expression appeared to localize specifically to 
Müller glia in the inner nuclear layer and in cells in the nerve fiber layer, presumably 
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astrocytes (Figure 2.5 o, p). In addition, high levels of lepb were detected in clusters 
throughout the tumorous lesion (Figure 2.5 o, bracket), whereas little vegfab was present 
in a similar section (Figure 2.5 g large bracket). The lepr receptor showed diffuse 
expression throughout both regions in the dysplastic retina (Figure 2.5 s, t). 
Apolipoprotein ApoE is expressed by activated Müller glia and astrocytes in the injured 
retina and promotes neurite outgrowth of various neuronal cell types (Lorber et al., 2009). 
lepb expression was similar to apoeb, which showed a substantial increase throughout the 
inner nuclear layer and ganglion cell layer and widespread expression in the retinal 
lesion, but appeared absent from neuronal cells (Figure 2.5 w, x), further supporting the 
restricted expression of lepb in glia within the Tg(flk1:RFP)is18 dysplastic retina. 
Together these results indicate that in the Tg(flk1:RFP)is18 retina, neurons and glia 
respond by expression of distinct growth factors and cytokines. vegfab expression is 
highly induced in neurons, and possibly Müller glia, in the inner nuclear layer. In 
contrast, lebp expression overlapped with apoeb and appeared restricted to the Müller 
glia and astrocytes in the nerve fiber layer.  
 A third canonical pathway identified by IPA analysis of the Tg(flk1:RFP)is18/+ 
transcriptome was mTOR signaling (Figure 2.4 c), which regulates cell growth and 
metabolism (Laplante and Sabatini, 2009). Activation of mTOR in response to hypoxia or 
growth factor signaling stimulates translation through phosphorylation of eukaryotic 
initiation factor 4E-binding protein (4EBP) and ribosomal protein S6-kinase, which 
stimulates phosphorylation of ribosomal protein S6 (Figure 2.6). mTOR can also act 
upstream of HIF1-α to activate VEGF signaling (Figure 2.6) indicating positive feedback 
between the hypoxia and mTOR pathways. Components of mTOR signaling 
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Figure 2.6  Tg(flk1:RFP)is18/+ dysplastic retina genes associated with IPA canonical 
pathway mTOR signaling. Upstream components phospholipase D (PLD), 
DNA damage induced transcript (DDIT), RAS and phosphoinositol 3-kinase 
(PI3K) predicted to activate mTOR signaling are upregulated. Downstream 
effectors of mTOR signaling, such as translation initiation factors eIF4E and 
eIF3 and ribosomal proteins including RPS6 are also upregulated. Mixed red 
and green color in VEGF symbol reflects ~11-fold vegfab upregulation and 
vegfb three-fold downregulation. 
 
located upstream and downstream of the mTORC1 complex that were upregulated in the 
dysplastic retina transcriptome included phospholipase D (PLD), DNA damage inducible 
transcript (DDIT4), RAS, phosphoinositol 3-kinase (PI3K), eukaryotic translation 
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initiation factors eIF4E and eIF3, ribosomal protein S6 (RPS6), and many ribosomal 
proteins (Figure 2.6).  
 To examine mTOR signaling in the Tg(flk1:RFP)is18/+ retina tissues were labeled  
with an antibody specific for phosphorylated ribosomal protein S6 (phospho-S6) (n=7  
wild type and n=8 Tg(flk1:RFP)is18/+ biological replicates). In wild type adult zebrafish 
retina phospo-S6 labeling was detected in numerous cell types. In the inner nuclear layer 
of the mature retina phospho-S6 labeled putative horizontal cells (Figure 2.7a, b small  
arrowheads) and amacrine cells and/or Müller glia (Figure 2.7a, b large arrowheads). 
Phospho-S6 labeling was also detected in the retinal ganglion cell layer, present in retinal 
ganglion cells and/or displaced amacrine cells (Figure 2.7a, arrows) (Diekmann et al., 
2015). Regions of the Tg(flk1:RFP)is18/+ retina with dysplasia (Figure 2.7c, d bracket, e, 
f) or advanced tumor (Figure 2.7g) showed phospho-S6 labeled cells distributed 
throughout the lesions. However, the percentage of phospho-S6 positive cells in 
Tg(flk1:RFP)is18/+ tumor tissue was not significantly different than in wild type retina 
(Figure 2.7h, 11.4% ± 0.9 vs. 13.9% ± 1.7, p=0.2291, n=9 sections, three sections each 
from three individuals of each genotype). In the Tg(flk1:RFP)is18/+ retina phospho-S6 
was also detected in the nerve fiber layer on the vitreal side of the retina (Figure 2.7d, e 
arrows). This labeling may represent active mTOR signaling in retinal ganglion cells, 
displaced amacrine cells, astrocytes in the nerve fiber layer, or blood vessels of the 
capillary plexus that extends across the vitreal surface of the retina. Together the data 
indicate mTOR signaling may contribute to the sustained growth of tumors in 
Tg(flk1:RFP)is18/+ retina.  
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Figure 2.7  Activated mTOR signaling marker phosphorylated-S6 in adult zebrafish wild 
type retina, Tg(flk1:RFP)is18/+ dysplastic retina and retinal tumor. a, b 
phospho-S6 (green) is detected in putative horizontal cells (small arrowheads), 
amacrine and/or Müller glia (large arrowheads) and retinal ganglion cells 
and/or displaced amacrine cells (small arrows) in the mature region of the 
retina. Nuclei are labeled with DAPI. Asterisk marks a blood vessel. c-g In 
Tg(flk1:RFP)is18/+ dysplastic retina phospho-S6 labeling is present in a  
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(Figure 2.7 continued) subset of cells throughout regions of the retina with 
increased cell number and disorganized retinal layers (c-f). Intense labeling of 
phospho-S6 was present in the ganglion cell and nerve fiber layers (c, d 
arrows). Large lesions contained phospho-S6 positive cells distributed 
throughout the tumor mass (d bracket, g). h Percentage of phospho-S6 
cells/total cells in wild type retina and Tg(flk1:RFP)is18/+ tumor. +/+ 11.4% 
± 0.9 vs. Tg(flk1:RFP)is18/+ 13.9% ± 1.7, p=0.2291. n=9 sections, three 
sections each from three individuals of each genotype. gcl, ganglion cell layer; 
inl, inner nuclear layer; onl, outer nuclear layer; pe, pigmented epithelium. 
Scale bars, a, g, f 50 μm; b, c 20 μm; d, e 100 μm; h 25 μm. 
 
Discussion 
 In this study we examined the onset of ectopic proliferation in the retina of adult 
Tg(flk1:RFP)is18/+ zebrafish predisposed to non-malignant retinal tumors and analyzed 
activation of signaling pathways that correlate with retinal dysplasia and tumor growth. A 
major finding from our time course analysis of proliferation is that multiple cell 
populations proliferate in the early dysplastic Tg(flk1:RFP)is18/+ retina, including cells 
in the pigmented epithelium, ganglion cell layer, and inner nuclear layer, as well as at the 
ciliary marginal zone. We also observed aberrant cell migration across the inner nuclear 
layer in the very early dysplastic retina, which could contribute to dysplasia and tumor 
growth. These cells may originate from angiogenic sprouting of blood vessels in the 
nerve fiber layer in response to release of VEGF by inner nuclear layer neurons. 
Together, our data indicate cells outside of the zebrafish retina ciliary marginal zone, in 
addition to Müller glia-derived progenitors, have the potential to proliferate. 
 A second major finding of our study is that expression of VEGFA and Leptin is 
significantly increased in early dysplastic retina, before formation of large lesions or 
tumors. Within the dysplastic retina neural and glial cell populations appear to respond 
differently, with vegfab expression upregulated in neurons, and lepb expression 
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overlapping with the glial marker apoeb. How this contributes to dysplasia in the retina, 
and separating and evaluating the distinct roles VEGF plays in neurogenesis directly vs. 
indirectly through enhanced angiogenesis, will require additional investigation. Leptin 
has previously been reported to function in Müller glia reprogramming (Zhao et al., 
2014), and our results showing increased expression of lepb in Tg(flk1:RFP)is18/+ 
retinal glia support a role for leptin signaling in glial-derived progenitor proliferation. 
Recent studies have identified a tissue regeneration enhancer element in the zebrafish 
lepb promoter that mediates high levels of leptin expression during fin and heart 
regeneration (Kang et al., 2016), suggesting the elevated expression of lepb in 
Tg(flk1:RFP)is18/+ retina may simply be due to enhancer activation. It is well 
documented that Hif1-α activates the VEGF and Leptin promoters (Cho et al., 2015; 
Grosfeld et al., 2002), consistent with elevation of the Hif1-α pathway in the dysplastic 
retina transcriptome. However, it is equally likely that additional upstream triggers may 
activate VEGF and Leptin expression in the Tg(flk1:RFP)is18/+ retina, leading to 
proliferation and dysplasia.  
 Our study also provides evidence that in wild type adult retina mTOR signaling is 
active in numerous cells in the inner nuclear layer and retinal ganglion cell layer, which 
has not previously been reported in zebrafish. mTOR activation was detected in putative 
horizontal cells, amacrine cells and retinal ganglion cells but was absent from the ciliary 
marginal zone. In Tg(flk1:RFP)is18/+ retina phospho-S6 positive cells were present in 
dysplastic regions with high cellularity and large tumor lesions. Compared to VEGF and 
Leptin signaling, mTOR activation may not be a factor in initiating inappropriate 
proliferation in the early dysplastic retina, but could contribute to the sustained growth of 
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retinal tumors. mTOR has been shown to be required for proliferation of Müller glia 
progenitors in response to injury in chick retina (Zelinka et al., 2016). While multiple 
signaling pathways most likely drive proliferation and tumor growth in the 
Tg(flk1:RFP)is18/+ model, our data is consistent with our previous analyses that suggest 
mTOR signaling could influence activation of Müller glia regeneration pathways in the 
Tg(flk1:RFP)is18/+ retina.  
 In summary, differential gene expression and cytological analyses of retinal 
dysplasia in adult Tg(flk1:RFP)is18/+ zebrafish predisposed to optic pathway tumors 
reveals ectopic proliferation is associated with elevated expression of markers in the 
VEGF, Leptin and mTOR pathways. The causative molecular mechanism inducing 
retinal dysplasia and tumor formation in the Tg(flk1:RFP)is18 line is not known. Our 
previous molecular characterization of the Tg(flk1:RFP)is18 line revealed a 500-copy 
number <flk1:RFP> transgene inserted into a lncRNA. Isolation of a 147kb deletion 
allele that removed the majority of the lncRNA gene did not cause tumor formation in 
heterozygous or homozygous adults (Solin et al., 2014). It is possible that the nature of 
this particular high copy number transgene is linked to deregulation of multiple signaling 
pathways, and this underlies proliferation and dysplasia. One possibility is that hundreds 
of copies of the flk1 promoter alters global gene expression, or a subset of vascular genes 
including VEGF. Elevated levels of VEGF can cause vascular permeability and leakage 
(Lange et al., 2016), which would disrupt exchange of nutrients and metabolic waste. 
Alternatively, high levels of membrane targeted RFP expressed from the transgene in 
vascular endothelial cells may compromise vascular integrity, leading to defective retina 
function and metabolism. One of the most highly overexpressed genes in the 
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Tg(flk1:RFP)is18 dysplastic retina transcriptome is homologous to Plasmalemma Vesicle 
Associated Protein (plvap), a marker of vascular permeability. This supports the idea that 
defective vasculature and metabolic recycling could contribute to persistent stimulation 
of neural progenitor proliferation, leading to retinal dysplasia and non-malignant tumor 
formation. Determining whether similar mechanisms regulate stem and progenitor cells 
throughout the nervous system will be important for a better understanding of CNS injury 
and repair. 
Materials and Methods 
Zebrafish 
 The Tg(flk1:RFP)is18 transgenic zebrafish line predisposed to optic pathway 
tumors was previously described (Solin et al., 2014). Zebrafish were housed in an 
Aquatic Habitat system (Aquatic Ecosystems, Inc., Apopka, FL) and maintained on a 14-
hr light/dark cycle at 27oC. Transgenic fish predisposed to tumor formation were raised 
side by side with non-transgenic siblings. Heterozygous and homozygous transgenic fish 
and sibling fish were monitored daily during routine feeding for viability and morbidity, 
and monitored bi-weekly for gross presentation of ocular tumors. Juvenile and adult fish 
were anesthetized and euthanized in MS-222 Tricaine Methanesulfonate according to 
experimental protocols approved by the Iowa State University Institutional Animal Care 
and Use Committee (Log # 11-06-6252-I) in compliance with the American Veterinary 
Medical Association and the National Institutes of Health guidelines for the humane use 
of laboratory animals in research. Adult fish were anesthetized and euthanized in MS-222 
Tricaine Methanesulfonate prior to sacrifice and tissue dissection for RNA isolation, 
histopathology and immunolabeling.  
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Histopathology and Immunocytochemistry 
 One month old intact juvenile fish or whole heads dissected from adult zebrafish 
were fixed in Davidson’s fixative (2:3:1:3 Formalin:Ethanol:Glacial Acetic Acid:Water) 
for 16 hr at 4oC, decalcified in Cal-Ex (Fisher) for 2 days at 4oC, and processed and 
embedded in paraffin blocks at the Clinical Histopathology Laboratory at Iowa State 
University. Paraffin blocks were serial sectioned at 6 µm on a Shandon Finesse 325 
microtome. Slides were stained with Hematoxylin 7211 Richard-Allan Scientific (Fisher) 
and 3% Eosin Y (Argos Organics), and mounted in Permount (Fisher). To aid antigen 
retrieval for PCNA labeling, slides with sectioned tissue were pretreated with 10 mM 
Sodium Citrate. Mouse monoclonal anti-PCNA (Sigma P8825) was used at 1:1000; 
rabbit anti-Sox2 polyclonal (Sigma-Aldrich/Millipore AB5603) was used at 1:200; rabbit 
anti-phospho-S6 ribosomal protein (Ser235/236) (Cell Signaling 2211) was used at 
1:300; Alexa-488 and Alexa-594 conjugated secondary antibodies (Invitrogen) were used 
at a dilution of 1:500. Antibody-labeled slides were stained with DAPI and mounted in 
Fluorogel (EMS). Hematoxylin and Eosin stained slides were imaged on a Zeiss 
Axioskop II using a Nikon Rebel camera. Immunofluorescence was imaged on a Zeiss 
LSM700 laser scanning confocal microscope. Images of histological staining and 
antibody labeling from the same fish were captured from tissue sections separated by 
~100 µm. 
Quantification and Statistics 
 For analysis of proliferation in early dysplastic regions of the retina, sections of 
retinal tissue adjacent to a section stained with H&E (Figure 2) were labeled with PCNA 
and Sox2 antibodies. The total number of PCNA and Sox2 labeled cells was counted in 
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three retinal sections each from three wild type and three Tg(flk1:RFP)is18/+ age 
matched siblings (18 sections total). The total number of positively labeled cells was 
counted separately in two regions of the retina: at the ciliary marginal zone and in a 300 
μm length of the inner retina. To quantify phospho-S6 labeling, three individual wild type 
and three individual Tg(flk1:RFP)is18/+ retinal tumors were examined. From each 
individual, three serial sections were imaged at 63X for a total of 18 images. The total 
number of DAPI positive cells and phospho-S6 positive cells were counted in a 100μm X 
100μm region of wild type retina and Tg(flk1:RFP)is18/+ tumor tissue in each section 
and used to calculate the percentage of phospho-S6 positive cells. Statistical comparison 
of quantification in wild type and Tg(flk1:RFP)is18/+ was performed using student’s t-
test in GraphPad Prism software.  
in situ Hybridization 
cDNA was amplified by RT-PCR out of total RNA isolated from wild type 5 dpf 
embryos and was cloned into the pCR4-TOPO vector (Invitrogen). Primers for 
amplification were as follows: apoe forward 5’ TAGCGGCCGCGAATTCGCCC 3’, 
apoe reverse 5’ TAGTCCTGCAGGTTTAAACGA 3’; lepb forward 5’ 
TGCTTGTTAATATCATCCCTGGT 3’, lepb reverse 5’ 
GAGAATGAATGTCTCAGCCACA 3’; lepr forward 5’ 
CGCTGTAAAGACGTGAACGA 3’, lepr reverse 5’ TCTGCCTGAAGTCCATTCCT 
3’; flk1 forward 5’ AAGTGGCTAAAGGCATGGAGTTC 3’, flk1 reverse 5’ 
GACACTCCATCTCCGAGTCAAGG 3’; vegfab forward 5’ 
CGCGTGCTCCAGTTATTTATTGTG 3’, vegfab reverse 5’ 
CACCTCCTTGGTTTGTCACATCTG 3’; vegfaa forward 5’ 
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TGATACAGTTATTTCTCGCGGCTC 3’, vegfaa reverse 5’ 
TTTGCAGGAGCATTTACAGGTGAG 3’.  Digoxygenin-labeled probes for in situ 
hybridization were synthesized using a DIG RNA labeling mix (Roche #11277073910) 
and T3 RNA polymerase (Roche #11031163001) and stored in 50% formamide at −20°C. 
Adult zebrafish tissues were dissected, fixed in 4% paraformaldehyde, and embedded in 
OCT medium. in situ hybridization on 12–16 µm cryosections of head and eye tissue was 
performed as described (Trimarchi et al., 2007). Tissues were photographed on a Zeiss 
Axioskop II microscope using a Nikon Rebel camera. 
RNA-Seq and Transcriptomic analyses 
 The transcriptome of retinal and tumor tissue from age-matched wild type sibling 
and Tg(flk1:RFP)is18/+ 6-month-old adults was reported previously (Solin et al., 2014) 
and the data deposited at the ArrayExpress database (www.ebi.ac.uk/arrayexpress) under 
accession number E-MTAB-2886. Briefly, total RNA from dissected retinas or tumor 
tissue from age matched 6-month-old sibling fish was isolated using an RNeasy RNA 
Isolation Kit (Qiagen). Three dissected wild type sibling retina, heterozygous 
Tg(flk1:RFP)is18/+ dysplastic retina, and heterozygous Tg(flk1:RFP)is18/+ retinal tumor 
tissue were pooled and used for total RNA isolation. Tg(flk1:RFP)is18/+ retinas were 
classified as dysplastic or tumor based on the gross appearance of the tissue. Dissected 
Tg(flk1:RFP)is18/+ retinas that were thicker than wild type but did not have obvious 
lesions were used for the dysplastic retina sample. Dissected Tg(flk1:RFP)is18/+ eyes 
that contained large masses filling the vitreous were used for the retinal tumor tissue 
sample. A single RNA-Seq library for 100bp paired end sequencing was prepared for 
each sample and the three libraries sequenced at the Genome Sequencing and Analysis 
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Core Resource, Duke Institute for Genome Sciences and Policy, Duke University. Wild 
type, dysplastic retina, and retinal tumor RNA-Seq libraries contained 436,511,378, 
444,838,528, and 422,324,454 reads, respectively. As previously described (Solin et al., 
2014), sequences were mapped to the zebrafish reference genome v9 using GSNAP, 
counted with HTSeq-count, upper quartile normalization applied, and the Fisher’s exact 
test used to determine differential gene expression. Q-value estimation of false discovery 
rate was performed in R using the open source software qvalue 
(http://bioconductor.org/biocLite.R). In the present study genes with at least 10 read 
counts were used for downstream analyses. Gene ontology GO Term (Boyle et al., 2004) 
analyses were done using the Princeton GO Term Finder website 
(http://go.princeton.edu/cgi-bin/GOTermFinder). Cluster frequency was calculated as the 
percentage of genes from the data set significantly associated with a particular term, 
while genome frequency (or background frequency) was calculated as the percentage of 
all genes in the Danio rerio genome associated with a particular term. p-value cutoffs 
were set at 0.01. p-values were Bonferonni corrected with an estimated false discovery 
rate of less than 0.01.  
 Transcriptome data were analyzed with QIAGEN’s Ingenuity Pathway Analysis 
(IPA, QIAGEN Redwood City, www.qiagen.com/ingenuity) using genes having a read 
count of at least 10 in all samples and a three-fold change in expression between wild 
type retina and Tg(flk1:RFP)is18/+ dysplastic retina or retinal tumor samples. Ensembl 
gene IDs for human homologs were extracted using Biomart (Smedley et al., 2015) at 
(http://useast.ensembl.org/biomart/martview/da30878652120cac4e352ddac342a16e). 
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Availability of supporting data 
 Raw transcriptome dataset supporting the conclusions of this article is available in 
the ArrayExpress repository (E-MTAB-2886 
https://www.ebi.ac.uk/arrayexpress/experiments/E-MTAB-2886/). An excel file 
containing normalized read counts for all genes was previously published in Solin et al., 
2014, Supplemental Table S7 (Solin et al., 2014).   
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Abstract 
In this study, we use comparative genomics and developmental genetics to identify 
epigenetic regulators driving oncogenesis in a zebrafish retinoblastoma1 (rb1) somatic-
targeting model of RB-defective brain tumors. Zebrafish rb1-brain tumors caused by 
TALEN or CRISPR targeting are histologically similar to human central nervous system 
primitive neuroectodermal tumors (CNS-PNET). Like the human oligoneural 
OLIG2+/SOX10+-CNS-PNET subtype, zebrafish rb1-tumors show elevated expression 
of neural progenitor transcription factors olig2, sox10, sox8, and the receptor tyrosine 
kinase erbb3a oncogene. Comparison of rb1-tumor and rb1/rb1 germline mutant larval 
transcriptomes shows the altered oligoneural precursor signature is specific to tumor 
tissue. Elevated expression of histone modifier histone deacetylase1 (hdac1) was also 
unique to tumor cells, while chromatin adaptor retinoblastoma binding protein4 (rbbp4) 
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was upregulated in both rb1-tumor and rb1/rb1 mutant. Analysis of germline mutants 
confirms zebrafish rb1, rbbp4 and hdac1 are required during brain development. rb1 is 
necessary for neural precursor cell cycle exit and terminal differentiation, rbbp4 is 
required for survival of post-mitotic precursors, and hdac1 maintains proliferation of the 
neural stem cell/progenitor pool. We present an in vivo assay using somatic CRISPR-
targeting plus live imaging of histone-H2A.F/Z-GFP in developing larval brain to rapidly 
test the role of chromatin remodelers in neural stem and progenitor cells. Our somatic 
assay recapitulates germline mutant phenotypes and reveals a dynamic view of their roles 
in neural cell populations. Our study provides new insight into the epigenetic processes 
that drive pathogenesis in RB-defective brain tumors and identifies RBBP4 and its 
associated chromatin remodeling complexes as potential target pathways to induce 
apoptosis in RB-defective brain tumor cells. 
Introduction 
The retinoblastoma tumor suppressor RB plays distinct roles in regulating 
proliferation and differentiation in stem, progenitor, and lineage restricted cell 
populations (Fong and Slack, 2017; Julian and Blais, 2015; Sage, 2012). The canonical 
tumor suppressor role of RB is to regulate proliferation by transcriptional repression of 
E2F targets driving cell cycle entry (Dyson, 2016). RB may also function as a tumor 
suppressor by promoting differentiation of lineage committed cells (Calo et al., 2010), 
survival of post-mitotic neurons (Naser et al., 2016; Vandenbosch et al., 2016) and 
preventing cellular reprogramming (Kareta et al., 2015). RB transcriptional control is 
mediated in part through association with chromatin remodelers that modify 
posttranslational marks on histones to activate or repress gene expression (Beshiri et al., 
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2012; Brehm et al., 1998; Lin et al., 2011). Like RB, many chromatin remodelers are 
mutated in human cancers (Vogelstein et al., 2013), implicating epigenetic control of 
gene expression as a significant contributor to oncogenesis (Conway et al., 2015; Suva et 
al., 2013). Recent analyses of the epigenome in human and mouse retinoblastoma show 
histone modification correlates with oncogenic gene expression (Aldiri et al., 2017; 
Benavente et al., 2013; Zhang et al., 2012). Understanding how RB loss affects 
epigenetic control in neural stem and progenitor cells during development and in brain 
cancer is important for identifying new pathways that contribute to carcinogenesis.  
Two epigenetic regulators that directly interact with RB are the retinoblastoma 
binding protein RBBP4 (Qian and Lee, 1995; Qian et al., 1993) and the Class I histone 
deacetylase HDAC1 (Brehm et al., 1998; Luo et al., 1998; Magnaghi-Jaulin et al., 1998). 
RBBP4 is a WD40-repeat histone chaperone (Burkhart and Sage, 2008; Murzina et al., 
2008; Nowak et al., 2011a; Song et al., 2008) and a chromatin adaptor component of 
multiple remodeling complexes, including the nucleosome remodeling and histone 
deacetylase complex NuRD (Alqarni et al., 2014) and the cell cycle regulatory DREAM 
complex (Harrison et al., 2006; Litovchick et al., 2007). RBBP4 expression is altered in 
human glioma (Forbes et al., 2017) and recently was shown to cooperate with the p300 
histone acetyl transferase to activate DNA repair pathway gene expression in 
glioblastoma cells in response to temozolomide (Kitange et al., 2016). HDAC1 is a 
component of NuRD and other repressive complexes which control maintenance of stem 
cell pluripotency and cell differentiation (Hayakawa & Nakayama 2011). Studies in 
zebrafish show hdac1 is necessary for central and peripheral nervous system 
development (Henion et al., 1996; Ignatius et al., 2013), and is required for cell cycle exit 
74 
 
and differentiation of neural precursors in the retina (Stadler et al., 2005; Yamaguchi et 
al., 2005). The role of HDAC1 in promoting proliferation versus differentiation may 
depend on the type and location of the neural cell population examined (Jaworska et al., 
2015). Examining the contribution of HDAC1 and RBBP4 to maintaining the progenitor-
like state of RB-brain tumors would shed light on the mechanism of chromatin 
remodeling in epigenetic control of tumor suppression. 
We previously demonstrated that genome editing nucleases can be used to model 
brain tumors in zebrafish by targeted somatic inactivation of the rb1 tumor suppressor 
gene (Solin et al., 2015). TALEN targeting of zebrafish rb1 leads to brain tumors with 
histological similarity to central nervous system primitive neuroectodermal tumors (CNS-
PNET) (Solin et al., 2015). PNET encompasses a group of aggressive, poorly 
differentiated tumors that feature neuroblast-like cells, which suggests this class of 
tumors originate from a progenitor population that mirrors the embryonic neuroectoderm 
(Ostrom et al., 2017) Chan et al., 2015. Recently, other zebrafish PNET models have 
been created by somatic targeting or oncogene overexpression. Targeting rb1 in a tp53-
mutant background produces medulloblastoma-like PNET tumors arising in the zebrafish 
hindbrain (Shim et al., 2017). Activation of RAS/MAPK signaling by NRAS 
overexpression in zebrafish oligoneural precursors leads to PNET (Modzelewska et al., 
2016) that molecularly resembles the human oligoneural PNET subtype 
OLIG2+/SOX10+ CNS-PNET (Picard et al., 2012; Sturm et al., 2016a), defined by 
elevated expression of the neural progenitor transcription factors OLIG2, SOX10, SOX8 
and SOX2. Together, these models suggest disruption of multiple cellular pathways can 
lead to formation of PNET. Whether epigenetic mechanisms also contribute to zebrafish 
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PNET oncogenesis, as suggested by genomic analyses of human and mouse tumors, 
remains to be examined. 
Here we use transcriptomics, somatic and germline CRISPR/Cas9 mutagenesis, 
and live cell imaging in zebrafish to identify candidate RB-interacting chromatin 
remodelers and examine their role in neural stem and progenitor cells during 
development. Our studies provide new insight into the genomic processes that drive 
oncogenesis in RB-defective brain tumors. Comparative transcriptome analysis of 
zebrafish rb1-brain tumors with rb1/rb1 homozygous mutant tissue suggests elevated 
expression of oligoneural precursor transcription factors and chromatin remodelers 
distinguishes neoplastic from mutant tissue. Isolation of rb1 germline mutants shows that 
in the developing nervous system, rb1 is required cell autonomously to block cell cycle 
re-entry in neural precursors. We demonstrate that the chromatin remodeling adaptor and 
histone chaperone rbbp4 is necessary for survival of neural precursors and that in the 
absence of rbbp4 neural precursor cells undergo apoptosis. In contrast. hdac1 is 
necessary to maintain proliferation in neural stem/progenitor cells. CRISPR somatic 
targeting recapitulates germline mutagenesis phenotypes. Live cell imaging of histone 
H2A-GFP in mutant larvae reveals a dynamic view of the effect of gene loss on neural 
stem and progenitor cell division and survival. rb1-mutant neural precursors re-enter the 
cell cycle but appear to stall in early mitosis, indicating a requirement for Rb1 in 
initiating quiescence as well as progression through the cell cycle. Our genomic and 
phenotypic comparisons reveal that in rb1-neoplastic cells, elevated levels of rbbp4 and 
hdac1 may contribute to proliferation and survival. Together these results identify RBPP4 
76 
 
and its associated chromatin remodelers as a potential new target for inhibiting tumor cell 
survival by driving neural cancer stem cells into apoptosis. 
Results 
Zebrafish rb1-brain tumors model OLIG2+/SOX10+ CNS-Primitive 
Neuroectodermal Tumors 
We previously developed a zebrafish rb1-brain tumor model that resembles 
poorly differentiated primitive neuroectodermal tumors by somatic targeting of zebrafish 
rb1 with TALENs (Solin et al., 2015). Targeting produces mosaic adults that develop 
brain tumors between 4-5 months of age (Figure 3.1A). To determine the molecular 
signature of the zebrafish rb1-brain tumors, 10 tumor bearing adults were dissected. Half 
of the tumor tissue was used for RNA isolation, and half was embedded for histological 
analysis (Figure 3.1A; Figure S3.1). RNA-Seq libraries were prepared from the 10 tumor 
biological replicates and two pools of three normal adult brains (Figure S3.2) and 
analyzed for differentially expressed genes (Table S3.1). E2F targets driving cell cycle 
entry were highly upregulated, and Ingenuity Pathway Analysis (IPA) revealed activation 
of mitosis, cell cycle, and DNA replication, recombination and repair pathways (Figure 
S3.3). Gene Set Enrichment Analysis (GSEA) analysis also indicated a positive 
correlation with RB-E2F oncogenic cell signaling and transcriptional regulation pathways 
and a negative correlation with neurological differentiation (Figure S3.4). These results 
are consistent with mis-regulation of RB-dependent pathways driving oncogenesis in the 
rb1-brain tumors. 
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Figure 3.1  Zebrafish rb1-brain tumors express an oligoneural precursor signature similar 
to human OLIG2+/SOX10+ CNS-PNET. A Zebrafish rb1-brain tumor model 
created by somatic targeting of rb1 exon 2 with CRISPR-Cas9 or TALEN 
genome editing nucleases. Gross brain tumors develop between 4-5 months of 
age. For transcriptome analysis, ½ of tumor tissue was dissected from 10 
tumor-positive fish for RNA isolation. The remaining tissue was embedded 
for pathology and immunolabeling. B Heat maps of log2(FPKM) show 
differential gene expression in zebrafish rb1-brain tumor transcriptome of 120 
genes in the human OLIG2+/SOX10+ CNS-PNET subtype. rb1 Tumor, RNA-
Seq of 10 biological replicates from 10 individual tumor positive adults. C, 
RNA-Seq of two biological replicates of three pooled normal adult zebrafish 
brain. C-L Histological and immunolabeling of wildtype adult zebrafish 
pretectum/diencephalon (C-G) and tumor containing brain tissue from 
transcriptome individual T2 (H, I) and T8 (J-L). Neoplastic cells in T2 tumor 
show small densely basophilic nuclei, consistent with primitive  
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(Figure 3.1 continued) neuroectodermal-like tumors (H, I). In normal adult 
brain Olig2, Sox2, and Sox10 labeling is restricted to cells at or adjacent to the 
ventricle (E-G). High levels of Olig2, Sox2 and Sox10 are detected in the 
neoplastic tissue in tumor T8. Phosphohistone-H3 mitotic cells are scattered 
throughout the lesion (J-L). Scale bars C, H 200µm; E, F, G, J, K, L 50µm. 
 
We next compared the zebrafish rb1-brain tumor transcriptome to other zebrafish 
brain tumor models and to human CNS-PNET. A set of 120 genes most highly up- and 
downregulated in the human OLIG2+/SOX10+ CNS-PNET subtype (Picard et al., 2012)  
was previously used to analyze differential gene expression in a zebrafish NRAS-CNS-
PNET model (Modzelewska et al., 2016). The zebrafish rb1-brain tumors showed a 
similar pattern of differential gene expression across the 60 up- and 60 downregulated 
genes. Defining factors of the human oligoneural CNS-PNET subgroup, olig2, sox10, 
sox8 and erbb3a, and the stem/progenitor marker sox2 (Figure 3.1B) were upregulated in 
the zebrafish rb1- tumors. Histopathological analyses of the remaining tumor tissue from 
the individuals used for transcriptome analyses were consistent with a proliferative, 
primitive neuroectodermal-like tumor (Figure 3.1 CL, Figure S3.1). In the 
diencephalon/pretectal region of wild type adult zebrafish brain, Olig2, Sox2 and Sox10 
immunolabeling is normally restricted to cells lining the ventricles and regions adjacent 
to the ventricular zone (Figure 3.1 C-G), where stem and progenitor cells are located. 
Immunolabeling of zebrafish rb1-tumors confirmed high levels of expression of Olig2, 
Sox2, and Sox10 and numerous phosphohistone H3-positive mitotic cells scattered 
throughout the lesion (Figure 3.1 H-L). Together these results demonstrate the zebrafish 
rb1- brain tumors have a highly proliferative, poorly differentiated state with an 
oligoneural precursor molecular signature found in human OLIG2+/SOX10+-CNS-PNET 
and zebrafish NRAS-CNS-PNET tumors. 
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Zebrafish rb1 is required cell-autonomously for neural precursor cell cycle exit and 
terminal differentiation during development  
The transcriptome and molecular analysis of zebrafish rb1- tumors indicated an 
oligoneural precursor phenotype drives tumor proliferation. To identify additional 
molecular and genomic changes that underlie transformation and oncogenesis in the 
absence of RB, we generated RNA-Seq libraries from larval zebrafish homozygous for a 
recessive loss of function rb1 mutation. The rb1/rb1 mutant transcriptome was used for 
comparative analysis with the tumor transcriptome to identify molecular pathways that 
distinguish transformed rb1- tumor cells from non-transformed rb1/rb1 mutant cells.   
We previously isolated a 7-base pair frameshift mutation in rb1 exon 2, rb1Δ7is54, 
and found the allele is homozygous lethal during the larval stage between five and ten 
days post-fertilization (dpf) (Solin et al., 2015). To generate the rb1Δ7/Δ7 transcriptome, 
5 dpf larva were collected from an incross between two heterozygous rb1Δ7/+ adults. 
rb1Δ7/Δ7 homozygotes do not show a dramatic gross morphological difference from 
wildtype or heterozygous siblings, other than the absence of a swim bladder. To confirm 
larval genotypes, larvae were dissected through the hindbrain; the head was placed in 
TRIzol and the trunk tissue used for genotyping (Figure 3.2A). Five confirmed wildtype 
+/+ and homozygous rb1Δ7/Δ7 heads were pooled in triplicate and used to prepare RNA-
Seq libraries (Figure 3.2A, Figure S3.4, Tables S3.2). Differential gene expression 
analysis of the rb1/rb1 mutant larval transcriptome showed upregulation of E2F targets 
driving cell cycle entry and IPA pathways controlling cell division, mitosis, and DNA 
replication, recombination and repair (Figure S3.6), as expected for activation of E2F-  
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Figure 3.2  Zebrafish rb1Δ7/Δ7 homozygous mutant larval brain transcriptome and 
neurogenic phenotype. A Zebrafish rb1/rb1 mutant transcriptome was 
generated from rb1Δ7/Δ7 homozygous and +/+ wildtype siblings from a cross 
between heterozygous rb1Δ7/+ adults. Heads from 5dpf larva were dissected 
and trunk tissue genotyped. 3 pools of 5 heads of each genotype were used to 
generate RNA-Seq libraries. Wildtype B, and rb1Δ7/Δ7 C 5 dpf larva. D 
Diagram of larval midbrain and retina with location of neural stem and 
progenitor cells at brain ventricle (V) in the optic tectum (OT) and thalamic 
region (Th) and at the retina ciliary marginal zone (cmz). Mature,  
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(Figure 3.2 continued) post-mitotic neurons are located in the lateral brain 
parenchyma and inner retina. E-L Immunolocalization with neural 
differentiation marker HuC/D and mitotic M-phase marker phosphohsitone-
H3. E, F, I, J Wild type brain and retina show the organization of mature 
neurons in dorsal brain optic tectum, ventral brain thalamus, and laminated 
retina. Only one mitotic cell is detected at the brain ventricle (F, green). G, H, 
K, L mutant brain shows M-phase cells scattered throughout the midbrain 
tectum and thalamus (G, H). In the retina, numerous M-phase cells are present 
across the entire inner nuclear layer (K, L), with occasional cells in the outer 
nuclear and ganglion cell layer. Scale bars B, C 200µm; E, I, G, K 50µm; F, J, 
H, L 20µm. 
 
dependent pathways in the absence of RB. The results were remarkably similar to the 
rb1-brain tumor transcriptome, suggesting activation of molecular pathways driving cell 
proliferation in rb1/rb1-mutant and rb1-transformed cells are controlled by similar 
mechanisms.  
To confirm the proliferative phenotype of rb1/rb1-mutant cells, brain sections of 
5dpf rb1/rb1 mutant larvae were labeled with proliferation and differentiation markers 
and showed an increase in mitotic-phase cells in the developing brain and retina (Figure 
3.2 B-L). In wildtype midbrain, mitotic cells are normally restricted to proliferative zones 
at the dorsal surface, ventricles, and lateral edges (Figure 3.2 E, F), and the ciliary 
marginal zone at the periphery of the retina (Figure 3.2 I, J). Phosphohistone-H3 labeled 
cells are absent from the brain parenchyma (Figure 3.2 F) and mature retina (Figure 3.2 J) 
where the cell bodies of post-mitotic differentiated neurons expressing the neuronal RNA 
binding protein HuC/D-Elavl3 are located in wild type brain tissue. In contrast, ectopic 
phosphohistone H3-positive cells were detected in the rb1/rb1 mutant larvae throughout 
the midbrain parenchyma in the optic tectum and thalamus (Figure 3.2 G, H), and in the 
inner and outer nuclear layers of the mature retina (Figure 3.2 K, L). Ectopic proliferation 
in the rb1/rb1 mutant was also detected in the forebrain, cerebellum and hindbrain, along 
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the entire anterior-posterior axis (Figure S3.7). Close examination of the rb1/rb1 mutant 
phosphohistone-H3 positive cells showed no labeling with HuC/D (Figure S3.8), 
suggesting the cells were in a cycling progenitor-like state. These results are consistent 
with a requirement for RB in neural precursor cell cycle exit and terminal differentiation.  
To examine whether the requirement for RB in neural precursor cell cycle exit 
was cell autonomous, genetic mosaics were created by transplanting rb1/rb1 mutant cells 
from blastula stage embryos into wildtype host embryos and examining their behavior in 
larval brain. Embryos from heterozygous rb1Δ7/+ crossed to heterozygous 
rb1Δ7/+;Tg(Tol2<ubi:DsRed2>) adults carrying a ubiquitous RFP reporter transgene 
were collected, and cells from blastula stage embryos were transplanted into a casper 
host embryo. The remaining donor embryo tissue was used to determine the rb1 genotype 
(Figure S3.9). Three host larva containing cells from a +/+ or rb1Δ7/Δ7 donor embryo 
were analyzed. At 5dpf, host larva were sectioned and co-labeled with antibodies to 
DsRed2, to identify the descendants of transplanted cells, and to the proliferation marker 
phosphohistone H3 or the neuronal differentiation marker HuC/D (Figure 3). The 
descendants of +/+ wildtype (Figure 3.3A, B, E, F) and rb1Δ7/Δ7 mutant (Figure 3.3 C, 
D, G, H) transplanted cells were incorporated into the developing brain and could be 
detected in the midbrain parenchyma. None of the +/+ wildtype cells labeled with 
phosphohistone H3 (Figure 3.3 A, B), and each cell was positive for the neuronal marker 
HuC/D (Figure 3.3 E, F). The majority of the rb1Δ7/Δ7 mutant cells were 
phosphohistone H3-negative. However, in each section one or two phosphohistone H3-
positive mutant cells with highly condensed chromatin was detected (Figure 3.3 C, D), 
indicating the cells were in M-phase. Each of the rb1Δ7/Δ7 mutant cells expressed  
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Figure 3.3  Cell-autonomous requirement for RB in blocking cell cycle entry in zebrafish 
neural precursors. Immunolabeling of 5dpf host larval brain sections 
containing descendants of +/+; ubi:DsRed2 and rb1Δ7/Δ7; ubi:DsRed2 
transplanted cells. A-D phosphohistone H3 and DsRed2 labeled sections. 
Wildtype (A, B) and rb1Δ7/Δ7 mutant (C, D) cells present in a wildtype host 
optic tectum. A few phosphohistone H3-positive rb1Δ7/Δ7 mutant cells can be 
detected (D, arrows). E-H Neuronal marker HuC/D and DsRed2 labeled 
sections. Wildtype (E, F) and rb1Δ7/Δ7 mutant (G, H) cells in a host optic 
tectum express HuC/D. A number of rb1Δ7/Δ7 mutant cells with highly 
condensed chromatin lack HuC/D labeling (H, arrows). I-J Boxed region in F, 
showing HuC/D and DsRed2-positive wildtype cells with interphase 
chromatin. M-P Boxed region in H shows DsRed2-positive rb1Δ7/Δ7 mutant 
cells with interphase chromatin also express HuC/D. HuC/D is absent from  
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 (Figure 3.3 continued) rb1Δ7/Δ7 mutant cells with highly condensed 
chromatin (arrows). Scale bars A, C, E, G 100µm; B, D, F, H 20µm; I, M 
10µm. 
 
HuC/D, except for the M-phase cells with condensed chromatin (Figure 3.3 G, H arrows). 
Higher magnification images show that each wild type (Figure 3.3 I-L) or rb1Δ7/Δ7 
mutant (Figure 3.3 M-P) cell that labels positively for HuC/D and DsRed2 contains 
chromatin characteristic of interphase cells. In contrast, the rb1Δ7/Δ7 mutant cells with 
highly condensed chromatin do not co-label with HuC/D (Figure 3.3 M-P). The presence 
of rb1Δ7/Δ7 cells that express HuC/D/Elavl3 and rb1Δ7/Δ7 cells with condensed 
chromatin in M phase, suggests the mutant neural precursors are able to re-enter the cell 
cycle. These results demonstrate the requirement for RB to block cell cycle entry in 
neural precursors is cell autonomous.  
Comparison of zebrafish rb1-transformed and rb1/rb1 mutant transcriptomes 
support epigenetics drive rb1-tumor growth  
The rb1Δ7/Δ7 mutant transcriptome and phenotypic analyses showed rb1/rb1 
mutant cells can re-enter the cell cycle and proceed into M phase, but lack continuous 
unregulated proliferation characteristic of rb1-transformed tumor cells. To gain insight 
into the molecular differences between rb1/rb1 mutant and rb1-transformed cells, we 
performed additional comparative analyses between the zebrafish rb1 mutant and brain 
tumor transcriptomes. We focused on transcriptional regulators which include epigenetic 
chromatin remodelers and transcription factors, since a number of studies indicate 
regulation of the epigenome is a critical component of oncogenesis (Suva et al., 2013). 
Of the 3302 transcriptional regulators in the zebrafish genome (Armant et al., 
2013), 1191 were differentially expressed in the rb1-tumor transcriptome, and 125 
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differentially expressed in the rb1/rb1 mutant transcriptome . The majority of the 
differentially expressed transcriptional regulators in both transcriptomes were 
transcription factors; approximately one fifth were chromatin regulators (Figure 3.4A). 
However, elevated expression of stem and neural progenitor transcription factors sox2, 
sox8, sox10, olig2, and ascl1b, and downregulation of proneurogenic transcription factors 
pax6a, pax2a, neurod1, and neurod6a, was unique to the tumor (Figure 3.4B).  
The chromatin adaptor rbbp4, a component of multiple chromatin remodelers 
controlling gene expression including NuRD, PRC2, histone acetyltransferase p300, and 
the cell cycle DREAM/MuvB complex, was upregulated in both rb1/rb1 mutant and rb1-
tumor transcriptomes (Figure 3.4B). In contrast, the catalytic component of NuRD, 
histone deacetylase 1 hdac1, and the DNA binding subunit mbd3a, showed differential 
expression only in the tumor. rbbp4, hdac1, olig2 and ascl1b were examined by qRT-
PCR to validate the similarity and differences between the tumor and rb1 mutant 
transcriptomes (Figure 3.4C). The differences in gene expression between the tumor and 
mutant transcriptomes suggest alteration of chromatin remodeler activity correlates with 
transformation of rb1-mutant cells, maintenance of the tumor progenitor-like state, and 
tumor oncogenesis.  
Distinct requirements for chromatin remodelers rbbp4 and hdac1 in neurogenesis 
To investigate how rbbp4 and hdac1 drive zebrafish rb1-brain tumorigenesis we 
isolated stable germline loss of function mutations in each and examined their role in 
neural development. CRISPR-Cas9 gene editing was used to generate a frameshift 
mutation in exon two of rbbp4 (Figure 3.5A-C) and exon five of hdac1 (Figure 3.5D-F). 
A recessive-lethal loss of function four base pair deletion mutation line was established  
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Figure 3.4  Differential Gene Expression of Transcriptional Regulators in rb1-tumor and 
rb1/rb1 mutant transcriptomes. A Comparative analysis of all differentially 
expressed Transcriptional Regulators in rb1-tumor and rb1/rb1 
transcriptomes. B Heat maps showing relative expression of components of 
the NuRD chromatin remodeler, neural progenitor and neurogenic 
transcription factors in rb1-tumor and rb1/rb1 mutant transcriptomes. C 
Quantitative RT-PCR validates elevated expression of rbbp4 in the tumor and 
mutant transcriptome, while upregulation of hdac1, olig2, and ascl1b is 
unique to the tumor. metap1, housekeeping gene used as a standard control for 
heat maps and qRT-PCR. 
 
for each, designated rbbp4Δ4is60 and hdac1Δ4is70. Homozygous mutant rbbp4Δ4/Δ4 
larvae are lethal between 5 and 10 days post fertilization and show a severe neurogenic 
phenotype with microcephaly and microphthalmia (Figure 3.5C). Similar to the 
previously published colgate mutant (Henion et al., 1996; Ignatius et al., 2008),  
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Figure 3.5  Requirement for Chromatin Remodelers rbbp4 and hdac1 in zebrafish 
neurogenesis. A CRISPR target site in exon 2 of rbbp4 used to isolate 4 base 
pair frameshift mutation rbbp4Δ4-is60. PAM sequence is underlined. SmlI 
restriction enzyme site overlapping the target site is shown in red. B 5dpf 
wildtype (+/+) larva. C Gross phenotype of 5dpf homozygous mutant 
rbbp4Δ4/Δ4 larva showing microcephaly and microphthalmia. D CRISPR 
target site in exon 5 of hdac1 used to isolate 4 base pair frameshift mutation 
hdac1Δ4-is70. PAM sequence is underlined. E 3dpf wildtype larva. F Gross 
phenotype of 3dpf homozygous mutant hdac1Δ4/Δ4 larva showing 
microcephaly and retinal coloboma (arrow). G Diagram of 2dpf larval 
midbrain and retina. Sections of wildtype (H), rbbp4Δ4/Δ4 (I), and 
hdac1Δ4/Δ4 (J) 2dpf larval heads labeled with neural differentiation marker 
HuC/D (red) and apoptosis marker activated caspase3 (green). I In 
rbbp4Δ4/Δ4, apoptosis is present in the dorsal and lateral tectum (arrows), and 
throughout the inner retina (brackets). J hdac1Δ4/Δ4 larval brain and retina are 
smaller than wildtype, but few apoptotic cells are detected in the brain or 
retina. OT optic tectum; Th thalamus; R retina. Scale bars B, C 500 µm; E, F 
200µm, H-J 100µm. 
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homozygous mutant hdac1Δ4/Δ4 are also larval lethal, and at 3 days post fertilization 
show a reduced body size, curved trunk, microcephaly, and coloboma in the retina 
(Figure 3.5F, arrow).  
Homozygous mutant larvae were examined at 2dpf to determine the defect 
underlying the reduced size of the brain and retina (Figure 3.5 G-J). In 2pdf wildtype 
larval brain and retina only a few apoptotic cells were labeled with an antibody to 
activated-caspase3 (Figure 3.5H). rbbp4Δ4/Δ4 mutants showed extensive apoptosis in the 
midbrain optic tectum and retina, regions of active proliferation as the embryo transitions 
to larval neurogenesis, demonstrating RBBP4 is required for survival of neural precursors 
(Figure 3.5I). The failure of rbbp4Δ4/Δ4 neural precursors to survive explains the 
reduced eye and microcephaly observed in mutant larvae. In contrast to rbbp4, apoptosis 
was not detected in the midbrain or retina of hdac1Δ4/Δ4 mutants at 2dpf. However, the 
size of the tectum and thalamus was reduced compared to wildtype, with a decrease in the 
amount of HuC/D expressing neurons in the parenchyma (Figure 3.5J). The absence of 
apoptosis combined with an overall reduced size suggests hdac1 is required for persistent 
proliferation of stem cells to generate the neural progenitor pool and new neurons. These 
results show a distinct requirement for rbbp4 in neural progenitor or precursor survival, 
whereas hdac1 may be required upstream for maintaining proliferation of the neural stem 
and/or progenitor pool. Similar roles in neural progenitor proliferation and survival may 
drive unregulated tumor growth in zebrafish rb1-brain tumors. 
 
 
89 
 
Somatic targeting assay to examine requirement of chromatin remodelers in neural 
stem and progenitor cells during development 
CRISPR-Cas9 somatic targeting in zebrafish provides a simple and rapid method 
to investigate the function of a gene during embryonic and larval development. We 
developed an in vivo live animal imaging assay to examine the role of chromatin 
remodelers and other candidate tumor suppressor genes in neural stem and progenitor 
cells during brain development (Figure 3.6A). CRISPR-Cas9 somatic targeting is 
performed in the Tg(H2A.F/Z-GFP) reporter line (Pauls et al., 2001) which expresses a 
histone H2A.F/Z-GFP fusion protein that labels chromatin in all nuclei. We validated the 
assay by somatic targeting of rb1, rbbp4, and hdac1, and comparing the phenotype in live 
5dpf larva to the fixed immunohistochemical analysis of homozygous germline mutants. 
CRISPR targeting of rbbp4 and hdac1 resulted in gross defects in the head (Figure 3.6B) 
consistent with the phenotype of stable germline loss of function mutants described 
above.  
To examine the effect of somatic targeting on neurogenesis at the cellular level, 
we imaged the optic tectum in live Tg(H2A.F/Z-GFP) 5dpf larva (Figure 3.6C). Larva 
were mounted with dorsal side upright. A confocal z-stack of 11 slices was collected at 3 
um steps, beginning ~30um below the surface of the tectum, moving ventrally towards 
the thalamic region. In this ventral region of the tectum the rate of stem cell division has 
slowed dramatically compared to the actively proliferative zone at the dorsal side. In wild 
type larva, a single confocal slice through the ventral tectum shows the highly organized 
radial pattern of neuronal nuclei extending laterally away from the midline. A clear 
demarcation of cells lining the ventricle marks the midline (Figure 3.6C uninjected). In  
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Figure 3.6  CRISPR somatic targeting-live imaging assay to test chromatin remodeler 
function in neural cell populations during brain development. Somatic 
inactivation recapitulates germline mutants and reveals distinct requirements 
for rb1, rbbp4, and hdac1 in neural progenitor proliferation, differentiation, 
and survival. A CRISPR targeting in histone H2A.F/Z-GFP fusion line and 
dorsal view, confocal live imaging of GFP in the brain at 5dpf.  B Gross 
defects in rb1, rbbp4 and hdac1 CRISPR targeted larvae at 5dpf recapitulates 
germline phenotypes. C Confocal imaging in the optic tectum in the brain of 
live 5dpf larva. Section through ventral region of optic tectum. Mitotic figures 
are rarely captured in uninjected larva at this level of the tectum (red 
arrowhead). rb1 CRISPR targeted, cells will nuclei containing condensed 
chromatin scattered throughout the post-mitotic region of the tectum. rbbp4 
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(Figure 3.6 continued) CRISPR targeted, intense, punctate fluorescence in 
presumed apoptotic nuclei (red arrowheads) and abnormally large, irregular 
nuclei (asterisks). hdac1 CRISPR targeted, Overall reduction in the 
size/cellular number of the tectum. Enlarged nuclei with faint GFP line the 
ventricle (red arrowheads). D Quantification of M-phase phosphohistone-H3 
positive nuclei in optic tectum in three uninjected control, rb1, rbbp4 and 
hdac1 targeted larvae. Targeting experiments were replicated three times for 
rb1, and two times for rbbp4 and hdac1. Plot shows mean number of positive 
nuclei in 11 sections, in 3 biological replicates, with error bars showing 
standard error mean. The number of M-phase nuclei in rb1 targeted larvae is 
significantly different than control. Two-tailed unpaired t-test, rb1 p=0.0145; 
rbbp4 p=0.3024; hdac1 p=0.1841. Middle and Right panels, PCR genotyping 
shows highly efficient mutagenesis in the 3 CRISPR-targeted individuals used 
for quantification. C, control uninjected individuals. rb1 exon 2, sequence 
shows location of CRISPR gRNA and ClaI enzyme site overlapping Cas9 cut 
site. rb1 targeting, U=undigested PCR amplicon, D=ClaI digested PCR 
amplicon surrounding exon 2. rbbp4 and hdac1 targeting was performed with 
the gRNAs used to isolate loss of function alleles described in Figure 5. rbbp4 
targeting, U=undigested exon 2 PCR amplicon, D=SmlI digested exon 2 PCR 
amplicon. hdac1 targeting, diffuse band for PCR amplicon in targeted 
individuals correlates with efficient mutagenesis. 
 
the larval midbrain stem cells line the ventricles and the anterior-lateral surface of the 
tectum. In the confocal section shown, a single metaphase mitotic figure is present near 
the anterior side of the uninjected wild type tectum (Figure 3.6C uninjected, arrowhead). 
Quantification of mitotic figures in all 11 wildtype sections showed 14-23 dividing cells 
total per tectum (n=3, Figure 3.6D, Table S3.4). 
Live imaging of the tectum in rb1 CRISPR targeted larva showed a dramatic 
increase in the number of cells with condensed chromatin (Figure 3.6C rb1 CRISPR 
arrowheads), consistent with the phosphohistone-H3 immunolabeling results from 
rb1/rb1 mutant fixed, sectioned tissue.  The M-phase cells were located near the ventricle 
and also distributed throughout the tectum, where the regular array of postmitotic neuron 
cell bodies are located. The total number of cells with condensed chromatin in rb1-
targeted embryos was significantly higher, ranging from 76-133 (n=3, p=0.0145, Figure 
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3.6D; Table S3.4), compared to 14-23 cells observed in wild type. The difference in total 
number may be due to the degree of mosaicism and formation of bi-allelic indel 
mutations in the rb1-targeted larva, although genotyping indicated each was efficiently 
mutagenized at the CRISPR target site (Figure 3.6D). These results suggested that 
rb1/rb1 mutant neural precursors can re-enter the cell cycle after migration into the post-
mitotic region of the tectum.  
To examine the behavior of rb1 mutant neural precursors in real time, time-lapse 
confocal images were captured of H2A-GFP in wildtype and homozygous mutant 
rb1Δ7/Δ7 larva brains (Fig. S3.9B). Live imaging of the dorsal surface of the optic 
tectum in wildtype at 3dpf  and 5dpf shows the tissue is highly proliferative, with 
multiple stem cells entering and completing mitosis. At 5dpf in more ventral regions of 
the tectum where tissue growth has slowed, a two-hour time lapse showed quiescent 
neural precursors, and only one stem cell at the periphery was captured undergoing 
mitosis. In contrast, in the rb1Δ7/Δ7 mutant, multiple cells throughout the tectum 
underwent chromosome condensation. Over the course of three hours, cells that had 
entered the cell cycle failed to progress through metaphase, and frequently appeared to be 
removed by microglia. These analyses confirmed in real time the requirement for 
zebrafish Rb1 in blocking neural precursor cell cycle re-entry, and support an additional 
role for rb1 in promoting metaphase progression and completion of mitosis. 
The role of zebrafish Rbbp4 and Hdac1 in neural cell populations during 
neurogenesis was also examined by live imaging in CRISPR targeted larva. 
Quantification confirmed that proliferation in the tectum was not significantly different 
than wild type after targeting rbbp4 (1-9 cells per larva; n=3, p=0.3024; Figure 3.6D; 
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Table S3.4). In rbbp4 targeted larvae cell nuclei throughout the tectum appeared 
fragmented or hyper-condensed (Figure 3.6C, rbbp4 CRISPR, arrowheads). Frequently, 
very enlarged nuclei or cells were detected near the tectum posterior border (Figure 3.6C, 
rbbp4 CRISPR, asterisks). Like the fixed tissue analysis in homozygous mutants, live 
imaging of the rbbp4 targeted larval brain revealed rbbp4 is required for survival of 
newborn or postmitotic neurons.  
hdac1 CRISPR targeted larvae also showed a consistent neurogenic phenotype 
but a range of severity. In some larvae the optic tectum was reduced in size, while in 
others the midbrain ventricle was completely open and tectal structures entirely missing. 
Imaging of hadc1 targeted larvae that had developed an optic tectum revealed no 
significant difference in the number of mitotic cells compared to wildtype (3-17 cells per 
larva, n=3, p=0.1841, Figure 3.6D; Table S3.4). However, the nuclei in cells lining the 
ventricle appeared enlarged, with diffuse GFP expression (Figure 3.6C, hdac1 CRISPR, 
arrowheads), indicating the chromatin was decondensed. The reduced size of the brain, 
together with decondensed chromatin in cells lining the ventricle, suggests the neural 
stem cells in the hdac1 targeted larvae had exited the cell cycle, and supports a 
requirement for hdac1 in maintenance of a proliferating neural stem cell population.  
Our CRISPR somatic targeting-live imaging assay is a simple, rapid method to 
test the function of transcriptional regulators in neural cells and gain additional insight 
into their roles in tumor cell proliferation and oncogenesis. The somatic targeting assay 
confirms the germline mutant phenotype and reveals a dynamic view of proliferation and 
commitment in neural cell populations in the developing midbrain (Figure 3.7). Our  
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Figure 3.7  Roles for rb1, rbbp4 and hdac1 in proliferation, survival and terminal 
differentiation of neural cell populations during development. Diagram of 
spatial organization of neurogenesis in the zebrafish midbrain. In the midbrain 
stem cells in the optic tectum (OT) and thalamus (Th) line the ventricles and 
undergo self-renewing divisions to produce progenitors. Progenitors exit the 
cell cycle, and neural precursors migrate to their final destination in the 
parenchyma where they differentiate into mature neurons. Germline mutant 
and CRISPR somatic targeting analyses showed zebrafish rb1 is required cell-
autonomously to prevent neural precursor cell cycle re-entry. rbbp4 is 
required for survival of neural precursors. hdac1 is necessary to maintain 
proliferation in the stem cell pool, possibly by preventing premature cell cycle 
exit and differentiation, and/or quiescence. 
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analyses suggest rb1 is necessary to block re-entry of neural precursors into the cell 
cycle. In the absence of rbbp4, neural precursors fail to survive and activate caspase-3 
mediated apoptosis. The production of new neural precursors is dependent on hdac1 
maintaining proliferation of the neural stem cell pool. Together these results suggest 
elevated expression of rbbp4 and hdac1 after rb1 loss may drive unregulated proliferation 
and growth in zebrafish rb1-brain tumors. 
Discussion 
In this study, we compared the transcriptome of somatically engineered zebrafish 
rb1-primitive neuroectodermal-like brain tumors with homozygous rb1/rb1 mutants and 
identified epigenetic regulators that may contribute to the mechanism of RB-defective 
oncogenesis. Our results suggest transcriptional regulation by epigenetic modifiers and 
neural progenitor transcription factors distinguishes transformed RB-defective tumor 
cells from homozygous mutant brain tissue harboring a simple loss of function mutation 
in rb1. We next performed phenotypic mutant analysis in the developing zebrafish larval 
brain to understand the role of rb1 and the chromatin remodelers rbbp4 and hdac1 in 
normal neurogenesis. As part of this analysis we developed a novel in vivo assay to 
examine RB and chromatin remodelers in neural precursor proliferation, survival and 
differentiation. The results show a cell autonomous requirement for rb1 in blocking cell 
cycle re-entry in neural precursors. While rbbp4 is required for neural progenitor and/or 
precursor survival, hdac1 is necessary for maintaining proliferation of the neural 
stem/progenitor pool. The requirements for rbbp4 and hdac1 in regulating neural 
progenitor proliferation and survival may contribute to oncogenesis after rb1 loss in 
zebrafish rb1-brain tumors. Our study provides novel insights into the tumor suppressive 
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role of zebrafish Rb1 and its candidate interacting proteins Rbbp4 and Hdac1 in driving 
persistent tumor growth, and identifies Rbbp4 as a potential target to inhibit tumor cell 
survival.  
Our zebrafish rb1-brain tumor model histologically and molecularly resembles 
human CNS-PNET, an embryonal tumor composed of proliferative neuroblast cells. 
Conditional RB knockout in mice neural precursors in combination with TP53 and PTEN 
tumor suppressors favors formation of CNS-PNET over glioma (Chow et al., 2011; 
Jacques et al., 2010). Although our zebrafish model results from inactivation of a single 
tumor suppressor rb1, tumor pathway analysis identified TP53 dependent signaling, DNA 
mismatch, base excision and homologous recombination repair pathways as altered in 
rb1-tumors and may contribute to transformation and tumorigenesis. In humans, CNS-
PNET has been genetically linked to mutation or alteration of RB/E2F, TP53, and DNA 
mismatch repair pathways (reviewed in (Larson and Largaespada, 2012). 4-15% of 
children carrying RB mutations have been reported to develop PNET outside of the retina 
(Blach et al., 1994; de Jong et al., 2015; Kivela, 1999) and silencing of CDKN2A, a 
negative regulator of RB inhibiting cyclin dependent kinases, occurs in sporadic PNETs 
(Li et al., 2005; Pfister et al., 2007). Sporadic CNS-PNET has also been associated with 
TP53 mutation and overexpression (Eberhart et al., 2005) and TP53 germline mutation in 
Li Fraumeni syndrome (Orellana et al., 1998). A number of tumors types including CNS-
PNET arise in individuals with Turcot syndrome Type I, which is linked to mutations in 
DNA mismatch repair genes hMLH1, hMSH2, hPMS1 and hPMS2 (De Vos et al., 2004). 
Altered expression of RB/E2F, TP53 and DNA mismatch repair pathways in the 
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zebrafish rb1-brain tumor model is consistent with the genetic origin of human CNS-
PNET. 
Comparative genomics revealed the zebrafish RB-defective brain tumors are most 
similar to the human OLIG2+/SOX10+-CNS-PNET subtype (Picard et al., 2012; Sturm 
et al., 2016a). We confirmed Olig2 and Sox10 protein are highly expressed in tumor 
tissue, supporting a mechanism in which oligoneural precursor transcription factors 
contribute to gene expression driving tumor cell proliferation. The previous observations 
that epigenetic mechanisms drive cell transformation and tumorigenesis in human and 
mouse retinoblastoma (Aldiri et al., 2017; Benavente et al., 2013; Zhang et al., 2012) 
suggested epigenome changes may also underlie oncogenesis in the zebrafish rb1-tumor 
model. Differential gene expression showed >25% of all transcriptional regulators, 
including >200 chromatin remodelers, are altered in the rb1-tumor transcriptome, 
supporting epigenetic control of gene expression drives tumorigenesis. RBBP4, a 
chromatin adaptor for multiple chromatin remodeling complexes, is an E2F target and, as 
expected, was increased in the zebrafish rb1-tumor and rb1/rb1 homozygous mutant 
transcriptome. Upregulation of hdac1, which is not a direct target of E2F transcriptional 
activation, was specific to the rb1-tumor. This suggests hdac1 is one of many chromatin 
remodelers whose activity may distinguish transformed tumor cells from mutant cells. 
Gene regulatory network analysis and simulation of tumorigenesis in a human cell line 
model has suggested chromatin remodelers cooperate with transcription factors as cells 
progress to transformation (Malysheva et al., 2016). A similar epigenetic mechanism in 
which Hdac1 and Rbbp4 associate with oligoneural precursor transcription factors may 
drive zebrafish rb1-brain tumor oncogenesis. 
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Our analysis of zebrafish loss of function rb1/rb1 mutants in neural development 
reveals a cell-autonomous requirement for rb1 in suppressing cell cycle re-entry in neural 
precursors. This is consistent with the original mouse RB knockout models demonstrating 
ectopic proliferation in the embryonic mouse brain (Clarke et al., 1992; Ferguson and 
Slack, 2001; Jacks et al., 1992; Lee et al., 1992; Lipinski and Jacks, 1999). More 
recently, conditional RB knockout in embryonic and adult mouse neural progenitors has 
shown RB is required to control neural precursor proliferation and for the long-term 
survival of newborn neurons in the olfactory bulb and hippocampus (Naser et al., 2016; 
Vandenbosch et al., 2016). Although our results do not indicate zebrafish Rb1 functions 
in long-term neuron survival, analysis of rb1/rb1 mutant cells over an extended time 
would be required to rule out this role. Our live imaging of histone H2A-GFP in zebrafish 
larval brain allowed a dynamic view of rb1/rb1 mutant neural precursor behavior and cell 
cycle entry. Following chromatin condensation, rb1/rb1 mutant cells failed to progress 
through mitosis and appeared to idle in prometaphase, indicating RB is also required to 
complete the cell cycle. A delay in cell cycle exit of retinal ganglion cell precursors was 
previously reported in the zebrafish rb1 mutant space cadet (Gyda et al., 2012). Whether 
rb1/rb1 mutant neural precursors remain arrested in M-phase, eventually exit the cell 
cycle, or undergo continuous rounds of inappropriate cell cycle entry will require 
additional analyses.  
Recently RB has been shown to cooperate with the DREAM complex subunit 
Lin37 to block cell cycle entry and transition cells from G1 to G0/quiescence (Mages et 
al., 2017). In budding yeast the transition from proliferation to quiescence is mediated by 
DREAM recruitment of the histone deacetylase HDAC1 to S phase genes to repress cell 
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cycle entry (Miles and Breeden, 2017), again connecting RB with chromatin remodeling 
in cell cycle regulation. RB has also been shown to interact genetically with the 
chromatin remodeler histone demethylase UTX in cell fate control in C. elegans (Wang 
et al., 2010b). Zebrafish rb1/rb1 mutant neural precursors fail to initiate quiescence, but 
may also lack the ability to respond to differentiation signals in the environment. RB in 
association with HDAC1 and other chromatin remodelers may be required to shift the 
gene expression program in G1 neural precursors to a neural differentiation program. The 
disruption of RB-dependent transcriptional mechanisms controlling neural precursor 
quiescence and differentiation may be a part of oncogenesis in RB-defective brain 
tumors.  
The zebrafish rbbp4 and hdac1 mutants we isolated and characterized have 
provided new insight into their roles in neural cell fate decisions. RBBP4 has not 
previously been studied in the developing vertebrate nervous system, and our analysis 
shows rbbp4 is necessary for neural precursor survival in zebrafish. RBBP4 acts as a 
chromatin adaptor for multiple chromatin regulatory complexes, including 
HDAC1/NuRD (Alqarni et al., 2014), PRC2 (Kuzmichev et al., 2002; Muller et al., 
2002), DREAM/MuvB (Harrison et al., 2006; Litovchick et al., 2007), and the 
transcriptional activator p300/Histone Acetyl Transferase (Kitange et al., 2016). In 
zebrafish neural precursors Rbbp4 could assist in genome maintenance through p300 
activation of gene expression in DNA repair pathways, as was reported in glioblastoma 
cells (Kitange et al., 2016). Additional phenotype and genetic interaction studies of 
zebrafish rbbp4 are necessary to dissect the contribution of RBBP4 and its chromatin 
remodeling complexes to preventing neural precursor apoptosis and facilitating neural 
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differentiation. Like RBBP4, HDAC1 is a component of multiple chromatin remodeling 
complexes that may function separately to control proliferation and differentiation, 
depending on the cell type and context. The zebrafish hdac1 mutant phenotype would 
support a role for HDAC1 in maintaining stem cell proliferation and the production of 
neural progenitors, either by blocking quiescence or premature differentiation in the stem 
cell population. The decondensed, enlarged nuclear phenotype of zebrafish hdac1 mutant 
stem cells in the brain suggest histone deacetylation is important for maintaining a 
proliferative stem cell pool. Global loss of histone acetylation due to overexpression of 
HDACs is a common feature in several human cancers (Brien et al. 2016; Haery et al. 
2015). Together with the survival promoting activity of RBBP4, HDAC1 and RBBP4 
may cooperate to drive persistent proliferation and growth of tumor cells in RB-defective 
brain cancer. 
Future studies to investigate the cooperation of RBBP4, HDAC1 and RB in 
specific neural precursor cell types will increase understanding of the mechanism by 
which RBBP4 prevents programmed cell death and HDAC1 maintains a balance between 
proliferation and differentiation and/or quiescence. Since the first description of somatic 
targeting in zebrafish using custom genome editing nucleases (Bedell et al., 2012), 
CRISPR/Cas9 and TALENs have been widely adopted to examine developmental 
mechanisms and model disease (Peng et al., 2014; Shah et al., 2016). Combined with the 
histone-GFP reporter live imaging assay we developed, our somatic screen provides a 
rapid method to test chromatin remodelers and further dissect the mechanism controlling 
RB-dependent proliferation and survival in neurogenesis and tumor suppression. The 
recent discovery of a WD40 Repeat inhibitor that binds the MLL subunit of PRC2 (Song 
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et al., 2017) suggests other WDR proteins, such as RBBP4, are strong candidates for 
chemical compound screening to identify therapeutic drugs. Given the requirement for 
RBBP4 in neural precursor survival, RBBP4 and its associated chromatin remodeling 
complexes represent a potential new target to inhibit tumor cells and induce neural cancer 
cell apoptosis. 
Materials and Methods 
Zebrafish care and husbandry 
Zebrafish were raised on an Aquatic Habitat housing system from Pentair Aquatic 
Eco-systems (Apopka, Florida) and maintained at 27oC on a 14hr light/10hr dark cycle. 
The zebrafish WIK wildtype strain and transparent casper mutant line (White et al., 
2008) were purchased from the Zebrafish International Resource Center 
(https://zebrafish.org/home/guide.php). Transgenic line Tg(H2A.F/Z-GFP) (Pauls et al., 
2001) was received from Dr. Brian Link, Medical College of Wisconsin. Isolation of the 
zebrafish rb1 7 base pair exon 2 frameshift mutation rb1Δ7is54 was described previously 
(Solin et al., 2015). All experimental protocols were approved by the Iowa State 
University Animal Care and Use Committee (Log#11-06-6252) and performed in 
compliance with American Veterinary Medical Association and National Institutes of 
Health guidelines for humane use of laboratory animals in research. The zebrafish rb1-
brain tumor model was generated by injection of rb1 TALENs targeting exon 2 (Solin et 
al., 2015). Animals were monitored according to the guidelines for endpoint in neoplasia 
studies as outlined in the NIH/Office of Animal Care and Use/Animal Research Advisory 
committee (ARAC) Guidelines for endpoint in neoplasia studies 
(oacu.od.nih.gov/ARAC/Guidelines for Endpoints in Animal Study Proposals). Adult fish 
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were monitored daily during feeding for general appearance, size, length, viability and 
morbidity relative to control siblings. Fish were monitored bi-weekly for evidence of 
cranial tumors and sacrificed before tumor burden reached 3 mm in size/25mg in weight, 
constituting less than 10% of the total body weight of an adult fish (300-500mg).  
RNA-Seq libraries, sequencing, and analysis 
Zebrafish rb1-brain tumor model RNA-Seq libraries: Tissues for isolation of total RNA 
were dissected from 10 adult fish with brain tumors and 6 control wild type siblings 
between the ages 6.5 to 10.5 months. One sagittal half of each brain from the 
diencephalon to behind the cerebellum was isolated for RNA extraction. The remaining 
half was processed and embedded in either paraffin blocks or OCT media (Fisher). Total 
RNA was isolated using TRIzol (Invitrogen), followed by DNase I (Qiagen) digestion 
and Qiagen RNeasy MinElute Cleanup (Qiagen). RNA quality was analyzed with the 
Agilent RNA 6000 Nano Kit on an Agilent 2100 Bioanalyzer. 1 µg of total RNA input 
was used for each library preparation. Replicate cDNA libraries were synthesized from 
10 individual brain tumor RNA samples and 2 pools of 3 wild type brain RNA samples 
using the Illumina TruSeq RNA Library Prep Kit v2., for a total of 24 barcode indexed 
libraries. The 24 cDNA libraries were multiplex 50bp single-end sequenced in 2 lanes (12 
per lane) on an Illumina HiSeq 2500 instrument at the Genome Sequencing Core, Center 
for Molecular Analysis of Disease Pathways, University of Kansas.   
Zebrafish rb1Δ7/Δ7 mutant 5 dpf larval brain RNA-Seq libraries: Heterozygous rb1Δ7/+ 
adults were in-crossed and embryos aged to 5 dpf for tissue isolation. Individual 5dpf 
larvae were dissected in two; the head was placed in TRIzol for storage at -80oC; the 
trunk was placed in 50mM NaOH, heated at 95oC for 30 minutes, and used for PCR 
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genotyping. 3 pools of 5 genotyped heads were used to prepare 3 wild type +/+ and 3 
rb1Δ7/Δ7 homozygous mutant barcoded indexed RNA-Seq libraries, as described above. 
The 6 indexed libraries were multiplex 50bp single-end sequenced in 2 lanes on an 
Illumina HiSeq 2500 instrument at the Genome Sequencing Core, Center for Molecular 
Analysis of Disease Pathways, University of Kansas.   
Reads were aligned to the GRCz10 zebrafish reference genome using GSNAP 
version 20150723 with the following parameters “-N 1 -t 8 -B 4 -m 5 -A sam --split-
output” to account for exon-exon splice junctions during alignment and a maximum of 5 
mismatches. The “uniq” SAM output files from GSNAP were funneled through Cufflinks 
2.2.1 for normalization. Python HT-Seq 0.9.1 was used to generate the count table from 
the GSNAP “uniq” SAM files. Gene exonic length was calculated from the 
Danio_rerio.GRCz10.89.gtf file in R using the “GenomicFeatures” package from 
Bioconductor. Fragments Per Kilobase of transcript per Million mapped reads (FPKM) 
was calculated using the following equation FPKM= (10^9 x Number of mapped reads to 
a gene)/ (Gene exonic length x Total mapped reads in the experiment). Count data 
generated from HT-Seq was analyzed for differential gene expression detection using 
DESeq2. Differentially Expressed Genes were defined by an adjusted p-value of less than 
or equal to 0.01 and a 1.5-fold change in either direction. 
Correlation coefficient plots were computed using FPKM in Microsoft Excel with 
the CORREL function. GSEA and E2F target gene analysis was performed at the Broad 
Institute website http://software.broadinstitute.org/gsea/index.jsp. Ingenuity Pathway 
Analysis (Qiagen 830036) was performed with software licensed to Iowa State 
University. For IPA, human homologs of zebrafish genes were identified at Biomart 
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(http://www.biomart.org). Differential gene expression of 3302 transcriptional regulators 
was analyzed using the gene list identified in (Armant et al., 2013). Heatmaps were 
generated in R with gplots heatmaps.2 or with Broad Institute GENE-E software 
(https://software.broadinstitute.org/GENE-E/). Venn diagrams were drawn at 
http://www.venndiagrams.net. 
Quantitative RT-PCR 
5dpf larva from an in-cross between rb1Δ7/+ adults were collected and dissected 
into head and trunk tissue. Head tissue was placed in TRIzol. Trunk tissue was digested 
in 50mM NaOH at 95°C for thirty minutes, then PCR genotyped to identify homozygous 
rb1Δ7/Δ7 and wildtype +/+ siblings. 33 homozygous rb1Δ7/Δ7 heads and 40 +/+ heads 
were pooled, and total RNA extracted. mRNA was purified from total RNA using a 
magnetic isolation kit (NEB E7490S), and checked for quality using an Agilent 2100 
Bioanalyzer. First strand cDNA was reverse transcribed with SuperScript III First-Strand 
Synthesis SuperMix for qRT-PCR (Invitrogen #11752-050). qPCR reactions were set up 
with SYBR Green (Applied Biosystems A25742) and a final primer concentration 
200nM. qPCR was run with standard temperature settings on a Roche Lightcycler 480 
instrument at the ISU Genome Technology Facility. 
Histology and Immunolocalization 
For histological analysis tumor tissue was fixed in 10% formalin, paraffin-
embedded, and 6µm microtome sections stained with Hematoxylin 7211 Richard-Allan 
Scientific (Fisher) and 3% Eosin Y (Argos Organics 152880250). For 
immunolocalization, tumor tissue and larval heads were fixed in 4% paraformaldehyde, 
embedded in Tissue-Tek OCT 4583 (Fisher) and sectioned at 16-20µm. Cryosections 
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were labeled with the following antibodies: rabbit polyclonal anti-Phosphohistone-H3 
(Cell Signaling Technology 9701) at 1:1000; rabbit polyclonal anti-SOX2 (EMD 
Millipore AB5603) at 1:200; rabbit polyclonal anti-SOX10 (GeneTex GTX128374) at 
1:200; rabbit polyclonal anti-OLIG2 (IBL America 18953) at 1:200; mouse monoclonal 
anti-HuC/HuD (Invitrogen A-21271) at 1:300; rabbit polyclonal Living Colors DsRed 
(Clonetech 632496) at 1:200; rabbit anti-activate-human-caspase-3 (BD Pharmingen 
559565) at 1:500; Alexa-488 (Invitrogen A-11008) and Alexa-594 (Invitrogen A-11005) 
conjugated secondary antibodies were used at a dilution of 1:500. Sections were stained 
with DAPI and mounted in Fluoro-Gel II containing DAPI (Electron Microscopy 
Sciences 17985-50). Immunolabeled sections were imaged on a Zeiss LSM700 laser 
scanning confocal microscope with 10X, 20X, 40X C-apochromat and 63X Plan-
Apochromat objectives. Images and figures were assembled in Adobe Photoshop. 
Isolation of Tol2<ubi:DsRed2> transgenic line  
The Tol2<ubi:DsRed2> transgene was assembled in the mini-pTol2 vector 
(Balciunas et al., 2006) by cloning in the zebrafish ubiquitin promoter (Mosimann et al., 
2011) followed by the DsRed2 cDNA (Clonetech) and the zebrafish β-actin 3’UTR (Dr. 
Darius Balciunas, Temple University; (McGrail et al., 2011) ). 1µg of linearized pT3TS-
Tol2 transposase plasmid (Balciunas et al., 2006) was used for in vitro synthesis of Tol2 
transposase capped, polyadenylated mRNA using the T3 mMessage mMachine High 
Yield Capped RNA transcription kit (Ambion AM1348). mRNA was precipitated with 
LiCl and resuspended in RNase, DNase-free molecular grade water. The 
Tol2<ubi:DsRed2> transgenic line was isolated by co-injection of 25pg Tol2 vector plus 
100pg Tol2 mRNA into 1 cell-stage zebrafish embryos. Two founder fish were screened 
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for germline transmission of ubiquitously expressed DsRed2. The 
Tg(Tol2<ubi:DsRed2>)is56  line was established from a single F1 adult.   
Blastula cell transplants to create genetic mosaic zebrafish embryos 
Transplant of cells from blastula-stage embryos was performed as described 
previously (Wang et al., 2010c). 30-50 cells from blastula stage embryos from adult 
rb1Δ7/+ crossed to rb1Δ7i/+ ; Tg(Tol2<ubi:DsRed2>)is56 were transplanted into blastula 
stage casper host embryos, and the remaining donor blastula tissue was used for 
genotyping. Host embryos were screened for DsRed2-positive fluorescence at 24 and 48 
hpf. Three host embryos containing DsRed2-expressing transplanted cells from three 
individual donor embryos of wildtype +/+ or homozygous mutant rb1Δ7/Δ7 genotype 
were aged to 5dpf. Larval heads were dissected, fixed, embedded, sectioned and 
immunolabeled for confocal imaging as described above.  
CRISPR-Cas9 gRNAs and isolation of loss of function rbbp4 and hdac1 mutations 
The following CRISPR gRNAs were used for somatic targeting of zebrafish rb1, 
rbbp4 and hdac1. rbbp4 and hdac1 gRNAs were also used to isolate the stable germline 
4bp frameshift mutations rbbp4Δ4-is60 and hdac1Δ4-is70. The rb1 exon 2 CRISPR site 
5’-GGAGAGGGAGATCAGATCGA-3’ contains a ClaI restriction enzyme site 
overlapping the Cas9 cut site upstream of the PAM.  The rbbp4 exon 2 CRISPR site 5’-
GATGACCCACGCCCTTGAG-3’ has an SmlI restriction enzyme site overlapping the 
Cas9 cut site. For hdac1 the exon 5 CRISPR site 5’-GACAGACAGTGCCATTAAC-3’ 
was used for targeting. CRISPR gRNAs were prepared by the cloning-free single-guide 
RNA synthesis method (Varshney et al., 2015) using Ambion T7 MEGAscript Kit 
(Ambion AM1334M) and purified with the Qiagen miRNeasy Kit (Qiagen 217004). 
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Cas9 mRNA was synthesized in vitro using the mMessage mMachine T3 kit (Life 
Technologies AM1348). 5-10ug of pT3TS-nlsCas9nls plasmid (Addgene 46767) was 
linearized with XbaI and purified with Qiaquick Spin kit (Qiagen 28104). 500ng-1ug 
purified linear pT3T3-nlsCas9nls DNA was used as template for mRNA synthesis, and 
the capped nls-Cas9-nls mRNA purified with the miRNeasy kit (Qiagen 217004). 
Primers for amplicons to test for mutagenesis were as follows: rb1 F 5’-
TTTCCAGACACAAGGACAAGGATCC-3’, R 5’-
GCAGATATCAGAAGAAAGAGTACATTTGTCTT-3’; rbbp4 F 5’-
GCGTGATGACAGATCTCATATTGTTTTCCC-3’, R 5’-
CTGGTGACATCTGGCAACCACT-3’; hdac1 F 5’-GCGGTGAAACTCAACAAACA-
3’, R 5’-GAATGGCCAGTACAATGTCG-3’. 
To isolate stable germline mutations, 25pg rbbp4 or hdac1 CRISPR guides were 
coinjected with 150pg Cas9 mRNA into WIK embryos. 8-10 targeted embryos were 
tested for mutagenesis by PCR genotyping, and sibling founders raised to adulthood. 
Adult founder fish were outcrossed to wildtype WIK fish and F1 embryos screened for 
inheritance of stable germline mutant alleles. Sibling F1 progeny were raised to 
adulthood and heterozygotes identified by genotyping of fin clip tissue. F2 families of 
heterozygous mutant fish were established by outcrossing to wild type WIK. 
CRISPR somatic targeting and larval brain live imaging 
CRISPR gRNAs were co-injected with 150pg Cas mRNA into 1 cell Tg(H2A.F/Z-
GFP) embryos. At 12hpf embryos were placed in (0.003%) 30mg/liter Phenyl-Thio-Urea 
(PTU) to inhibit melanin synthesis. 5dpf larvae were mounted in 1.2% low-melt agarose 
containing 160ug/ml Tricaine methanesulfonate ventral side down on coverslip-bottom 
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35mm petri dishes. The dish was filled with embryo water (Westerfield, 1995) containing 
Tricaine and PTU. Live larvae were imaged on a Zeiss LSM700 laser scanning confocal 
microscope using a 40X W-N Achroplan water immersion objective. Z series containing 
11 sections were captured beginning ~30um below the dorsal side of the optic tectum and 
descending ventrally at 3 um intervals. Three control un-injected Tg(H2A.F/Z-GFP) 
larvae and three CRISPR gRNA injected Tg(H2A.F/Z-GFP) larvae for each gene were 
imaged. After imaging larvae were digested in 50mM NaOH and genotyped by PCR. 
Mitotic figures in each section were counted in ImageJ. Mitotic figure quantification was 
plotted and the significance calculated using a two-tailed unpaired t test in GraphPad 
Prism 7.0 (GraphPad Software). 
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Supplemental Figures and Tables 
 
Figure S3.1  Histological analysis of neoplastic populations in TALEN induced rb1-brain 
tumor T3 and T4 is consistent with primitive neuroectodermal-like tumor. 
H&E stained sections of tissue remaining after dissection of tumors T3 (A, 
B) and T4 (C, D) used for transcriptome analysis. Sections exhibit an 
unencapsulated, multifocally infiltrative neoplastic population within the 
neuropil.   
 (Figure S3.1 continued) Neoplastic cells are small with deeply basophilic, 
round to oval to wedge-shaped nuclei, densely clumped chromatin, and 
scant amounts of cytoplasm. Scale bars A, C 200µm; B, D 50 µm. 
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Figure S3.2  Correlation coefficients for RNA-Seq libraries from 10 rb1-brain tumor and 
two pools of 3 wildtype adult brains show high correlation between 
technical and biological replicates. 
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Figure S3.3  Differentially expressed E2F target genes and Ingenuity Pathway Analysis 
of zebrafish rb1-brain tumor transcriptome. A Heat map of differentially 
expressed E2F cell cycle target genes in rb1-tumor transcriptome (rb1-
Tumor, T1-T10) compared to normal adult brain (C, C1-C2). B Ingenuity 
Pathway Analysis Canonical Pathways represented in the rb1-tumor 
transcriptome. 
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Figure S3.4  Gene Set Enrichment Analysis of the rb1-tumor transcriptome. GSEA shows 
positive correlation with RB-E2F, ES cell, pediatric tumor marker, ERB2, 
mTOR, SHH, ATF2, PRC2 and SNF5 pathways, and negative correlation 
with neurological systems.  
 
 
Figure S3.5  Correlation coefficients for RNA-Seq libraries from 3 rb1Δ7/Δ7 and 3 +/+ 
5dpf larva show high correlation between technical and biological 
replicates. 
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Figure S3.6  Differentially expressed E2F target genes and Ingenuity Pathway Analysis 
of zebrafish rb1Δ7/Δ7 homozygous mutant 5pdf transcriptome. A Heat map  
(Figure S3.6 continued) of differentially expressed E2F cell cycle target 
genes in rb1Δ7/Δ7 mutant transcriptome (M1-M3) compared to +/+ 
wildtype siblings (WT1-3). B Ingenuity Pathway Analysis Canonical 
Pathways represented in the rb1Δ7/Δ7 mutant transcriptome. 
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Figure S3.7  Ectopic M-phase phosphohistone-H3 positive cells in the 
telencephalon/forebrain and hindbrain of rb1Δ7/Δ7 mutant 5dpf larva. A 
wildtype, +/+ and B rb1Δ7/Δ7 mutant 5dpf larvae labeled with antibodies to 
the neuronal marker HuC/D (red) and mitotic M-phase marker 
phosphohistone-H3 (green). Sections through the telencephalon (C-F) and 
hindbrain (G-J) show that in wild type mitotic cells are absent or rare, but in 
the rb1Δ7/Δ7 mutant many ectopic phosphohistone-H3 positive cells are 
scattered throughout the region containing HuC/D-positive cell bodies of 
neurons. 
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Figure S3.8  rb1Δ7/Δ7 mutant cells in M-phase lack expression of the neuronal 
differentiation marker HuC/D. A, B High magnification image of 
phosphohistone-H3 positive nuclei and HuC/D-positive cells in the tectum 
of a 5dpf rb1Δ7/Δ7 mutant brain. No overlap is detected between cells 
expressing HuC/D (C, red) and phosphohistone-H3 (D, green, arrows, 
dashed outlines). The chromatin in the phosphohistone-H3 positive cells 
appears highly condensed (E), consistent with cells in S phase or 
prophase/prometaphase of the cell cycle.  
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Figure S3.9  Genotyping of blastula donor embryos used for cell transplants and 5dpf 
larva used for time lapse imaging. A PCR genotyping of remaining tissue in 
blastula stage donor embryos from rb1Δ7/+ x rb1Δ7/+; 
Tg(Tol2<ubi:DsRed2>) after transplanting cells into host casper embryos. 
Genotype of individual embryos is shown below. Sections of host 5dfp 
larvae containing transplanted cells from +/+ embryo #13 and rb1Δ7/rb1Δ7 
embryos #6 and #12 are shown in Figure 3. B PCR genotyping of 5dpf +/+; 
Tg(H2A.F/Z-GFP) and rb1Δ7/Δ7; Tg(H2A.F/Z-GFP) larva imaged in time 
lapse Movies S2-S4. 
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Table S3.1 Reads and quality control statistics from rb1-brain tumor and normal adult 
brain RNA-Seq libraries. 
 
 
 
Table S3.2  Reads and quality control statistics from zebrafish homozygous mutant 
rb1Δ7/Δ7 and wildtype +/+ 5dpf larval head RNA-Seq libraries. 
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Table S3.3  qRT-PCR primers. 
 
 
 
Table S3.4  Quantification of phosphohistone H3-positive M-phase cells in live 5dpf 
larva. 
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Abstract 
 
Retinoblastoma-Binding Protein 4 (RBBP4) is a chromatin adaptor protein that 
associates with numerous activating and repressive chromatin regulatory complexes. 
RBBP4 is overexpressed in human gliomas, and has been shown to promote survival of 
GBM cells and p300-dependent expression of DNA repair genes (Kitange et al., 2016). 
We previously established a zebrafish RB-defective neural progenitor-like brain tumor 
model (Solin et al., 2015) and recently found Rbbp4 is highly upregulated in the RB- 
brain tumors. Here we demonstrate Rbbp4 is essential for zebrafish brain development 
and show it has distinct requirements in neural stem and progenitor cells. CRISPR/Cas9 
targeting was used to isolate a 4 base-pair frameshift mutation in the zebrafish homolog 
rbbp4. Homozygous mutant rbbp4Δ4/Δ4 are lethal at approximately 5-7 days post 
fertilization and show a dramatic reduction in the size of the brain and retina. 
Overexpression of rbbp4 cDNA in a Tg(Tol2<ubiquitin:rbbp4>) transgenic line rescues 
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the rbbp4 mutant phenotype, demonstrating disruption of neurogenesis in rbbp4Δ4/Δ4 
homozygotes is due to lack of functional Rbbp4. Beginning at 2 days post fertilization, γ-
H2AX and activated caspase labeling was detected in post-mitotic regions in the larval 
midbrain and retina, suggesting RBBP4 is required to prevent DNA-damage and 
apoptosis in neural progenitors or newborn neurons. γ-H2AX and caspase were not 
detected in the stem cell niches at the brain ventricle or retinal ciliary marginal zone, 
however, stem cell morphology was abnormally large. Pulse chase BrdU labeling 
experiments confirmed a delay in stem cell proliferation and a lack of survival of post-
mitotic neural progenitors. TP53 morpholino knockdown in rbbp4Δ4/Δ4 homozygotes 
transiently suppressed neural progenitor apoptosis, indicating the absence of Rbbp4 
activates TP53-dependent programmed cell death. Together these results suggest distinct 
requirements for Rbbp4 in neural stem cell proliferation and neural progenitor survival. 
Overall, our results indicate RBBP4 may drive RB-defective brain tumor growth by 
promoting proliferation and preventing DNA damage induced apoptosis of tumor cells. 
Introduction 
Chromatin modification is an important and diverse mechanism employed by the 
cell to control gene expression beyond the level of the basal transcriptional machinery. 
Chromatin is comprised of an octamer of histones, two each of H2A, H2B, H3 and H4, 
encompassed by 146 bp of DNA which together make up the nucleosome. Densely 
packed heterochromatin is generally associate with decreased gene expression, while 
open euchromatin is associated with increased gene expression. Several modifications to 
the N- or C-terminal tails of histones are known such as alterations such as adenylation, 
acetylation, methylation, phosphorylation, and ubituitylation. There is a wide array of 
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chromatin modifying complexes that are responsible for generating and reading these 
modifications (reviewed in (Clapier and Cairns, 2009)).  While the role of chromatin 
modification and epigenetic regulation is well understood in a developmental paradigm, 
how these mechanisms are altered in transformed cells and promote tumorigenesis is less 
well understood. 
The zebrafish embryo, with its transparency and rapid development, and large 
numbers, makes an excellent model to study neurogenesis (reviewed in (Schmidt et al., 
2013)).  As such the development of the central nervous system (CNS) of the zebrafish 
has been well defined. The CNS is specified as early as the 16-cell stage in which four 
blastomeres are generated that will eventually give rise to the entire nervous system. 
During gastrulation, the neural plate or neural ectoderm is specified and then undergoes 
neurulation to form a solid neural keel unique among zebrafish. Neurogenesis begins 
shortly after gastrulation and the early embryonic phase of zebrafish development is 
defined by rapid proliferation and neurogenesis leading to the appearance of distinct brain 
and retina structures by 2 days post fertilization (dpf). Indeed by 2 dpf zebrafish embryos 
are already able to move and respond to stimuli. The next larval stage of development is 
marked by a decrease in proliferative activity and the increased neural specification and 
formation of specific brain structures and retinal layers. The retina starts as an optic cup 
containing a pseudostratified epithelium. At 24 hpf a wave of neurogenesis originating at 
nasal retina progresses to the temporal retina such that by 60 hours post fertilization (hpf) 
all retinal cell types are specified. By adulthood, zebrafish contain neurogenic regions 
along the entire A-P axis and in fact parts of the brain and retina can regenerate (Kizil et 
al., 2012) (Than-Trong and Bally-Cuif, 2015).  
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Neurogenesis begins with stem cells located at specific niches in the brain and 
retina which give rise to proliferative progenitors that generate an expanded progenitor 
pool. This pool of progenitors is maintained by lateral inhibition through Notch/Delta 
(Appel et al., 2001). The process of becoming a neuron starts with the expression of 
proneural transcription factors, such as acscl1a, neurog1, and neuroD, which promote 
progressive steps of specification and commitment in progenitor cells toward a neural 
fate. This culminates in final cell cycle exit and the process of differentiation whereby the 
cell adopts the morphology and function of the cell type it has been specified to become. 
Concomitant with this process of specification is the migration of progenitor cells away 
from neurogenic niches in both the brain and retina, usually along the processes of radial 
glia, to their final specified location in the brain or retina (Wullimann and Puelles, 1999) 
(Mueller and Wullimann, 2003).  
RBBP4 (RB Binding Protein 4), along with its homolog RBBP7 (RB Binding 
Protein 7) (Qian and Lee, 1995), is highly conserved in organisms ranging from plants to 
invertebrates to mammals (Ach et al., 1997) (Guitton and Berger, 2005) (Souza et al., 
2002) (Wen et al., 2012). Structurally RBBP4 is a WD40 domain protein exhibiting a 7 
blade β-propeller structure. While it does not have any enzymatic activity, RBBP4 binds 
with histone H4 (and NuRD complex member MTA1) through a binding pocket on the 
side of the β-propeller and histone H3 (and transcriptional regulator FOG1) through a 
binding pocket on the top of the β-propeller (Song et al., 2008; Torrado et al., 2017) 
(Nowak et al., 2011a) (Zhang et al., 2013) (Lejon et al., 2011). RBBP4 was first 
discovered as a binding partner of the tumor suppressor RB1 in yeast (Qian et al., 1993). 
RBBP4 is a component of several major chromatin modifying complexes, and it is 
129 
 
thought that the main functionality of RBBP4 is through providing specificity and 
stability of these complexes to chromatin.  
Included among these are the co-repressor complexes NuRD (Xue et al., 1998) 
(Zhang et al., 1999) and SIN3 (Vermaak et al., 1999) which repress gene expression via 
de-acetylation by HDAC1 and HDAC2. The NuRD complex also remodels chromatin 
through chromodomain ATP dependent helicase CHD4 and is involved in DNA damage 
repair, stem cell biology, and development (Basta and Rauchman, 2015; Denslow and 
Wade, 2007; O'Shaughnessy and Hendrich, 2013). Additionally, RBBP4 is a component 
of PRC2 which is involved in gene silencing through H3 lysine 27 di- and tri-methylation 
(H3K27me2/3) via Ezh1 or Ezh2 (Kuzmichev et al., 2002) (Vaute et al., 2002) 
(Margueron et al., 2008). In addition to its role in repressive complexes, RBBP4 is also a 
member of CAF-1 (Tyler et al., 1996) (Verreault et al., 1996) and CBP/p300 (Zhang et 
al., 2000) which are involved in nucleosome assembly after replication and 
transcriptional co-activation respectively. Finally, RBBP4 is plays a role in the DREAM 
complex which controls cell cycle and entry into quiescence (Litovchick et al., 2007).  
Early work in C. elegans revealed that the RBBP4 homolog lin-53 is ubiquitously 
expressed during embryogenesis, loss of lin-53 is embryonic lethal, and it is required to 
negatively regulate the expression of genes involved in vulval induction (Lu and Horvitz, 
1998). Additionally, studies in planarians have shown that the RBBP4 homolog 
DjRbAp48 is expressed in neoblasts and is required for functional regeneration after 
wounding in the adult (Bonuccelli et al., 2010). While these limited studies suggests a 
definite role for RBBP4 in development, many recent studies have also implicated 
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RBBP4 in the progression of tumorigenesis as well as the response of transformed cells 
to different cancer treatments (Zheng et al., 2013) (Wu et al., 2017) (Kitange et al., 2016).  
We recently found that Rbbp4 is upregulated in a zebrafish model of rb1-
primitive neuroectodermal brain tumors and showed that Rbbp4 is required for neural 
precursor survival during neural development (Schultz et al., 2017, Submitted). Here we 
examine the expression of Rbbp4 in neural cells in the developing zebrafish brain and 
retina and provide a molecular characterization of the mutant phenotype. Our results 
show that Rbbp4 is expressed in the brain and retina of embryonic and larval zebrafish. 
Histological analysis reveals this cause of this gross phenotype to be the apoptosis of 
neural precursors in the dorsal midbrain and retina prior to differentiation. Additional 
experiments indicate the accumulation of DNA damage and a tp53-dependent apoptotic 
response leading to tissue loss in the absence of Rbbp4. 
Results 
Rbbp4 is expressed throughout the zebrafish embryonic brain 
In order to elucidate the role of RBBP4 in zebrafish neural development, we first 
characterized its expression in the wildtype embryonic midbrain and retina. 
Immunolocalization with an antibody against Rbbp4 was used to label sectioned 
zebrafish heads. We examined heads at 2 days post fertilization (dpf) during rapid 
proliferation and differentiation as well at the post-embryonic stage at 5 dpf. Western blot 
on whole protein extract from 5 dpf larvae showed a single band of approximately 47 
kDa, confirming the specificity of the antibody in zebrafish (Supplemental Figure 
S4.1A). 
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At 2 dpf the zebrafish midbrain consists of a highly proliferative dorsal optic 
tectum and a ventral region, both of which contain proliferating cells lining the ventricles 
juxtaposed by regions of neural specification and differentiation (Mueller and 
Wullimann, 2003). Immunolabeling revealed Rbbp4 is present in the nuclei throughout 
all cells of the midbrain and retina (Figure 4.1A’,B’,C’). Furthermore, Rbbp4 co-labeling 
with PCNA, an S-phase marker of proliferating cells, was observed at the brain ventricle 
and CMZ of the retina (Figure 4.1A,A’’,B,B’’,C,C’’).  These results indicate that at this 
stage RBBP4 is expressed in both proliferating precursor and stem cells and early-
differentiated neural cells.  
Rbbp4 expression levels vary in stem cells, precursors and neurons in the larval 
midbrain 
After the transition from embryonic to larval neurogenesis, growth in the brain 
becomes asymmetric (Mueller and Wullimann, 2003) (Stigloher et al., 2008). By 5 dpf 
regions of proliferation are confined to the stem cell niches at the ventricles and the 
medial tectal proliferative zone in the brain (Figure 4.2A-C’’’) and the ciliary marginal 
zone (CMZ) in the retina (Figure 4.2D-E’’’) (Wullimann and Puelles, 1999) (Schmitt and 
Dowling, 1999). At this stage the level of Rbbp44 in the midbrain begins to vary in 
intensity in the proliferative zones which contain stem and progenitor cells. Specifically, 
there appears to be a decrease in the level of Rbbp4 in cells in the stem cell niches in the 
brain and retina, and varying levels in nuclei of post-mitotic neurons. In the medial tectal 
proliferative zone in PCNA+ cells Rbbp4 expression is absent or very faint (Figure 4.2B-
B’’’ outlined area).  At the midbrain ventricles in the tectum and dorsal thalamus, 
expression is greatly reduced or completely absent in most cells (Figure 4.2C-C’’’  
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Figure 4.1  Rbbp4 is ubiquitously expressed in the embryonic zebrafish brain and retina. 
(A-A’’’) Representative transverse cryosection (n=3) through the 2 dpf 
wildtype zebrafish midbrain labeled with antibodies to Rbbp4 (green), 
proliferation maker PCNA (red), nuclear stain DAPI (blue). Boxes outline the 
ventricle at the top of the thalamus in the midbrain (B) and the ciliary 
marginal zone (CMZ) of the retina (C). (B-B’’’) Higher magnification view of 
the midbrain ventricle at the thalamus. (C-C’’’) Higher magnification view of 
the ciliary marginal zone of the retina (C-C’’’). Scale bars: 100 um (A-A’’’), 
20 µm (B-C’’’). 
 
outlined area). However, there are a few cells in which co-labeling with Rbbp4 and 
PCNA does occur (Figure 4.2B-B’’’, C-C’’’ arrows). Lateral to the proliferative zones in 
the optic tectum and the thalamus in the regions containing post-mitotic neurons, Rbbp4 
expression is relatively ubiquitous though present at varying levels (Figure 4.2A-A’’’).   
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Figure 4.2  Rbbp4 expression levels vary in neural precursors and neurons in the larval 
zebrafish brain and retina. Representative transverse cryosection (n=3) of 5 
dpf wildtype zebrafish midbrain (A-A’’’) and retina (D-D’’’) labeled with 
antibodies to Rbbp4 (green), proliferation maker PCNA (red), nuclear stain 
DAPI (blue). Higher magnification view of the medial tectal proliferative 
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(Figure 4.2 continued) zone (B-B’’’), brain ventricle (C-C’’’), ciliary marginal 
zone (E-E’’’), and central laminated layers of the retina (F-F’’’). The highly 
proliferative, PCNA+ population of cells are outlined; arrows indicate cell co-
labeled with Rbbp4 and PCNA. GCL, ganglion cell layer; INL, inner nuclear 
layer; ONL, outer nuclear layer. Scale bars: 100 µm (A-A’’’) (D-D’’’), 10 µm 
(B-B’’’) (C-C’’’) (E-E’’’) (F-F’’’).  
 
In the retina at 5 dpf the proliferative CMZ containing stem and progenitor cells, 
like the proliferative regions of the midbrain, shows a reduction in the level of Rbbp4 
compared to the more mature regions of the inner retina (Figure 4.2D-D’’’,E-E’’’ 
outlined area). Expression in the ganglion cell layer (GCL) is similar to post-mitotic 
regions of the midbrain with ubiquitous expression at varying intensities (Figure 4.2F-
F’’’). On the vitreal side of the inner nuclear layer (INL) where the cell bodies of 
amacrine cells and Mueller glia are located, high level expression is seen in all cells, 
while expression is seen only in a subpopulation of cells in the portion of the INL 
containing the bipolar cells (Figure 4.2F-F’’’). In the outer nuclear layer (ONL) a low 
level of Rbbp4 is detected in the photoreceptor cells (Figure 4.2F-F’’’).  In summary, 
during the developmentally active and dynamic period at 2 dpf, Rbbp4 is expressed 
ubiquitously in the stem, precursor, and newly born neural cells in the midbrain and 
retina. However, by 5 dpf Rbbp4 expression is enriched in neurons in post-mitotic 
regions of the brain and retina, while the level of RBBP4 is reduced in proliferative 
regions containing stem and progenitor cells. These results suggest Rbbp4 is required in 
post-mitotic or newly differentiated cells in the zebrafish brain and retina. 
Rbbp4 is essential for development of brain and neural crest derived structures 
Previously we isolated a 4 base pair frameshift deletion rbbp4Δ4is60 allele using 
CRISPR/Cas9 targeting and demonstrated the requirement for Rbbp4 in normal neural 
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development (Schultz et al., 2018, Submitted). Homozygous rbbp4Δ4/Δ4 larvae display 
defects in cellular texture in the midbrain that can be observed at 2 dpf under a 
stereomicroscope (data not shown). By 4-5 dpf, rbbp4Δ4/Δ4 homozygotes show gross 
neural developmental defects including microcephaly and microphthalmia as compared 
to wildtype (Figure 4.3A,B). Western Blot analysis and Rbbp4 immunolabeling on 5 dpf 
embryos confirmed that the rbbp4Δ4/Δ4 mutants lack Rbbp4 protein (Supplemental Figure 
S4.1A,B,C). Additional characterization of the gross rbbp4Δ4/Δ4 mutant phenotype by 
alcian blue staining revealed several abnormalities formation of cartilage structures in the 
head. This included abnormal positioning of the ceratohyal cartilage (Figure 4.3C-F), 
compression of the ceratobranchial cartilage (Figure 4.3E,F), and shrinkage of the 
Meckel’s cartilage (Figure 4.3E,F). These results indicate that RBBP4 is essential for 
proper development of the central nervous system. 
We performed overexpression rescue experiments to confirm that the observed 
rbbp4Δ4/Δ4 mutant phenotype is due to lack of functional Rbbp4. A Tol2<ubi:rbbp4-2A-
GFPpA> transposon construct was built containing the zebrafish ubiquitin promoter 
(Mosimann et al., 2011) cloned in front of the full length rbbp4 cDNA, followed by the 
viral 2A peptide and the green fluorescent protein (GFP) cDNA (Figure 4.3G). 
Transgenics were isolated by Tol2 transposase-mediated transgenesis and a single copy 
insertion line Tg(Tol2<ubi:rbbp4-2A-GFPpA>)is61 was established. rbbp4Δ4/Δ4 embryos 
containing the Tg(Tol2<ubi:rbbp4-2A-GFPpA>) transgene as indicated by the ubiquitous 
expression of GFP were viable through larval stages and showed a rescue in gross mutant 
morphology. Comparisons of eye width (Figure 4.3A, white arrow) and midbrain height 
(Figure 4.3A, black arrow) were performed between wildtype and rbbp4Δ4/Δ4 embryos at 5  
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Figure 4.3  rbbp4 cDNA rescue of rbbp4Δ4/Δ4 homozygotes demonstrates requirement for 
Rbbp4 in brain and neural crest development. (A) Lateral view of 5 dpf 
wildtype zebrafish indicating location of measurements for brain height (black 
arrow) and eye width (white arrow). (B) Lateral view of 5 dpf rbbp4Δ4/Δ4 
homozygote showing gross defects including microcephaly and 
microphthalmia. Lateral view of 5 dpf wildtype (C) and rbbp4Δ4/Δ4 
homozygous (D) larval stained with alcian blue to reveal cartilage structures. 
(E) Ventral view of wildtype and (F) rbbp4Δ4/Δ4 homozygote stained with 
alcian blue. (G) Schematic of Tol2<ubi:rbbp4-2A-eGFP> cDNA rescue 
construct driving expression of rbbp4-2A-eGFP by the ubiquitin promoter. 
(H) 5 dpf transgenic Tg(Tol2<ubi:rbbp4-2A-eGFP>)  and (I) 5 dpf transgenic 
rbbp4Δ4/Δ4 ; Tg(Tol2<ubi:rbbp4-2A-eGFP>) larva showing ubiquitous GFP 
expression. Ubiquitous expression of rbbp4 rescues the rbbp4Δ4/Δ4 
homozygous mutant phenotype. (J) Measurement of brain height in non-
transgenic (GFP-) and transgenic (GFP+) +/+ and rbbp4Δ4/Δ4 siblings. Non-
transgenic rbbp4Δ4/Δ4, GFP- homozygotes (n=6) have a significantly smaller 
head height compared to wildtype (n=3) (p=0.0015). Comparison of +/+ 
GFP+ (n=4) and transgenic rbbp4Δ4/Δ4 GFP+ (n=4) shows no significant 
difference in head height (p=0.4595). (K) Measurement of eye width in non-
transgenic (GFP-) and transgenic (GFP+) +/+ and rbbp4Δ4/Δ4 siblings. Non-
transgenic rbbp4Δ4/Δ4 GFP- homozygotes (n=8) have a significantly smaller 
eye width compared to wildtype (n=5) (p=0.0001). Comparison of +/+ GFP+ 
(n=8) and rbbp4Δ4/Δ4 GFP+ (n=5) shows no significant difference in eye size 
(p=0.6293). Graphs plot measurement in individual larvae with mean ± s.e.m. 
p values were calculated with one-tailed Student’s t-test. ch, ceratohyal 
cartilage; m, Meckel’s cartilage; cbs, ceratobranchial cartilage. Scale bars: 100 
µm.  
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dpf (Figure 4.3H,I). The homozygous embryos lacking the overexpression transgene 
show a statistically significant decrease in the size of both the eye and brain (Figure 
4.3A,B,J,K). However, homozygotes containing the overexpression transgene showed no 
significant difference in the size of the eye or height of the midbrain in comparison to 
wildtype (Figure 4.3H-K, Supplemental Figure S4.2).  Tg(Tol2<ubi:rbbp4- 2A-GFPpA>) 
containing animals displayed no defects in growth, viability, or fertility (Supplemental 
Table S4.1). Furthermore, rbbp4Δ4/Δ4; Tg(Tol2<ubi:rbbp4-2A-GFPpA>) individuals are 
viable and fertile into adulthood. These results indicate that the observed defects in neural 
development are caused by a loss of Rbbp4. 
Loss of Rbbp4 leads to stem cell hypertrophy and disrupts midbrain and retina 
development 
We next examined homozygous rbbp4Δ4/Δ4 mutants for the effect of loss of Rbbp4 
on neural cell populations in the developing brain and eye. 5 dpf larvae were labeled with 
antibodies to stem/progenitor cell marker Sox2 and the proliferating cell marker PCNA. 
In the wildtype brain Sox2-positive cells are found lining the ventricle and scattered 
through the dorsal tectum and may represent a stem and/or progenitor cells (Figure 
4.4A,C). Intense PCNA labeling is apparent at the ventricle and in cells in the dorsal 
medial tectal proliferative zone where the proliferating stem and progenitors are located 
(Figure 4.4A,C). In the midbrain the rbbp4Δ4/Δ4 mutant shows a dramatic reduction in the 
size of the optic tectum on the dorsal side while the ventral portion of the brain remains 
relatively normal (Figure 4.4A-D, brackets). The PCNA-positive proliferative progenitor 
cells in the dorsal medial tectal proliferative zone are missing (Figure 4.4C,D). With the 
exception of the specific population of cells comprising the subcommissural organ, the  
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Figure 4.4  Neurogenesis is disrupted in the midbrain tectum and retina in rbbp4Δ4/Δ4 
mutant larvae. (A-H) Transverse sections of midbrain and retina from wild 
type +/+ (n=5) and homozygous mutant rbbp4Δ4/Δ4 (n=4) 5 dpf zebrafish 
larvae labeled with antibodies to proliferative marker PCNA (red) and  
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(Figure 4.4 continued) stem/progenitor marker Sox2 (green) and the nuclear 
stain DAPI (blue). (A, C) In wildtype PCNA and Sox2-positive stem cells line 
the midbrain ventricle (A, C dashed outline). Sox2-positive progenitors lie 
adjacent to the ventricle in the tectum (C bracket). (B, D) PCNA and Sox2-
positive cells with enlarged morphology line the midbrain ventricles in 
rbbp4Δ4/Δ4 mutant (B, D outline). The dorsal tectum is significantly reduced in 
height in the rbbp4Δ4/Δ4 mutant (D bracket). (E, G) In wild type retina PCNA-
positive stem cells are restricted to the outer edge of the ciliary marginal zone 
(G outline). Sox2-positive amacrine and displaced amacrine cells are 
distributed throughout the inner nuclear and ganglion cell layers. (F, H) 
PCNA-positive stem cells with enlarged, hypertrophic morphology are present 
at the ciliary marginal zone in rbbp4Δ4/Δ4 mutant retina (F, H outline). Arrow 
shows missing tissue adjacent to the ciliary marginal zone. Sox2-positive cells 
representing early born amacrine cells are present in the retinal layers. (I-P) 
Transverse section of midbrain and retina from wild type +/+ (n=3) and 
rbbp4Δ4/Δ4 homozygous (n=3) labeled with antibodies to glial markers Gfap 
(red) and Blbp (green) and nuclear stain DAPI (blue). (I, K) In wild type 
midbrain Blbp and Gfap label radial glia cell bodies and projections in the 
tectum (K bracket) and thalamic regions, respectively. (J, L) The rbbp4Δ4/Δ4 
mutant midbrain contains mature radial glia in the thalamic region (J). Intense 
Blbp labeling is present where hypertrophic stem cells are located at the 
ventricle (L bracket). (M, O) Blbp and Gfap label Mueller glia cells bodies 
and projections across the inner plexiform layer of the wild type retina. (N, P) 
Early born radial glia can be detected with Blbp and Gfap in the rbbp4Δ4/Δ4 
mutant retina. (Q-X) Transverse section of midbrain and retina from wild type 
+/+ (n=3) and rbbp4Δ4/Δ4 mutant (n=3) 5 dpf larvae labeled with antibodies to 
the synaptic vesicle marker Sv2 (red) and interneuron and ganglion cell 
marker Calretinin (green) and the nuclear stain DAPI (blue). (Q, S) Sv2 labels 
the neuropil of wild type brain and Calretinin labels the cell bodies of a subset 
of mature neurons in the thalamus and tectum (S bracket). (R, T) The 
rbbp4Δ4/Δ4 mutant shows a reduction in the tectal neuropil and number of 
Calretinin-positive neurons (T bracket). (U, W) Sv2 and Calretinin labeling 
reveal lamination of the wild type retina. (V, X) Early born neurons maintain 
Calretinin labeling and Sv2 labeled projections across the inner and outer 
plexiform layers in the rbbp4Δ4/Δ4 mutant retina. Scale bars: 50 µm (A, B, E, 
F, I, J, M, N, Q, R, U, V); 20 µm (C, D, G, H, K, L, O, P, S, T, W, X). 
 
Sox2 expressing cells are also absent from the dorsal midbrain in the rbbp4Δ4/Δ4 mutant 
(Figure 4.4C,D). PCNA/Sox2-positive cells remained present in the stem cell niche lining 
the brain ventricle of the rbbp4Δ4/Δ4 mutant, however they appeared hypertrophic (Figure 
4.4D, outlined).   
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The wildtype retina consists of the CMZ containing proliferative stem cells 
(Figure 4.4E,G, outlined). This niche gives rise to the cells that eventually mature and 
populate the ordered layers of the laminated central retina consisting. In the retina of the 
rbbp4Δ4/Δ4 mutants some lamination is still present in the central retina though overall the 
retina is reduced in size (Figure 4.4F,N,V). Similar to the brain, the PCNA/Sox2-positive 
presumed stem cells at the CMZ of the retina are present and again show an enlarged 
hypertrophic morphology (Figure 4.4H, outlined). Adjacent to the CMZ at the site of 
neurogenesis and progenitor cell commitment and differentiation there is an obvious area 
of missing tissue (Figure 4.4H, arrows).   
We next examined whether the loss of RBBP4 affected neuronal and glial 
populations. In wildtype brain Blbp and Gfap are expressed in radial glial cells along the 
ventricle of the dorsal midbrain (Figure 4.4I,K) and in Müeller glia extending from the 
ganglion cell layer (GCL) to the inner nuclear layer (INL) in the retina (Figure 4.4M,O). 
Gfap labels glial processes in the ventral midbrain (Figure 4.4I) and emanating from the 
GCL in the retina (Figure 4.4M,O). In the rbbp4Δ4/Δ4 mutants there is continued Blbp and 
Gfap labeling in the brain and retina (Figure 4.4J,L,N,P). However, the Blbp labeling in 
particular appears decreased in areas where there is a dramatic loss of tissue such as the 
dorsal midbrain and under-developed central retina (Figure 4.4L,P). Antibody labeling 
with the synaptic vesicle marker SV2 and neuronal calcium binding protein Calretinin 
was performed to examine populations of mature neuronal cells and grey matter. In 
wildtype Sv2 labels the acellular regions of the peripheral midbrain (Figure 4.4Q) and the 
plexiform layers of the retina (Figure 4.4U). Calretinin labels cells in the brain at the 
peripheral regions away from the ventricles (Figure 4.4Q,S) and cell bodies and processes 
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in the GCL, IPL, and INL of the retina (Figure 4.4U,W). In the rbbp4Δ4/Δ4 mutant where 
mature tissue is still present in the midbrain and central retina Calretinin and Sv2 labeling 
is still apparent (Figure 4.4R,T,V,X). The fact that the ventral midbrain and central retina 
in the rbbp4Δ4/Δ4 mutants appear somewhat normal may be due to the presence of 
maternal rbbp4 RNA. This early and temporary rbbp4 expression may protect the earliest 
born progenitors and neurons in the eye and brain, allowing them to migrate to their final 
location where they undergo normal differentiation. Together, the above results indicate 
that Rbbp4 is not required for survival of stem cells or differentiated neurons and glial 
cells. However, Rbbp4 is necessary for survival of neural precursors that become the 
mature glia and neurons in the growing brain and retina during development. This defect 
in neural precursor survival accounts for the observed microcephaly and microphthalmia 
seen in the rbbp4Δ4/Δ4 mutant. 
Loss of Rbbp4 leads to neural precursor arrest and apoptosis at the terminal cell 
division 
Examination of rbbp4Δ4/Δ4 mutants with stem/progenitor, neural, and glial 
markers suggested that the defect in dorsal brain and retina development is due to the loss 
of neural precursors in the absence of Rbbp4. To explore the timing of rbbp4 mutant 
neural precursor loss, we examined expression of markers of progressive neural cell fate 
commitment in the post-embryonic zebrafish retina. Neurogenesis in the zebrafish retina 
is spatially organized such that specific neural cell populations can be finely resolved into 
distinct regions. Stem cells are located at the ciliary marginal zone (CMZ) at the 
periphery while mature glia and neurons are located inwards towards the central part of 
the retina (Mosimann et al., 2011). Retinal neurogenesis has been described as a 
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conveyor belt in which cells generated at the CMZ undergo progressive steps of 
differentiation as they migrate inward toward the central retina (Cerveny et al., 2012) 
(Devès and Bourrat, 2012).   
We first used BrdU labeling to examine the fate of newborn cells at the CMZ in 
the rbbp4Δ4/Δ4 mutants. At 2 pdf embryos were exposed to a 3 hour BrdU pulse and 
collected immediately or chased in embryo media until 3 dpf and 5 dpf. Immediately 
following the pulse, in 2 dpf wildtype embryos BrdU labeling is present in cells at the 
CMZ and in the inner nuclear layer and photoreceptor layer of the retina (Figure 4.5A). 
In the 2dpf rbbp4Δ4/Δ4 mutant retina BrdU labeling at the cmz region appears similar to 
wildtype, but the inner nuclear layer appears slightly disorganized (Figure 4.5B). At 3 dpf 
in the wildtype retina the classic conveyor belt pattern of neurogenesis is observed. BrdU 
labeling is no longer detected in cells at the CMZ as BrdU positive cells generated during 
the pulse at 2 dpf have migrated away from the CMZ with the newest cells born post-
labeling filling in behind them (Figure 4.5C, outline). In the rbbp4Δ4/Δ4 mutants at 3 dpf, 
cells in the CMZ are no longer labeled, and a small population of BrdU-positive cells can 
be detected adjacent to the cmz migrating away from the periphery (Figure 4.5D, 
outline). This limited population of BrdU positive cells at 3 dpf could indicate that the 
stem cells are continuing to divide but at a reduced rate. At 5 dpf in the wildtype retina 
the conveyor belt pattern of movement is again seen as BrdU positive cells have migrated 
even further toward the central retina leaving stem cells and newly born unlabeled cells at 
the peripheral most CMZ (Figure 4.5E, outline). In the rbbp4Δ4/Δ4 mutant by 5 dpf the 
population of BrdU labeled cells appears to be almost completely gone (Figure 4.5F) 
suggesting that the progeny of the stem cells, either committed progenitors or newborn  
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Figure 4.5  BrdU pulse-chase labeling to examine the fate of newborn neurons in the 
rbbp4Δ4/Δ4 mutant retina. (A, B) 2 dpf zebrafish embryos treated with a 2.5 
hour BrdU pulse and immediately sacrificed. Transverse sections of retina 
from wildtype (n=4) and rbbp4Δ4/Δ4 mutants (n=5) were labeled with 
antibodies to BrdU and mitotic marker phosphohistoneH3 (pH3). BrdU labels 
proliferating cells at the retina ciliary marginal zone and cells scattered 
throughout the laminating retina. (C,D) Pulse-chased larvae at 3 dpf. In 
wildtype retina (n=8) BrdU labeled cells are located in the region adjacent to 
the cmz where neural precursors and newly differentiated neurons reside (C 
outline). A small section of BrdU labeled cells remains at the ciliary marginal 
zone in the rbbp4Δ4/Δ4 mutant retina (n=6) (D outline). (E,F) Pulse-chased 
larvae at 5 dpf. In wildtype (n=7) the BrdU labeled cells are now more 
centrally located in an older region of the growing retina (E outline). 
rbbp4Δ4/Δ4 mutant retina (n=7) older born neurons in the central retina 
maintain BrdU labeling, however, BrdU-labeled newborn neurons are absent. 
BrdU-negative stem cells persist at the ciliary marginal zone in the rbbp4Δ4/Δ4 
mutant (F arrow). Scale bars: 50 µm. 
 
neurons, failed to survive after leaving the CMZ. The population of stem cells at the 
CMZ however remains intact (Figure 4.5F, arrow). The BrdU labeled cells in the central 
part of the mutant retinas are most likely rod progenitors derived from early born Mueller 
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glia in the INL (Figure 4.5F). Together, these results suggest that in the absence of Rbbp4 
neural stem cells continue to cycle, but at a slower rate than in wildtype.  Progenitors or 
newborn neurons fails to survive, possibly due to an inability to commit to or initiate 
neuronal differentiation. 
In order to identify the stage at which retinal neural precursors die in the 
rbbp4Δ4/Δ4 mutant we performed in situ hybridization with markers that distinguish retinal 
progenitors progressively more committed toward a neuronal cell fate. In the wildtype 
CMZ at 3 dpf, the peripheral-most cells label with the stem cell marker mz98 (Pujic et al., 
2006) (Figure 4.6A, arrow). The next population of cells are the ccnD1-expressing 
proliferating progenitors (Das et al., 2009) (Figure 4.6B, bracket). Following these are the 
ath5-expressing neural precursors committed to neural cell fate (Masai et al., 2000) 
(Poggi et al., 2005) (Figure 4.6C, bracket). Finally are the cdkn1-expressing cells which 
have exited the cell cycle, arrested in G1 and are in the process of transitioning to a 
differentiated cell (Ohnuma et al., 1999) (Shkumatava and Neumann, 2005)  (Figure 
4.6D, arrow). In the rbbp4Δ4/Δ4 mutant retina mz98-expressing stem cells are restricted to 
a small population at the edge of the CMZ (Figure 4.6E, arrow). The population of 
ccnd1- and ath5-expressing cells appears expanded in the mutant (Figure 4.6F,G 
brackets). Finally, whereas there is a clear population of cdkn1c-expressing cells in the 
wildtype retina, this population of cells is absent in the rbbp4Δ4/Δ4 mutant retina (Figure 
4.6H, arrow).  These results suggest Rbbp4 is necessary for neural precursor committed 
cells to complete terminal cell division and exit the cell cycle in G1. The failure of ath5-
expressing cells to differentiate likely underlies neural precursor cell death and the 
observed tissue loss in the retina of the rbbp4Δ4/Δ4 mutant.  
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Figure 4.6  Neural precursors fail to differentiate in the rbbp4Δ4/Δ4 homozygous mutant 
retina. Transverse sections of 3 dpf zebrafish retina labeled by in situ 
hybridization to examine expression of the stem cell marker mz98 (A, E 
arrows), proliferating progenitor marker ccnD1 (B,F brackets), committed 
progenitor marker ath5 (C,D brackets) and differentiating precursor marker 
cdkn1c (D,H arrows). (A-D) Wildtype retina (n=5) shows location of 
progressively committed precursor cell populations extending away from the 
stem cells at the ciliary marginal zone. In the rbbp4Δ4/Δ4 homozygous mutant 
retina (n=3) the proliferating and committed neural progenitor cell 
populations are expanded compared to wildtype. Expression of the 
differentiating neural precursor marker cdkn1c is absent in the rbbp4Δ4/Δ4 
mutant retina (H arrow). Scale bars: 50 µm. 
 
Rbbp4 is required to prevents apoptosis and persistent DNA damage in neural 
precursor cells  
To determine if Rbbp4 is required to prevent programmed cell death in neural 
precursors we examined apoptosis in the rbbp4Δ4/Δ4 mutant using an antibody to activated 
Caspase-3. At 2 dpf in the wildtype dorsal midbrain and retina there is almost a complete 
absence of Caspase-3 labeling (Figure 4.7A). At 2 dpf in the rbbp4Δ4/Δ4 mutant there is 
extensive Caspase-3 labeling in the dorsal midbrain and retina (Figure 4.7B). At 3 dpf 
there is a limited amount of random Caspase-3 labeling in the midbrain and retina (Figure  
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Figure 4.7. Neural precursor apoptosis underlies defects in rbbp4Δ4/Δ4 midbrain and retina 
neurogenesis. Transverse sections of zebrafish midbrain and retina labeled 
with antibodies to the neural marker HuC/D (red), apoptosis marker activated 
Caspase-3 (green), and nuclear label DAPI (blue). (A, C) Few activated 
Caspase-3 labeled cells are detected in wildtype at 2 dpf (n=4) and 3 dpf 
(n=3). (B, D) Extensive activated-Caspase-3 labeling is present throughout the 
midbrain tectum and retina in the rbbp4Δ4/Δ4 mutant at 2 dpf (n=7) and 3 dpf 
(n=5). E, F Counts of activated Caspase-3 positive cells plotted for individual 
larva show a significant difference between wildtype and rbbp4Δ4/Δ4 mutant at 
2 dpf in the midbrain (E, p=0.0022) and in the retina (F, p=0.0010). At 3 dpf 
the difference is no longer significant in the midbrain (E, p=0.2569) and only 
slightly significant in the retina (F, p=0.0358), due to loss of cells by       
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(Figure 4.7 continued) apoptosis. Graphs plot counts in individual larvae with 
mean ± s.e.m. p values were calculated with one-tailed Student’s t-test.  (G,H) 
Higher magnification view of nuclear morphology shows extensive nuclear 
fragmentation and pyknosis in the rbbp4Δ4/Δ4 mutant 2dpf retina (H). Scale 
bars: 100 µm (A, B, C, D); 10 µm (G,H). 
 
4.7C). At 3 dpf in the in the rbbp4Δ4/Δ4 mutant, as the rate of proliferation in the brain and 
retina slows, the amount of apoptosis also appears to progressively decrease (Figure 
4.7D). Counts of Caspase-3 positive cells in the midbrain and retina confirm a 
statistically significant increase in apoptotic cells at 2 dpf in the rbbp4Δ4/Δ4 mutant 
compared to wildtype (Figure 4.7E,F). A significant increase in apoptotic cells was also 
observed at 3 dpf  in the retina with a trending increase at 3 dpf in the midbrain (Figure 
4.7E,F). Furthermore, the location of the activated Caspase-3 labeling at 2 and 3 dpf is 
restricted to the regions of the midbrain and retina which normally contain actively 
dividing progenitors (Figure 4.7B,D). Neuronal HuC/D labeling did not overlap with 
activated Caspase-3, again suggesting the affected cells are neural progenitors or 
newborn neurons rather than differentiated neurons (Figure 4.7B,D; Supplemental Figure 
S4.3).  Apoptosis was also apparent in the presence of DAPI-labeled nuclei undergoing 
pyknosis and fragmentation which is completely absent from the wildtype (Figure 
4.7G,H). Together these results suggest that in rbbp4 mutant, neural precursors undergo 
apoptosis before initiating the process of differentiation, and is the likely cause of the 
observed rbbp4Δ4/Δ4 mutant phenotype in which loss of cells in the dorsal midbrain and 
retina leads to microphthalmia and microcephaly.  
 To begin to elucidate the underlying cause of neural precursor apoptosis in the 
rbbp4Δ4/Δ4 mutant midbrain and retina, we examined 2 and 3 dpf zebrafish larvae for the 
accumulation of DNA damage. DNA damage was detected with an antibody to γ-H2AX, 
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which recognizes phosphorylated histone H2AX that forms at DNA double strand breaks 
(DSB) and more broadly labels damaged chromatin in nuclei in apoptotic cells (Burma et 
al., 2001). Similar to activated Capsase-3 labeling, there is little γ-H2AX labeling in the 
wildtype midbrain or retina at 2 dpf (Figure 4.8A). In the rbbp4Δ4/Δ4 mutant at 2 dpf there 
is an increase in γ-H2AX labeling (Figure 4.8B). Again, while little to no γ-H2AX 
labeling is seen in the wildtype at 3 dpf (Figure 4.8C), in the rbbp4Δ4/Δ4 mutant at 3 dpf 
there is an increase in labeling (Figure 4.8D). This observation of increased γ-H2AX 
labeling and therefore DNA damage response is confirmed by counts of γ-H2AX positive 
cells which are significantly higher in the rbbp4Δ4/Δ4 mutant than wildtype at 2 dpf in the 
midbrain and retina and trending higher in the mutant as compared to wildtype at 3 dpf in 
the midbrain and retina (Figure 4.8E,F). Of note is the observation that the location of γ-
H2AX staining roughly approximates that of the Caspase-3 labeling, indicating the same 
cells that are showing signs of DNA damage are also undergoing apoptosis. 
Interestingly, the pattern of γ-H2AX staining varied in the rbbp4Δ4/Δ4 mutant cells. 
In some cells it resembled the dotted foci pattern of DSB labeling in the nucleus (Figure 
4.8H, dotted arrow), while in others it appeared as a defined ring around the nucleus 
(Figure 4.8H, open arrow) or was overall pan-nuclear (Figure 4.8H, closed arrow). The 
majority of γ-H2AX labeled cells showed rings or pan-nuclear pattern and contained 
small fragmented nuclei characteristic of cells actively undergoing apoptosis (Figure 
4.8H). The varied patterns of γ-H2AX observed in rbbp4Δ4/Δ4 mutant may capture 
multiple steps in DNA damage induced programmed cell death. Nuclear foci may 
represent labeling at DSB to induce the initial DNA damage response, while pan-nuclear 
labeling occurs in cells during the process of nuclear fragmentation and apoptosis.  
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Figure 4.8  γ-H2AX labeling reveals persistent DNA damage in rbbp4Δ4/Δ4 mutant neural 
precursors. (A-D) Transverse sections of zebrafish midbrain and retina labeled 
with an antibody to the DNA damage marker γ-H2AX (green) and nuclear 
label DAPI (blue). (A, C) Few γ-H2AX labeled cells are present in wildtype 
midbrain or retina at 2 dpf (n=3) and 3 dpf (n=3). (B, D) In the rbbp4Δ4/Δ4 
mutants (n=3) at 2 dpf a significantly greater number of cells with γ-H2AX 
labeling was present in the brain (E, p=0.0008) and retina (F, p=0.0032). By 3 
dpf (n=3) the number was not significantly different than in wildtype 
(midbrain E, p=0.1211; retina F, p=0.0537), due to loss of cells by apoptosis. 
Graphs plot counts in individual larvae with mean ± s.e.m. p values were 
calculated with one-tailed Student’s t-test.  (G,H) Higher magnification view 
of nuclear morphology and γ-H2AX labeling in the rbbp4Δ4/Δ4 mutant 2dpf 
retina (H). Closed arrow shows pannuclear staining; open arrow shows 
nuclear ring staining; dotted arrow shows foci pattern of staining. Scale bars: 
100 µm (A, B, C, D); 10 µm (G, H). 
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Alternatively, this labeling may represent an alternative pathway to apoptosis rather than 
a DNA damage response. 
Apoptosis due to loss of Rbbp4 is dependent on the Tp53 pathway 
We next wanted to investigate the mechanism of apoptosis occurring in the 
rbbp4Δ4/Δ4 mutant midbrain and retina. To address this question we injected tp53 
antisense morpholino into the rbbp4Δ4/Δ4 mutant to suppress tp53 function. The tp53 
morpholino had little to no effect on the wildtype midbrain or retina at any age as seen by 
counts of activated Caspase-3 labeled cells (Figure 4.9A,B,E,F,I,J). Where there is a 
statistical difference between injected and un-injected wildtype at 2 dpf in the midbrain 
and 3 dpf in the retina appears to be an artifact of low overall count numbers and 
comparison to 0. At 2 dpf injection of the tp53 morpholino into the rbbp4Δ4/Δ4 mutant led 
to a near complete and statistically significant suppression of activated Caspase-3 
labeling, and thus apoptosis, in the midbrain and retina (Figure 4.9C,D,I,J). At 3 dpf 
injection of the tp53 morpholino into the rbbp4Δ4/Δ4 mutant caused a trending and 
significant decrease in Caspase-3 labeling in the midbrain and retina respectively (Figure 
4.9G,H,I,J). The fact that the inhibition of Caspase-3 labeling is attenuated by 3 dpf is 
most likely do to the fact that the antisense morpholino does not persist and suppression 
of tp53 is not maintained passed 2 or 3 dpf. Overall, these results indicate that loss of 
Rbbp4 leads to apoptosis that is dependent on the activation of a Tp53-dependent 
pathway. 
 We next tested the effect of knockdown of tp53 expression on γ-H2AX labeling 
in the wildtype and rbbp4Δ4/Δ4 mutant. tp53 knockdown had no effect on γ-H2AX 
labeling in the wildtype midbrain or retina at 2 or 3 dpf (Figure 4.9K,L,O,P,S,T).  
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Figure 4.9  Tp53-dependent activation of DNA damage response and apoptosis in 
rbbp4Δ4/Δ4 mutant neural precursors. 2 dpf and 3 dpf wildtype and rbbp4Δ4/Δ4 
larval midbrain sections after tp53 antisense morpholino knockdown. 
Uninjected siblings were used as a control. (A-H) Activated Caspase-3  
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(Figure 4.9 continued) (green), HuC/D (red) and DAPI (blue) labeling at 2 dpf 
(A-D) and 3 dpf (E-H). (I) Counts of Caspase-3 positive cells in the midbrain 
were compared between un-injected and p53 MO injected wildtype at 2 dpf 
(un-injected n=4; p53 MO injected n=4; one-tailed p-value=0.017), rbbp4Δ4/Δ4 
homozygotes at 2 dpf (un-injected n=2; p53 MO injected n=4; one-tailed p-
value=0.0112), wildtype at 3 dpf (un-injected n=3; p53 MO injected n=3; one-
tailed p-value=0.3349), and rbbp4Δ4/Δ4 homozygotes at 3 dpf (un-injected n=4; 
p53 MO injected n=6; one-tailed p-value=0.1736). (J) Counts of Caspase-3 
positive cells in the retina were compared between un-injected and p53 MO 
injected wildtype at 2 dpf (un-injected n=4; p53 MO injected n=4; one-tailed 
p-value=0), rbbp4Δ4/Δ4 homozygotes at 2 dpf (un-injected n=2; p53 MO 
injected n=4; one-tailed p-value=0.0032), wildtype at 3 dpf (un-injected n=3; 
p53 MO injected n=3; one-tailed p-value=0.0285), and rbbp4Δ4/Δ4 
homozygotes at 3 dpf (un-injected n=4; p53 MO injected n=6; one-tailed p-
value=0.0037). (K-R) γ-H2AX labeling (green), and nuclear stain DAPI (blue) 
at 2 dpf (K-N) and 3 dpf (O-R). (S) Counts of γ-H2AX positive cells in the 
midbrain were compared between un-injected and p53 MO injected wildtype 
at 2 dpf (un-injected n=4; p53 MO injected n=3; one-tailed p-value=0.2344), 
rbbp4Δ4/Δ4 homozygotes at 2 dpf (un-injected n=2; p53 MO injected n=4; one-
tailed p-value=0.0024), wildtype at 3 dpf (un-injected n=3; p53 MO injected 
n=5; one-tailed p-value=0.1101), and rbbp4Δ4/Δ4 homozygotes at 3 dpf (un-
injected n=6; p53 MO injected n=10; one-tailed p-value=0.0657). (T) Counts 
of γ-H2AX positive cells in the retina were compared between un-injected and 
p53 MO injected wildtype at 2 dpf (un-injected n=4; p53 MO injected n=3; 
one-tailed p-value=0), rbbp4Δ4/Δ4 homozygotes at 2 dpf (un-injected n=2; p53 
MO injected n=4; one-tailed p-value=0.0001), wildtype at 3 dpf (un-injected 
n=3; p53 MO injected n=5; one-tailed p-value=0.5784), and rbbp4Δ4/Δ4 
homozygotes at 3 dpf (un-injected n=6; p53 MO injected n=10; one-tailed p-
value=0.0128). Scale bars: 100 µm. 
 
However, at 2 dpf and 3 dpf there is a significant decrease in the number of γ-H2AX 
labeled cells in the morpholino injected rbbp4Δ4/Δ4 mutant retina, and a significant (2 dpf) 
and trending (3 dpf) decrease in the midbrain (Figure 4.9M,N,Q,R,S,T). Interestingly, 
phosphorylation of H2AX by ATM due to double strand breaks occurs 
independently/upstream of p53 activation. Together, our analysis shows DNA damage 
and neural precursor apoptosis in the absence of Rbbp4 is due to activation of Tp53 
dependent programmed cell death. Therefore, the fact that the γ-H2AX labeling observed 
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in the rbbp4Δ4/Δ4 mutant is dependent on tp53 expression suggests that it is a read out of 
an alternate type of DNA damage or a different physiological process altogether. 
Discussion 
In this study we characterized the expression of Rbbp4 in vivo and demonstrate its 
requirement in vertebrate neurogenesis. Results show that Rbbp4 is expressed in the 
developing zebrafish nervous system. Expression is widespread in the brain and retina at 
the early stages of embryonic development. At the later larval stages expression of Rbbp4 
becomes more restricted in the stem and progenitor populations while remaining widely 
expressed in post-mitotic and mature cells. This pattern suggests a requirement for Rbbp4 
in properly differentiated neurons.  A frameshift allele was isolated and examination of 
rbbp4Δ4/Δ4 mutants revealed distinct roles for Rbbp4 in neural stem and progenitor cells 
during larval neurogenesis. While neural stem cell survival is unaffected, an alteration in 
morphology suggests defects in cell cycle progression. Additionally, we have shown that 
Rbbp4 is required for the survival of certain populations of cells, most likely 
differentiating precursor cells in the brain and retina. Apoptosis of this population of cells 
is p53-dependent and due in part to the accumulation of DNA damage.  
An interesting finding of our experiments is the differential effect of the loss of 
Rbbp4 on stem versus progenitor or precursor cells. In particular, the survival of the stem 
cells located at the ventricles of the midbrain and the CMZ of the retina is unaffected. 
Lineage tracing with BrdU indicates that these cells are still able to progress through the 
cell cycle and divide. However, by 5 dpf the stem cells appear enlarged and abnormal in 
morphology. This enlarged morphology could represent the onset of senescence which is 
commonly characterized by cellular hypertrophy (Dulic, 2013) (Blagosklonny, 2006). 
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Other research has shown that knockdown of Rbbp4 in vitro leads to induced cellular 
senescence which the authors argue is caused by impaired nuclear transport efficiency 
(Tsujii et al., 2015). Additional experiments in vitro have shown that high levels of 
Rbbp4 are associated with increased pluripotency (O'Connor et al., 2011). These 
observations are consistent with our results suggesting that Rbbp4 is necessary to 
maintain a normal rate division and function in neural stem cells. Rbbp4 is known to be a 
component of the DREAM complex, specifically as a part of the MuvB core complex, 
which has been shown to regulate progression through the cell cycle (Sadasivam et al., 
2012).  Findings in C. elegans have shown that the MuvB complex and Rbbp4 is required 
for progression through the cell cycle, specifically from G1 through S phase, and without 
it cells become prematurely senescent. It is possible that the fact that the stem cells in the 
rbbp4Δ4/Δ4 mutant continue to cycle, although at a slower rate, is due to remaining 
maternal rbbp4. Examination of these cells at later time points is necessary to determine 
the exact nature of the cell cycle defects. Further experiments such as β-galactose 
labeling and testing for increased expression of cyclin-dependent kinase inhibitors could 
be performed to confirm whether or not the stem cells in the rbbp4Δ4/Δ4 mutants are in 
fact in senescence. 
A major finding of our experiments is the extensive, p53-dependent apoptosis that 
occurs in the progenitor populations of the brain and retina in the absence of Rbbp4. 
While there are many possible causes of the observed apoptosis, DNA damage is highly 
likely to be one of the main causes as is evident by the presence of γ-H2AX labeling.  Of 
note is our observation of several different patterns of γ-H2AX labeling in addition to the 
classical foci present at the sites of DSB (Burma et al., 2001). There is a growing body of 
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evidence suggesting that γ-H2AX labeling can represent more than just foci labeling 
DSBs. Specifically, pan-nuclear (Fragkos et al., 2009) (Ding et al., 2016) (Meyer et al., 
2013) and nuclear ring labeling patterns (Solier and Pommier, 2009) (Solier and 
Pommier, 2014), and even in some cases the classis focal labeling pattern that don’t co-
label with 53bp1 (de Feraudy et al., 2010), may label early apoptotic events subsequent to 
the initial DSB induced DDR. Several different mechanisms have been proposed for this 
altered γ-H2AX labeling including ring like labeling that occurs in response to extrinsic 
TRAIL induce apoptotic stimuli (Wang and El-Deiry, 2003), JNK1-mediated 
phosphorylation of tyrosine 142 of H2AX (Cook et al., 2009), and phosphorylation of 
H2AX by ATM/DNAPK in early apoptosis that is required to completely fragment DNA 
during apoptosis preventing tumorigenesis and autoimmune responses (Rogakou et al., 
2000) (Mukherjee et al., 2006) (Lu et al., 2006). Therefore, the fact that we observed 
multiple patterns of γ-H2AX labeling could represent a snapshot of cells at different 
temporal stages of apoptosis, ranging from initial DNA damage to early apoptosis when 
chromatin begins to fragment. Additionally, the fact that γ-H2AX labeling is dependent 
on p53 highly suggests that in this instance it is not indicative of early labeling of DSBs 
which is upstream and independent of p53 activation. Labeling experiments with Rad51 
or other markers specific to DSBs could be performed to confirm these observations. 
Similar p53-dependent γ-H2AX pannuclear labeling has also been observed in human 
peripheral blood lymphocytes after X-ray irradiation (Ding et al., 2016). The atypical γ-
H2AX labeling pattern in rbbp4Δ4/Δ4 mutants could be a result of accumulation of 
extensive, persistent DNA damage leading to the bypassing of the usual attempts to repair 
the DNA and instead activation of p53-induced apoptosis.  
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There are several ways in which the loss of Rbbp4 could lead to defects in DNA 
integrity and in the DDR. Specifically, Rbbp4 is a member of the CAF-1 complex which 
functions to maintain genome integrity during replication (Tyler et al., 1996) (Verreault 
et al., 1996). Studies have found that RBBP4, likely through this association with the 
CAF-1 complex, is necessary to prevent unequal segregation in anaphase (Hayashi et al., 
2004) or accumulation of mitotic defects in vitro (Satrimafitrah et al., 2016). In addition 
to genome integrity, Rbbp4 likely plays a role in the DNA damage response through its 
association with CBP/p300 (Zhang et al., 2000). A recent study revealed that in cultured 
Glioblastoma Multiforme cells Rbbp4 associates with CBP/p300 to acetylate and activate 
the promoters of DNA damage response genes such as MGMT and Rad51 in response to 
treatment with temozolomide (Kitange et al., 2016). Further testing for the presence of 
abnormal spindle formation by labeling with alpha-tubulin could be performed to confirm 
the presence of genome instability.   
In addition to DNA damage, another possible cause of apoptosis in precursor cells 
could be a failure to initiate quiescence and expression of neural differentiation program 
as Rbbp4 is associated with several complexes involved in proper differentiation such as 
the NuRD and PRC2 complexes. One of the few other in vivo studies of Rbbp4 to date 
has been performed in planarians.  Results from these experiments demonstrated that the 
loss of Rbbp4 prevents regeneration and led to apoptosis in neoblast progeny, possibly 
due to a failure of these cells to commit or differentiate (Bonuccelli et al., 2010).  Our in 
situ results suggest that in the retina of the rbbp4Δ4/Δ4 mutant there is an expanded 
population of ath5 expressing cells and a loss of cdkn1c expressing cells. Previous studies 
of the flotte lotte/Elys mutant in zebrafish have shown neural precursors that fail to exit 
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the cell cycle undergo apoptosis in the zebrafish retina (Cerveny et al., 2010). However, 
unlike the flotte lotte/Elys mutant, the rbbp4Δ4/Δ4 mutant retina still contain ath5 
expressing cells at the CMZ but lack cdkn1c expressing cells which have exited the cell 
cycle.  As ath5 is associated with the terminal cell division (Masai et al., 2000), this could 
indicate that the defects in the rbbp4Δ4/Δ4 mutants are specific to differentiation and not 
cell cycle exit. Additionally, this defect may not be intrinsic; rather the lack of proper 
environmental signals from the missing adjacent cdkn1c expressing cells could contribute 
to the failure of committed ath5 progenitors to exit the cell cycle (Mu et al., 2005) 
(Cerveny et al., 2010) (Neumann and Nuesslein-Volhard, 2000). This would lead to 
observed expansion of the ath5-positive cell population in the rbbp4 homozygous retina. 
As the use of morpholinos provides a transient suppression of gene expression, the 
generation of an rbbp4; tp53 double mutant would prevent apoptosis and allow us to 
examine the fate of rbbp4 mutant precursors in the absence of tp53 activated programmed 
cell death and test their ability to differentiate. 
Our results indicate that mature neurons and glia are largely unaffected by the loss 
of Rbbp4, suggesting it does not play a major role in the maintenance of differentiation 
status. However, Rbbp4 is associated with several chromatin remodeling complexes, 
many of which function to maintain epigenetic marks on chromatin in differentiated cells. 
It is conceivable that if we were able to follow the mutant cells past 5 dpf with the use of 
conditional knockouts we may see an effect on maintenance of differentiation. For 
instance, a study of the Arabidopsis homolog AtMSI1 revealed a progressive de-
differentiation phenotype in primary shoot apical meristem that is likely due to loss of 
epigenetic repression of developmental gene programs (Hennig et al., 2003). 
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  Rbbp4 has been implicated in the pathogenesis of numerous different cancers 
including brain cancers such as medulloblastoma, glioma and Glioblastoma Multiforme 
(Pauty et al., 2017) (Kong et al., 2007) (Pacifico et al., 2007) (Wu et al., 2017) (Gao et 
al., 2017) (Vavougios et al., 2015) (Li et al., 2015a) (Song et al., 2004) (Haskins et al., 
2012) (Lohavanichbutr et al., 2009) (Leivo et al., 2005) (Bai et al., 2015) (Casas et al., 
2003) (Bunt et al., 2013). Our own previous studies identified Rbbp4 as being 
upregulated in zebrafish primitive neuroectodermal-like tumors resulting from somatic 
inactivation of rb1 (Solin et al., 2015) [Schultz et al., submitted]. Studies have shown that 
expression of Rbbp4 is specifically induced in fibroblasts by the binding of deregulated 
E2F to GC repeats in its promoter (Kitamura et al., 2015). These results provide a 
possible explanation as to how Rbbp4 becomes overexpressed in rb1-deficient tumors. 
How dysregulated Rbbp4 contributes to tumorigenesis remains to be fully elucidated, 
which complexes mediate its activity in oncogenesis in neural cancer cells. Our data 
suggests it is likely that Rbbp4 plays an important role in several of the fundamental 
processes that are altered in cancer such as genome maintenance and differentiation 
status. It is possible to imagine how altered Rbbp4 along with further accumulation of 
mutations, such as in the tp53 apoptotic pathway, could lead to cells in which DNA 
damage or an undifferentiated state is tolerated, resulting in cellular transformation. 
Future studies focusing on the role of Rbbp4 specifically in stem and progenitor cells are 
necessary and can be achieved using conditional alleles generated with targeted gene 
editing [Wierson et al., in preparation]. As recent studies have shown that WD40 repeat 
proteins, such as Rbbp4, may make druggable targets for novel cancer treatments and our 
results suggest that inhibiting Rbbp4 may lead to apoptosis in tumor cells, this gene 
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product represents a valuable target for future work in the development of cancer 
treatments. 
Materials and Methods 
Zebrafish care and husbandry 
Zebrafish were reared in an Aquatic Habitat system (Aquatic Ecosystems, Inc., 
Apopka, FL). Fish were maintained on a 14-hr light/dark cycle at 27°C. Transgenic lines 
were established in a WIK wild type strain obtained from the Zebrafish International 
Research Center (http://zebrafish.org/zirc/home/guide.php). The zebrafish rbbp4Δ4is60 4 
bp deletion mutant was isolated by CRISPR/Cas9 mutagenesis as previously described 
(Schultz et al., under review.) For in situ hybridization and immunohistochemistry 
experiments, embryos were collected and maintained at 28.5°C in fish water (60.5 mg 
ocean salts/l) until harvesting. Embryos were staged according to published guidelines 
(Kimmel et al., 1995). All experimental protocols were approved by the Iowa State 
University Institutional Animal Care and Use Committee (Log # 11-06-6252-I) and are in 
compliance with American Veterinary Medical Association and the National Institutes of 
Health guidelines for the humane use of laboratory animals in research.  
rbbp4 genotyping and isolation of transgenic line Tg(Tol2<Ubi:rbbp4-2AGFP>)is61 
Primers to amplify rbbp4 exon 2 containing the rbbp4Δ4is60 mutation: Forward 5′ 
GCGTGATGACAGATCTCATATTGTTTTCCC 3′; Reverse 5′ 
CTGGTGACATCTGGCAACCACT 3′. The Tol2<ubi:rbbp4-2AGFP> transgene was 
assembled in the mini-pTol2 vector (Balciunas et al., 2006) by cloning the zebrafish 
ubiquitin promoter (Mosimann et al., 2011) followed by an in-frame 2A viral peptide 
GFP cassette (Trichas et al., 2008) and the zebrafish β-actin 3’UTR (Dr. Darius 
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Balciunas, Temple University; (McGrail et al., 2011)). 1g of linearized pT3TS-Tol2 
transposase plasmid (Balciunas et al., 2006) was used as template for in vitro synthesis of 
Tol2 transposase capped, polyadenylated mRNA with T3 mMessage mMachine High 
Yield Capped RNA transcription kit (Ambion AM1348). Synthesized mRNA was 
precipitated with LiCl and resuspended in RNase, DNase-free molecular grade water. 
The Tg(Tol2<ubi:rbbp4-2AGFP>)is61 transgenic line was isolated by co-injection into 1-
cell WIK zebrafish embryos of 25pg Tol2 vector plus 100pg Tol2 mRNA. 14 founder fish 
were screened for germline transmission of ubiquitously expressed GFP. A single F1 
adult that showed Mendelian transmission of the Tol2<ubi:rbbp4-2AGFP> transgene to 
the F2 generation was used to establish the line. 
Immunohistochemistry  
For immunohistochemistry, embryonic (2 dpf) or larval (3-5 dpf) zebrafish were 
anesthetized in MS-222 Tricaine Methanesulfonate and head and trunk dissected. Trunk 
tissue was placed in 20µl 50mM NaOH for genotyping. Heads were fixed in 4% 
paraformaldehyde overnight at 4°C, incubated in 30% sucrose overnight at 4°C, then 
processed and embedded in Tissue-Tek OCT (Fisher 4583). Tissues were sectioned at 14-
16 µm on a Microm HM 550 cryostat. For BrdU labeling experiments, 2 dpf embryos 
were incubated in 5 µM BrdU (Sigma catalog #B5002) in embryo media (Westerfield, 
1995) for 2.5 hours, placed in fresh fish water, then sacrificed immediately or at 3 dpf 
and 5 dpf. Primary antibodies used for labeling : rabbit polyclonal anti-RB Binding 
Protein 4 RBBP4 1:200 (Bethyl; A301-206A-T); rabbit polyclonal anti-SOX2 1:200 
(EMD Millipore; AB5603); mouse monoclonal anti-proliferating cell nuclear antigen 
PCNA 1:300 (Sigma; P8825); mouse monoclonal anti-glial fibrillary acid protein GFAP 
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1∶1000 obtained from the Zebrafish International Research Center (ZIRC; zrf-1); rabbit 
polyclone anti-phospho-histone H3 PH3 1:1000 (Cell Signaling Technology; 9701); 
rabbit polyclonal anti-Brain Lipid Binding Protein BLBP 1∶200 (Abcam; ab32423); 
mouse monoclonal anti-hu antigen D HUC/D 1:500 (Invitrogen; A-21271); rabbit 
polyclonal anti-gamma H2A histone family, member X γ-H2AX 1:200 (GeneTex; 
GTX127342); rabbit polyclonal anti-CASPASE-3 1:500 (BD Biosciences; 559565); 
mouse monoclonal anti-SV2 1∶100 (Developmental Studies Hybridoma Bank; 
AB_2315387); rabbit polyclonal anti-CALRETININ 1:1000 (Millipore; AB5054); anti-
BrdU 1∶500 (Bio-Rad; MCA2483). Alexa-594 (Invitrogen; A-11005) and Alexa-488 
(Invitrogen; A-11008) conjugated secondary antibodies were used at a dilution of 1:500. 
Tissues were counterstained with 5 µg/ml DAPI and mounted in Fluoro-Gel II containing 
DAPI (Electron Microscopy Sciences 17985-50). To aid antigen retrieval before BrdU 
labeling tissues were pretreated with 2 M HCl. Sections were imaged on a Zeiss LSM700 
laser scanning confocal microscope and assembled in Adobe Photoshop CC. 
in situ hybridization and alcian blue staining 
cDNA was amplified by reverse transcription-polymerase chain reaction out of 
total RNA isolated from wild-type 5 day post-fertilization embryos and cloned into the 
pCR4-TOPO vector (Invitrogen). Primers for amplification were as follows: mz98 
forward 5′CCGGACACTACACACTCAATGC3′, mz98 reverse 
5′GTGCTGGATGTAGCTGTTCTCG3′; ccnD1 forward 
5′GCGAAGTGGATACCATAAGAAGAGC3′, ccnD1 reverse 
5′GCTCTGATGTATAGGCAGTTTGG3′; ath5 forward 
5′GATTCCAGAGACCCGGAGAAG3′, ath5 reverse 
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5′CAGAGGCTTTCGTAGTGGTAGGAG3′; cdkn1c forward 
5′CGTGGACGTATCAAGCAATCTGG3′, cdkn1c reverse 
5’GTCTGTAATTTGCGGCGTGC3′. Digoxigenin-labeled probes for in situ 
hybridization were synthesized using T3 RNA polymerase (Roche #11031163001) and 
DIG RNA labeling mix (Roche #11277073910) according to the manufacturer’s 
instructions and stored in 50% formamide at −20°C. Embryonic and larval zebrafish 
tissues were fixed in 4% paraformaldehyde and embedded in Tissue-Tek OCT (Fisher 
4583). in situ hybridization on 14–16 μm cryosections of head tissue was performed as 
described (Trimarchi et al., 2007). For alcian blue staining of cartilage, zebrafish larvae 
were anesthetized and fixed in 4% paraformaldehyde overnight at 4°C and incubated in 
0.1% alcian blue solution overnight at 4°C. Embryos were rinsed in acidic ethanol and 
stored in 70% glycerol. Whole larvae and tissue sections were imaged on a Zeiss 
Discovery.V12 stereomicroscope or Zeiss Axioskop 2 microscope, respectively, and 
photographed with a Nikon Rebel camera. 
Western blotting 
Whole protein extract was generated by dounce homogenization of ~70 5 dpf 
embryos in 200 uL Cell Extraction Buffer (ThermoFisher catalog # FNN0011). Lysates 
were run on a NuPAGE™ 12% Bis-Tris Protein Gel (Invitrogen catalog # NP0342BOX) 
and blotted onto PVDF membrane (BioRAD catalog # 1620177). After blocking, 
membranes were incubated in either rabbit polyclonal anti-RB Binding Protein 4 RBBP4 
(Bethyl A301-206A-T) at 1:800 or mouse monoclonal anti-β-actin (Sigma catalog 
#A2228) at 1:5000 overnight at 4°C. Membranes were incubated in Anti-Rabbit IgG 
F(ab′)2-Alkaline Phosphatase (Sigma catalog #SAB3700833) or Anti-Mouse IgG 
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F(ab′)2-Alkaline Phosphatase (Sigma catalog #SAB3700994) at 1:500 for one hour at 
room temperature. Membranes were developed with CSPD (Roche catalog 
#11655884001) and imaged on a BioRAD Molecular Imager ChemiDoc XRS System. 
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Supplemental Figure S4.1  Absence of Rbbp4 protein in rbbp4Δ4/Δ4 homozygous mutant 
larvae at 5dpf. A Western blot of whole protein lysate from 
wildtype +/+ and homozygous mutant rbbp4Δ4/Δ4 5 dpf larvae  
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(Supplemental Figure S4.1 continued) probed with a rabbit 
polyclonal anti-Rbbp4 antibody. The antibody recognizes a 
single polypeptide band of ~50kDA, close to the Rbbp4 
predicted size of 48kDa. The band is absent from the 
rbbp4Δ4/Δ4 mutant protein extract. Lower panel, loading 
control blot probed with mouse monoclonal antibody β-actin 
shows similar levels in wildtype and rbbp4Δ4/Δ4 mutant 
extracts. (B, C) Immunolabeling with Rbbp4 and proliferative 
marker PCNA antibodies on transverse sections through the 
head of 5 dpf wildtype (B) and rbbp4Δ4/Δ4 homozygous mutant 
(C) zebrafish larvae. Confocal images for each larva were 
captured at approximately the same gain settings, with a 
slightly higher gain setting for the homozygote, to confirm the 
absence of Rbbp4 signal. Images were adjusted equally for 
brightness in Photoshop. In wildtype brain (B) high levels of 
Rbbp4 are present in the nucleus of neurons in the tectum and 
thalamic regions. In the rbbp4Δ4/Δ4 homozygote (C) Rbbp4 
levels are nearly absent. Scale bars: 50 µm. 
 
 
 
 
Supplemental Figure S4.2  Genotype confirmation of rbbp4Δ4/Δ4 ; Tg(Tol2<ubi:rbbp4-
2A-GFP>) rescue experiment presented in Figure 3. rbbp4 
genotyping primers amplify a 196 bp amplicon surrounding 
the 4 bp deletion mutation in exon 2. The rbbp4Δ4 allele 
overlaps a SmlI restriction enzyme site. SmlI digestion of wild 
type (WT) DNA generates 150 and 46 bp fragments, while the 
rbbp4Δ4 DNA is resistant to digestion. After imaging, the 
larvae shown in Figure 3A, B, H, I were lysed in 50mM 
NaOH to release genomic DNA used as template for 
genotyping. The digested bands in lanes 2 and 6 confirm the  
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(Supplemental Figure S4.2 continued) GFP+ animals in 
Figure 3A and 3H are wild type +/+, while the resistant bands 
in lanes 4 and 8 confirm the GFP+ animals in Figure 3B and 
3I are homozygous for the rbbp4Δ4 allele. U, un-digested; D, 
digested. 
 
 
Supplemental Figure S4.3  Caspase-3 labeled rbbp4Δ4/Δ4 mutant retinal cells undergoing 
apoptosis do not express the neuronal marker HuC/D. (A-H) 
Transverse sections of 3 dpf zebrafish retinas labeled with 
antibodies to the apoptosis marker activated caspase-3 (green), 
neuronal marker HuC/D (red), and nuclear stain DAPI (blue). 
A-D In wildtype HuC/D is detected in neuron cell bodies in 
the inner nuclear layer and photoreceptor layers of the retina. 
E-H In the rbbp4Δ4/Δ4 homozygous retina cells expressing 
activated caspase-3 do not co-label with HuC/D. Arrow points 
to an activated caspase-3-negativ/HuC/D-positive cell 
surrounded by activated caspase-3-positive/HuC/D-negative 
cells. Scale bars: 100 µm. 
 
Supplemental Table S4.1  Frequency of progeny genotypes and phenotypes from 
heterozygous rbbpΔ4/+ crossed to heterozygous 
rbbpΔ4/+;Tg(Tol2<ubi:rbbp4-2A-GFP>) zebrafish. Three 
independent crosses were set up between female rbbpΔ4/+ 
heterozygotes and male rbbpΔ4/+;Tg(Tol2<ubi:rbbp4-2A-
GFP>) transgenic heterozygotes. Embryo clutches were sorted 
for the presence or absence of GFP expression at 2 dpf, and  
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(Supplemental Table S4.1 continued) phenotype and genotyped 
at 5 dpf. “Total” column shows approximately 50% GFP- and 
GFP+ in each clutch, indicating the Tg(Tol2<ubi:rbbp4-2A-
GFP>) line contains a single transgene insertion. Scoring of 
GFP negative embryos revealed close to Mendelian 
segregation of the rbbpΔ4/Δ4 gross mutant phenotype in one 
quarter of the progeny (28.2%, 21.3%, 29%). A random 
sampling of embryos from clutches 2 and 3 were genotyped 
and confirmed Mendelian segregation of the phenotype with 
the rbbpΔ4 allele. In each clutch, none of the GFP positive 
embryos showed the rbbp4 mutant phenotype. Random 
sampling and genotyping confirmed ~ one quarter of the 
morphologically normal GFP+ larvae were homozygous 
mutant rbbpΔ4/Δ4 (32.4%, 20.8%, 20.8%). 
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CHAPTER 5.  CONCLUSION 
 
Summary 
In the first paper of this dissertation, an adult zebrafish retinal tumor model was 
used to examine the different signaling pathways involved in promoting and maintaining 
excessive proliferation in non-malignant, glial-originating tumors. The dysplastic tumors 
analyzed showed sustained proliferation in cell populations that are not normally 
proliferative. Furthermore, transcriptome analysis of tumor samples indicate that hypoxia 
inducible factor HIF-1α and its downstream targets angiogenic growth factor VEGF and 
the cytokine Leptin are upregulated in the tumor. These results were confirmed with in 
situ analysis which further showed that vegfab appears to be upregulated in neuronal cells 
while lepb expression is upregulated in glial cells suggesting a cell specific response to 
HIF-1α signaling. Additionally, mTOR signaling was found to upregulated in the tumor, 
an observation confirmed by immunolabeling of tumor samples, indicating a possible 
mechanism in which overproliferation is sustained once initiated by other signaling 
pathways. Overall, this study is a good example of two of the hallmarks of cancer, 
namely the ability to evade growth suppression and sustain proliferative signaling. 
Furthermore, this is an excellent example of how normal developmental paradigms can 
become re-activated and dysregulated in tumorigenesis. Specifically, adult zebrafish 
retain populations of glia that can de-differentiate and re-program giving rise to 
proliferative progenitors in response to injury. We propose a mechanism whereby 
sustained signaling due to hypoxia and chronic inflammation drive transformation of 
glial-derived progenitors leading to un-regulated proliferation and tumor growth. This 
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work is important in highlighting the way different signaling pathways when 
dysregulated can converge to drive the transformation of normal cells.  
 With the growing appreciation of the role of pRB a multifunctional regulatory 
protein rather than just cell cycle gatekeeper, the second paper of this dissertation 
examines the role of pRB in chromatin modification through interaction with different 
chromatin associated proteins. Transcriptome analysis of poorly differentiated brain 
tumors generated by somatic inactivation of rb1 demonstrates that these tumors display a 
similar expression signature as human oligoneural CNS-PNET subgroup in which olig2, 
sox10, sox8, sox2 and erbb3a were upregulated. In order to better understand how loss of 
pRB drives tumorigenesis in the zebrafish brain, we generated a germline rb1-/-  mutant 
allele to compare phenotype and transcriptome signatures that define transformed vs. 
mutant tissue. The rb1 mutant embryos display ectopic proliferation in the brain and 
retina at 5 dpf but are otherwise largely normal indicating that certain cells in the mutant 
can re-enter the cell cycle and proceed into M phase but lack continuous unregulated 
proliferation characteristic of rb1-transformed tumor cells. Transcriptome analysis of 
rb1-/- mutant embryo heads showed similar upregulation of pathways controlling cell 
division, mitosis, and DNA replication as would be expected upon upregulation of E2F. 
However, the tumor transcriptome showed more transcriptional regulators were 
dysregulated (1191) than were in the mutant (125). Additionally, the expression of 
several stem and neural progenitor transcription factors were upregulated and several 
proneurogenic transcription factors were downregulated in the tumor but not the mutant 
transcriptomes. We specifically analyzed the role of two genes in particular that were 
found to be dysregulated in the tumor and are known to interact with pRB, rbbp4 and 
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hdac1. Both genes are involved in chromatin remodeling and thus may provide insights 
into how epigenetic dysregulation may lead to transformation. Histological analysis of 
rbbp4-/- and hdac1-/- mutant embryos suggest rbbp4 is required for neural progenitor 
survival while hdac1 is required for maintaining proliferation of the neural stem cell pool. 
In addition to identifying underlying chromatin modifying mechanisms that may be 
driving transformation, another important output of this study is the generation of 
CRISPR/Cas9 somatic mutagenesis coupled with histone-GFP live imaging to rapidly 
and effectively screen potential pRB interacting genes driving tumor formation. 
 Finally, the third paper in this dissertation contains an in-depth examination of the 
mutant phenotype associated with loss of rbbp4 in zebrafish embryos. Results show that 
loss of rbbp4 causes microcephaly, microphthalmia, and cartilage defects of the jaw 
visible by 5 dpf and eventually leading to lethality at ~9 dpf. Histological examination of 
rbbp4-/- mutant embryos revealed severe loss of tissue in the dorsal midbrain and retina 
by 5 dpf. Immunolabeling at 2 and 3 dpf confirms that the loss of tissue is due to 
apoptosis in regions of progenitor/precursor cells in the retina and midbrain. Additional 
in situ and immunolabeling suggest that excessive DNA damage and failures in cell cycle 
exit/differentiation in progenitor/precursor populations are contributing factors to the 
observed apoptosis. Finally, p53 morpholino experiments confirm that the apoptosis 
observed is dependent on p53 signaling. These results are significant in that RBBP4 has 
been the subject of several studies in recent years, including many suggesting a role in 
cancer. Furthermore, this is the first study to date analyzing the loss of RBBP4 in a 
vertebrate model. Recent studies suggest WD40 domain containing proteins such as 
RBBP4 may be druggable targets for cancer therapeutics. However, given the prevalence 
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of RBBP4 in so many different regulatory complexes it is important to understand how 
its interaction with each of these complexes contributes to its function in vivo.  
 Overall, the studies presented in this dissertation help advance our knowledge of 
how the dysregulation of certain genes and pathways can contribute to the initiation of 
cellular transformation. Novel insights include discovering the over-expression of Leptin 
in a retinal tumor which is not a tissue it is normally associated with, the development of 
novel techniques that will allow for rapid screening of candidate genes contributing to 
tumor initiation, and the finding that loss of a non-enzymatic chromatin adaptor protein is 
lethal in zebrafish and thus highly important to normal neurogenesis and development. 
These studies also highlight the utility of a multi-faceted approach, both adult and 
embryonic, and the versatility of the zebrafish in modeling cancer and developmental 
defect. Finally, the hope is that these studies and the novel mechanisms they uncover will 
help lead to novel treatments and diagnoses of human tumors. 
Future Directions 
AIM 1: Clarify the role that RBBP4 plays in normal stem cell function vs. 
progenitor/precursor cell function. 
Background: Initial experiments suggest that RBBP4 plays very distinct roles in different 
populations of cells. Specifically, upon loss of RBBP4, stem cells survive but they appear 
to be enlarged and possibly display a slower rate of division. However, in precursor cells, 
the loss of RBBP4 leads to apoptosis likely due to a combination of DNA damage and 
failure of the cells to complete normal commitment, cell cycle exit, and/or differentiation. 
Question/Hypothesis: The goal of these experiments is to answer the question of how 
specifically stem and progenitor cells are affected by the loss of RBBP4. We hypothesize 
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that the enlarged stem cell morphology is indicative of induced senescence and delays in 
cell cycle. We also hypothesize that defects in proper DNA replication due to CAF-1 
dysfunction lead to replicative stress in cycling progenitor cells and DNA damage. 
Additionally, based on in situ results we hypothesize that defects in commitment/cell 
cycle exit/differentiation of progenitor cells is occurring and resulting in apoptosis.  
Experiments:  
Testing for senescence in Rbbp4-/- mutant stem cell populations. Cellular hypertrophy, 
similar to that observed in the neural stem cell populations of the Rbbp4-/- mutant 
embryo, is a classic hallmark of senescence which is the permanent and irreversible exit 
from the cell cycle usually due to cellular stress. To confirm that these cells are in fact 
senescent, tests for several signs of senescence can be performed including beta-
galactosidase staining, qPCR or immunolabeling to detect increases in the cyclin 
dependent kinase inhibitors p21 and p16, DAPI labeling to detect Senescence-associated 
heterochromatin foci, immunolabeling to detect H3K9me3 and H4K20me3. Previous 
studies have suggested that loss of RBBP4 is associated with defects in nuclear import 
leading to senescence (Tsujii et al., 2015). Therefore, to examine nuclear import 
efficiency in vivo, transgenic animals containing a NLS-GFP construct could be 
examined in a wildtype versus mutant Rbbp4-/- background. 
BrdU labeling. Initial BrdU experiments were performed in which embryos were 
incubated in BrdU for several hours and then chased in fish water for one to three days. 
The purpose of this experiment was to track the movement of newly born/labeled cells. 
However, to address the issue of whether or not there is a delay in S-phase, a different 
experiment can be performed in which embryos receive a short 15 minute pulse with 
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BrdU and then are collected at several different time points and labeled with Ph3 to 
determine the number of BrdU labeled cells that have progressed to M-phase. This 
quantification can be compared between wildtype and Rbbp4-/- mutant embryos 
beginning at 2 dpf. 
Analysis of p53/Rbbp4 double mutants. Rbbp4-/- mutant progenitor/precursor populations 
normally undergo apoptosis beginning at 2 dpf making the analysis of the defects in these 
cell populations difficult. Therefore, by examining the Rbbp4-/- mutant phenotype in a 
p53-deletion background, we can suppress apoptosis and examine the behavior of the 
progenitor/precursor cells beyond 2 dpf. Experiments to perform in the p53/Rbbp4 
double mutant would include repeating the Sox2/PCNA, Blbp/Gfap, and Sv2/Calretinin 
immunolabeling, the in situ hybridization with mz98, ccnD1, ath5, and cdkn1c, as well as 
the 2.5 hour BrdU pulse-chase experiments. The in situ hybridization experiments will 
tell us what stage in the commitment/cell cycle exit/ differentiation process the aberrant 
cells are and the immunolabeling experiments will tell us whether or not in the 
suppression of apoptosis is these cells are able to differentiate into normal glial or neural 
cells. Finally, by preventing apoptosis, we can fully track the movement of newly born 
mutant cells labeled with BrdU.  
Transplant experiments to test cell autonomy. To answer the question of whether or not 
the Rbbp4-/- mutant phenotype is cell autonomous, cells from homozygous animals 
containing the H2A-gfp transgene can be implanted into wildtype blastocysts. If the 
mutant cells still undergo apoptosis even in a wildtype background then the phenotype is 
cell autonomous and not dependent on external cues.  
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Conditional knockouts to examine spatial and temporal effects of loss of RBBP4. The 
difficulty in studying the function of a gene product with an embryonic/larval lethal 
phenotype is the inability to examine mutant cells at later time points in development or 
even in the adult. Therefore, conditional Rbbp4-/- alleles that can be inactivated by Cre 
driven by different spatial or temporal drivers will allow us to study the function of 
RBBP4 in later developmental time points or in a tissue-specific manner in the adult. 
AIM 2: Determine which interacting partners/complexes are dysregulated upon loss 
of RBBP4 and how that dysregulation contributes to the observed Rbbp4-/- mutant 
phenotype.  
Background: RBBP4 is an interacting partner of several regulatory and chromatin 
modifying, complexes such as NuRD, Sin3, RB1/E2F, CAF-1, PRC2, DREAM, and 
CBP/p300. Loss of RBBP4 in the developing zebrafish leads to failures in differentiation 
of precursor populations in the brain and retina leading to p53 dependent apoptosis. 
However, this exact phenotype is not phenocopied when components of some of its 
interacting partners are mutated. For example, inactivation of RB1 leads to ectopic 
proliferation and no apoptosis, while inactivation of HDAC1, a subunit of NuRD and 
Sin3, leads to a more severe phenotype likely resulting from a failure of stem cells to 
proliferate. Therefore, the phenotype observed when RBBP4 is inactivated is likely due 
to a combinatorial, synergistic effect of the dysregulation of several different complexes.  
Question/Hypothesis: The main question at hand is how the function of the different 
interacting complexes of RBBP4 are affected when RBBP4 is lost. The hypothesis is that 
programs of gene expression that are controlled by NuRD, PRC2, and RB1/E2F will be 
altered in the absence of RBBP4. Additionally, it is hypothesized that dysfunction of the 
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CAF-1 complex upon loss of RBBP4 will lead to genomic instability of newly 
synthesized DNA in proliferating cell populations. 
Experiments: 
Transcriptome analysis. To help elucidate the physiological processes contributing to the 
observed Rbbp4-/- mutant phenotype, transcriptome analysis on mutant tissue can be 
performed. The patterns of gene expression changes observed in the mutant can help us 
determine why certain populations of cell are undergoing apoptosis. For example, if 
genes involved in proper neuronal commitment, cell cycle exit, or differentiation are 
downregulated we can infer that defects in this process are contribution to apoptosis. 
Additionally, we can analyze which DNA damage response genes are activated as well as 
which apoptosis-related genes are altered to help clarify the triggers of the observed 
apoptosis. Because the apoptosis phenotype is most pronounced at 2-3 dpf, the heads of 2 
dpf wildtype as well as Rbbp4-/- mutant embryos would be pooled and analyzed. 
Acetylome analysis. One of the primary functions of the NuRD and Sin3 complexes is to 
deacetylate histone tails via the action of HDAC1/2. Therefore, we want to analyze 
global changes in histone acetylation patterns upon loss of RBBP4 to determine its role in 
proper histone deacetylation. ChIPSeq can be performed to obtain the gene sequences 
associated with particular histone acetylation marks in the wildtype and Rbbp4 mutant 
embryos. Specifically we would analyze H3K27 and H3K9 which are both deacetylated 
by the NuRD complex and H4K5, H4K12, and H4K16 which are deacetylated by the 
Sin3 complex. These experiments would again be performed in 2 dpf pooled embryo 
head samples from wildtype and Rbbp4-/- mutant.  
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Methylome analysis. PRC2 is known to function by controlling patterns of DNA 
methylation, especially during development. We propose to perform MBDCap-seq 
experiments (Li et al., 2015b) on 2 dpf embryo heads to analyze global changes in DNA 
methylation patterns in the wildtype vs. Rbbp4-/- mutant samples. 
ChIP-seq analysis. To determine the specific effect loss of RBBP4 has on the localization 
of RB1/E2F, ChIP-seq experiments using an antibody to different E2F proteins to 
analyze their interaction with the genome in the wildtype versus mutant embryo can be 
carried out. We will analyze pooled samples of embryonic heads at 2 dpf. To further 
analyze the role of the interaction between RB1 and RBBP4 on E2F localization, we will 
also perform these experiments in double Rb1/Rbbp4 homozygous embryonic heads at 2 
dpf.  
Analysis of chromosomal defects. CAF-1 is involved in assembly of newly synthesized 
DNA into chromatin, and therefore defects in CAF-1 function upon loss of RBBP4 could 
cause chromatin-specific defects. Experiments to test for these defects include 
immunolabeling for H3K9me3 foci which label the formation of normal heterochromatin, 
FISH (fluorescence in situ hybridization) to test for aneuploidy, and alpha-tubulin and 
gamma-tubulin immunohistochemistry to label mitotic spindles and centrosomes 
respectively. 
Analysis of replicative stress. It has been demonstrated that CAF-1 is necessary for 
efficient replication fork progression (Hoek and Stillman, 2003) and imperfect DNA 
replication can result in replicative stress and subsequent DNA damage response. 
Therefore, we want to test for the presence of replicative stress which could possibly be 
leading to DNA damage/DDR in the Rbbp4-/- mutant. Experiments to test for this would 
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include a new method known as DNA combing (Iyer and Rhind, 2017) to detect 
replication fork stall and BrdU labeling to test for delayed s-phase progression.  
Live-imaging to test for genetic interactions. Initial experiments analyzing static sections 
of tissue from double Rb1/Rbbp4 homozygous mutants revealed no alteration to either 
phenotype in the double mutant. However, real-time analysis of double homozygotes 
containing a H2A-GFP transgene may allow us to detect alterations, for example in 
timing or quantity, in the observed phenotypes in the double mutant. Therefore, we can 
analyze the double mutants in real time at 2, 3, and 5 dpf time points and look for 
changes in timing of mitoses or apoptosis.  
AIM 3: Examine the role of RBBP4 in tumorigenesis and response to therapeutics 
including DNA damaging agents.  
Background: Several studies have indicated that the expression of Rbbp4 is altered in 
different tumor types. However, whether Rbbp4 is up or down regulated depends on the 
tumor or cell type. Our analysis of poorly differentiated, PNET-like tumors caused by the 
somatic inactivation of Rb1 showed that Rbbp4 expression was increased 6-fold in the 
tumor as compared to wildtype. This increase in expression may be due to the fact that 
deregulated E2Fs have been shown to bind to the promoter of Rbbp4. Somatic 
inactivation of Rbbp4 did not lead to tumor formation in F0 animals despite the high 
efficiency of the CRISPR designed against Rbbp4. While our data shows that loss of 
Rbbp4 leads to an increase in apoptosis, and studies in tumor cell lines have shown that 
loss of Rbbp4 also leads to increased apoptosis in response to temozolomide due to the 
lack of DNA repair proteins. 
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Question/Hypothesis: The main question is how altered RBBP4 contributes to tumor 
formation and progression as well as response to therapeutic treatments. Based on our 
transcriptome analysis, we hypothesize that overexpression of RBBP4 will lead to a more 
severe phenotype in tumors formed by somatic inactivation of pRB. We also hypothesize 
that overexpression of RBBP4 will lead to a decrease in sensitivity to DNA damaging 
agents while the loss of RBBP4 will have the opposite effect. 
Experiments: 
Overexpression of RBBP4 in a tumor background. Transgenic animals have been 
generated which express RBBP4 linked to GFP with H2A. After quantification of the 
amount of overexpressed protein as compared to wildtype, these animals can then be used 
to generate Rb1 somatically inactivated tumors via the microinjection of TALENs or 
CRISPRs. Tumors can then be analyzed for changes in severity, timing, or phenotype as 
compared to the original Rb1-targeted tumors.  
Temporal-specific conditional knockout of Rbbp4. Even though somatic targeting of 
Rbbp4 did not lead to tumor formation in F0 animals, it is still worth testing whether or 
not disrupting Rbbp4 in stem and progenitor populations in the adult brain and retina will 
produce tumors. This can be achieved by constructing tamoxifen-inducible Cre drivers 
targeted to neural stem and progenitor cells and a floxed conditional Rbbp4 allele. 
Animals can then be monitored for the formation of tumors.  
Analysis of DNA damage response. To analyze response to DNA damage in the presence 
or absence of RBBP4, embryos either homozygous for the Rbbp4-/- mutant allele or 
containing the overexpression transgene, can be treated with a DNA damaging agent such 
as UV irradiation and then the subsequent DNA damage response can be evaluated. This 
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can be done with immunolabeling to DNA damage response proteins such as gamma-
H2AX or with qPCR analysis of the expression of specific DNA damage response genes. 
Finally, apoptosis can also be analyzed with the use of Caspase-3 immunolabeling.  
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